archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,2.8267e-05,0.37482,0.39329,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,4.5779e-05,0.26399,0.29881,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0017696,0.23345,0.1917,1,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0172,0.16968,0.15484,1,1
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.045233,0.15438,0.091879,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0015882,0.088582,0.13856,1,1
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,4.5779e-05,1.3473,1.2283,1,1
2,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,2.8267e-05,1.3162,1.2983,1,1
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.00010181,1.2871,1.1126,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,2.8267e-05,1.2695,1.2171,1,1
2,GO DENDRITIC CELL APOPTOTIC PROCESS,4.5779e-05,1.2502,1.1888,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,1.6059e-05,1.1976,1.1257,1,1
2,GO CHRONIC INFLAMMATORY RESPONSE,1.2035e-05,1.166,1.0039,1,1
2,GO TOLERANCE INDUCTION,8.3641e-05,1.0921,0.9378,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.1191e-05,1.0774,1.0385,1,1
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,5.6086e-05,1.0762,0.93325,1,1
2,GO HYPERSENSITIVITY,3.248e-05,1.075,1.0001,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.6689e-06,1.0566,1.023,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.4947e-05,1.0462,1.0267,1,1
2,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00015974,1.0434,1.0145,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,7.3279e-05,1.0397,0.9764,1,1
2,GO T CELL TOLERANCE INDUCTION,0.00012367,1.0309,0.94207,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,8.9843e-06,1.0303,1.0168,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.00020554,1.0295,0.86245,1,1
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,6.8565e-05,1.0293,0.91249,1,1
2,GO NEGATIVE T CELL SELECTION,4.5779e-05,1.0182,0.97037,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.9888e-05,0.99862,0.94811,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,4.8997e-05,0.99143,0.95855,1,1
2,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.00017019,0.99107,0.77769,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,5.7533e-06,0.98813,0.99596,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.1191e-05,0.98527,0.95856,1,1
2,GO DENDRITIC CELL MIGRATION,3.4805e-05,0.97983,0.86374,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,3.7287e-05,0.97669,0.89033,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.5779e-05,0.9764,0.89471,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0304e-05,0.9754,0.94601,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2939e-05,0.96391,0.87601,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,1.0403e-05,0.94512,0.87876,1,1
2,GO SYNAPSE PRUNING,3.4805e-05,0.94434,1.0171,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.8524e-05,0.93451,0.90261,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.2907e-05,0.9336,0.80445,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.8997e-05,0.93239,0.84768,1,1
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,3.0304e-05,0.93037,0.89165,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,3.9936e-05,0.92589,0.81245,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.6059e-05,0.92497,0.85597,1,1
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00013188,0.92431,0.967,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7287e-05,0.92033,0.84674,1,1
2,GO T CELL CHEMOTAXIS,3.0304e-05,0.91746,0.82836,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,2.4576e-05,0.91309,0.81386,1,1
2,GO RESPONSE TO PROTOZOAN,2.2907e-05,0.91174,0.80392,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,1.3909e-05,0.91136,0.85793,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.9095,0.86753,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,2.8267e-05,0.90882,0.85178,1,1
2,GO DENDRITIC CELL DIFFERENTIATION,3.7287e-05,0.90857,0.81405,1,1
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.7287e-05,0.90013,0.83762,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,8.9327e-05,0.89968,0.83641,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.2939e-05,0.89764,0.80491,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,2.636e-05,0.89692,0.83488,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.1191e-05,0.88948,0.88765,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,3.9936e-05,0.8884,0.89315,1,1
2,GO DETECTION OF OTHER ORGANISM,2.2907e-05,0.88355,0.81017,1,1
2,GO INTERLEUKIN 10 PRODUCTION,1.6059e-05,0.88275,0.76367,1,1
2,GO POSITIVE T CELL SELECTION,5.9985e-05,0.88118,0.77332,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,4.5779e-05,0.87903,0.79836,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.2939e-05,0.87738,0.80534,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,2.1347e-05,0.87504,0.81521,1,1
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.4576e-05,0.87226,0.84793,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,3.7287e-05,0.87117,0.76319,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.9888e-05,0.86576,0.81785,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.1347e-05,0.8647,0.81937,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.8997e-05,0.8626,0.7323,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.86101,0.80064,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,2.1347e-05,0.8599,0.82795,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.2939e-05,0.85721,0.83104,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,4.2763e-05,0.85506,0.78494,1,1
2,GO POSITIVE THYMIC T CELL SELECTION,0.00010866,0.85384,0.8319,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,2.636e-05,0.85309,0.84855,1,1
2,GO LEUKOCYTE AGGREGATION,3.248e-05,0.8515,0.88935,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,6.6813e-06,0.84808,0.84406,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.8565e-05,0.84441,0.82511,1,1
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.2428e-05,0.84301,0.73001,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,3.248e-05,0.84084,0.71004,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,1.2939e-05,0.83957,0.78879,1,1
2,GO CYTOLYSIS,3.7287e-05,0.83877,0.87952,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,1.2939e-05,0.83775,0.81036,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.4576e-05,0.83633,0.73997,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,1.2035e-05,0.83629,0.82087,1,1
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0010209,0.83371,0.71117,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.7249e-05,0.83206,0.72692,1,1
2,GO RESPONSE TO CHEMOKINE,7.7514e-06,0.83105,0.80893,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.2907e-05,0.8309,0.74977,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,5.6086e-05,0.83075,0.8456,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.9936e-05,0.82915,0.75125,1,1
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,2.8267e-05,0.82835,0.81143,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,2.636e-05,0.8282,0.86888,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.8524e-05,0.82699,0.80281,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,3.0304e-05,0.82687,0.73068,1,1
2,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,4.5779e-05,0.8252,0.83529,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.7249e-05,0.82352,0.76222,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.8524e-05,0.82258,0.80996,1,1
2,GO MONOCYTE CHEMOTAXIS,8.3461e-06,0.82228,0.85929,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,3.248e-05,0.82211,0.73301,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.8267e-05,0.82057,0.76082,1,1
2,GO CYCLOOXYGENASE PATHWAY,1.3909e-05,0.81668,0.85515,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.2939e-05,0.81658,0.82124,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,3.248e-05,0.81415,0.83447,1,1
2,GO CELLULAR DEFENSE RESPONSE,3.248e-05,0.81281,0.77619,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,2.4576e-05,0.81242,0.70661,1,1
2,GO B CELL PROLIFERATION,4.2763e-05,0.81081,0.74896,1,1
2,GO T CELL SELECTION,6.8565e-05,0.81056,0.72635,1,1
2,GO EOSINOPHIL MIGRATION,0.00014989,0.81034,0.84504,1,1
2,GO TYPE 2 IMMUNE RESPONSE,1.1191e-05,0.80958,0.77421,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,3.9936e-05,0.80914,0.72671,1,1
2,GO DETECTION OF BIOTIC STIMULUS,1.6059e-05,0.80884,0.71302,1,1
2,GO LYMPHOCYTE MIGRATION,3.248e-05,0.80883,0.74924,1,1
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,2.8267e-05,0.80765,0.80169,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.80703,0.72476,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.2939e-05,0.80686,0.7535,1,1
2,GO T CELL MIGRATION,3.248e-05,0.80663,0.76849,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.5779e-05,0.80654,0.72615,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4947e-05,0.80527,0.77117,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.9936e-05,0.80454,0.79313,1,1
2,GO COMPLEMENT ACTIVATION,2.4576e-05,0.80439,0.83768,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,4.8997e-05,0.80309,0.7659,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,1.1191e-05,0.80302,0.75255,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,8.9327e-05,0.80283,0.79908,1,1
2,GO INTERLEUKIN 2 PRODUCTION,1.0403e-05,0.80167,0.7572,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.80104,0.72416,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.4576e-05,0.79816,0.79601,1,1
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010181,0.79672,0.68776,1,1
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00015974,0.79581,0.71695,1,1
2,GO T CELL EXTRAVASATION,1.6059e-05,0.79425,0.71614,1,1
2,GO THYMIC T CELL SELECTION,8.3641e-05,0.79367,0.7488,1,1
2,GO INTERLEUKIN 4 PRODUCTION,2.2907e-05,0.79312,0.75416,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.3909e-05,0.79266,0.81239,1,1
2,GO RESPONSE TO INTERLEUKIN 18,7.8298e-05,0.79218,0.70904,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,2.4576e-05,0.79089,0.757,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.8267e-05,0.79083,0.73372,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.9888e-05,0.78892,0.74893,1,1
2,GO NEUTROPHIL MIGRATION,1.6059e-05,0.78851,0.71299,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.636e-05,0.78812,0.7516,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,3.7287e-05,0.78783,0.71936,1,1
2,GO NEUTROPHIL CHEMOTAXIS,2.636e-05,0.78756,0.74537,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,1.3909e-05,0.78715,0.72733,1,1
2,GO IMMUNOGLOBULIN SECRETION,3.248e-05,0.78338,0.65095,1,1
2,GO INTERLEUKIN 13 PRODUCTION,1.1191e-05,0.77998,0.80081,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,2.2907e-05,0.77742,0.6935,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,3.9936e-05,0.77586,0.72395,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.8997e-05,0.77577,0.71094,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.248e-05,0.77505,0.68889,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00013188,0.77393,0.71105,1,1
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00011593,0.77306,0.70804,1,1
2,GO GLIAL CELL ACTIVATION,2.636e-05,0.77237,0.75713,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.9936e-05,0.77101,0.80299,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.3461e-06,0.77099,0.77697,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,1.9888e-05,0.76966,0.73984,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,3.7287e-05,0.76926,0.75334,1,1
2,GO CHEMOKINE SECRETION,2.1347e-05,0.76716,0.81212,1,1
2,GO EOSINOPHIL CHEMOTAXIS,0.00010866,0.76681,0.81943,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.8524e-05,0.76553,0.72215,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,0.76467,0.75596,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.7287e-05,0.76426,0.71544,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.8524e-05,0.76364,0.76986,1,1
2,GO T CELL CYTOKINE PRODUCTION,1.9888e-05,0.76265,0.70028,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.7249e-05,0.76081,0.69732,1,1
2,GO RESPONSE TO INTERLEUKIN 15,1.6059e-05,0.75858,0.78503,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,1.6059e-05,0.75836,0.75628,1,1
2,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,3.4805e-05,0.75796,0.79923,1,1
2,GO OPSONIZATION,0.00045436,0.75704,0.64349,1,1
2,GO INTERLEUKIN 12 PRODUCTION,7.8298e-05,0.75702,0.70856,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,5.2428e-05,0.75689,0.76227,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00010866,0.75646,0.65538,1,1
2,GO REGULATION OF B CELL PROLIFERATION,3.7287e-05,0.75617,0.71515,1,1
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00031664,0.75557,0.65015,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.0403e-05,0.75529,0.71717,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.636e-05,0.75471,0.80441,1,1
2,GO T CELL MEDIATED IMMUNITY,1.8524e-05,0.75431,0.67381,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,5.9985e-05,0.75408,0.68168,1,1
2,GO MONONUCLEAR CELL MIGRATION,6.2007e-06,0.75404,0.77834,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.7287e-05,0.75377,0.65896,1,1
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,8.3641e-05,0.75364,0.70354,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00010866,0.75347,0.66921,1,1
2,GO ALPHA BETA T CELL PROLIFERATION,0.00010866,0.75338,0.67269,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,9.5377e-05,0.74968,0.6358,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.8997e-05,0.74944,0.66551,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.00012367,0.74888,0.63003,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.1347e-05,0.74778,0.68556,1,1
2,GO REGULATION OF CELL KILLING,2.636e-05,0.74758,0.6975,1,1
2,GO GRANULOCYTE MIGRATION,1.6059e-05,0.74623,0.67435,1,1
2,GO REGULATORY T CELL DIFFERENTIATION,0.00033648,0.7449,0.59968,1,1
2,GO RESPONSE TO INTERFERON GAMMA,1.9888e-05,0.74021,0.69987,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,3.7287e-05,0.73976,0.69275,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.2763e-05,0.73953,0.7064,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8267e-05,0.73918,0.65364,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.2907e-05,0.73834,0.70131,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,3.0304e-05,0.7376,0.66721,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.7287e-05,0.73717,0.84769,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.2939e-05,0.73693,0.75417,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.337e-06,0.73651,0.71558,1,1
2,GO INTERFERON GAMMA PRODUCTION,3.248e-05,0.7357,0.71789,1,1
2,GO INTERLEUKIN 1 PRODUCTION,9.6689e-06,0.73515,0.71667,1,1
2,GO MATURE B CELL DIFFERENTIATION,2.4576e-05,0.73315,0.7216,1,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,5.2428e-05,0.73235,0.70215,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,8.3641e-05,0.73203,0.71705,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.7249e-05,0.73193,0.68311,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.7287e-05,0.73075,0.63989,1,1
2,GO GRANULOCYTE CHEMOTAXIS,1.8524e-05,0.73075,0.6961,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.3909e-05,0.73064,0.67259,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.2907e-05,0.73027,0.64984,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.248e-05,0.72959,0.68593,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,9.5377e-05,0.72753,0.64353,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.8267e-05,0.72707,0.66325,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00011593,0.72702,0.68119,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.9936e-05,0.72583,0.64883,1,1
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00013188,0.72461,0.69886,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.0304e-05,0.72417,0.67494,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.2907e-05,0.72409,0.66144,1,1
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,3.248e-05,0.72384,0.68501,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.00011593,0.72341,0.63273,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.9422e-06,0.72219,0.83473,1,1
2,GO ALPHA BETA T CELL ACTIVATION,4.2763e-05,0.722,0.6646,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.3641e-05,0.72172,0.64935,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.0304e-05,0.71912,0.67409,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,9.6689e-06,0.71875,0.73589,1,1
2,GO GERMINAL CENTER FORMATION,9.5377e-05,0.71872,0.76418,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,7.3279e-05,0.71844,0.75009,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,1.1191e-05,0.7175,0.75615,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.0403e-05,0.71699,0.75208,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.0304e-05,0.71633,0.68165,1,1
2,GO NEUROINFLAMMATORY RESPONSE,4.5779e-05,0.71617,0.68949,1,1
2,GO ETHANOL OXIDATION,1.4947e-05,0.71519,0.88788,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,4.5779e-05,0.71507,0.71252,1,1
2,GO NEGATIVE REGULATION OF BONE REMODELING,9.5377e-05,0.71436,0.67209,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.5779e-05,0.71199,0.63512,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,4.5779e-05,0.71159,0.6646,1,1
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.00020554,0.71148,0.62274,1,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00024771,0.71118,0.616,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,4.2763e-05,0.70961,0.63487,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.7249e-05,0.70949,0.67183,1,1
2,GO INTERLEUKIN 17 PRODUCTION,2.2907e-05,0.7081,0.69287,1,1
2,GO B CELL MEDIATED IMMUNITY,2.4576e-05,0.70792,0.68193,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0304e-05,0.70764,0.66184,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.0304e-05,0.70764,0.63855,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.8267e-05,0.70648,0.69172,1,1
2,GO INTERLEUKIN 8 PRODUCTION,7.7514e-06,0.70617,0.66196,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,3.0304e-05,0.70563,0.64369,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1347e-05,0.70397,0.65827,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,2.1347e-05,0.7031,0.68256,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.8267e-05,0.70186,0.62624,1,1
2,GO REGULATION OF LYMPHOCYTE MIGRATION,4.2763e-05,0.70117,0.63466,1,1
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.4576e-05,0.70092,0.68583,1,1
2,GO REGULATION OF MYOBLAST FUSION,9.5377e-05,0.69786,0.67848,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.2428e-05,0.69762,0.69722,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.2763e-05,0.69066,0.63472,1,1
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,9.5377e-05,0.68752,0.70044,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.0304e-05,0.68695,0.61404,1,1
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,0.68497,0.64268,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,6.4139e-05,0.68431,0.64906,1,1
2,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00014989,0.68287,0.70225,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,7.3279e-05,0.68248,0.64424,1,1
2,GO RESPONSE TO INTERFERON BETA,7.8298e-05,0.68045,0.59917,1,1
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.6086e-05,0.68044,0.59768,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,5.6086e-05,0.67956,0.65142,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.9936e-05,0.6788,0.6033,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,3.7287e-05,0.67761,0.61084,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,8.3641e-05,0.6765,0.60404,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.248e-05,0.67622,0.62949,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,3.4805e-05,0.67518,0.61479,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.00018128,0.67389,0.62311,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,7.1973e-06,0.67352,0.69965,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.0017696,0.6724,0.56066,1,1
2,GO MACROPHAGE MIGRATION,1.0403e-05,0.67221,0.65438,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00010866,0.67177,0.66531,1,1
2,GO REGULATION OF T CELL MIGRATION,5.2428e-05,0.67168,0.62863,1,1
2,GO CELLULAR EXTRAVASATION,4.5779e-05,0.67092,0.62752,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.3279e-05,0.66864,0.73163,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.9936e-05,0.66683,0.60472,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00042807,0.66612,0.64876,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,6.8565e-05,0.66463,0.73663,1,1
2,GO REGULATION OF PHAGOCYTOSIS,2.4576e-05,0.66416,0.63299,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.636e-05,0.66366,0.63577,1,1
2,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.3909e-05,0.66318,0.66096,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.66198,0.60946,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,3.9936e-05,0.66066,0.57802,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.2763e-05,0.66043,0.59934,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.7287e-05,0.66021,0.60971,1,1
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,9.5377e-05,0.65941,0.63805,1,1
2,GO INTERLEUKIN 5 PRODUCTION,0.00024771,0.65937,0.62274,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.00012367,0.6588,0.56426,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,7.3279e-05,0.6587,0.61988,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00045436,0.65848,0.58212,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,2.8267e-05,0.65759,0.64415,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,5.9985e-05,0.65699,0.57445,1,1
2,GO MACROPHAGE PROLIFERATION,0.00010181,0.65682,0.7491,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.4576e-05,0.65652,0.58519,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.0304e-05,0.65573,0.70362,1,1
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00013188,0.65519,0.55971,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.8997e-05,0.65423,0.60948,1,1
2,GO APOPTOTIC CELL CLEARANCE,4.5779e-05,0.65404,0.62467,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.4576e-05,0.65264,0.59716,1,1
2,GO CYTOKINE METABOLIC PROCESS,1.0403e-05,0.65137,0.64236,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010866,0.6512,0.6616,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.9985e-05,0.64989,0.56002,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,1.2035e-05,0.64975,0.63884,1,1
2,GO RESPONSE TO LIPOTEICHOIC ACID,1.4947e-05,0.64947,0.70589,1,1
2,GO LEUKOCYTE PROLIFERATION,4.8997e-05,0.64868,0.6048,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,1.7249e-05,0.64742,0.66419,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,6.4139e-05,0.64733,0.65464,1,1
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00076864,0.64651,0.54466,1,1
2,GO REGULATION OF B CELL ACTIVATION,6.4139e-05,0.64634,0.61517,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,2.2907e-05,0.64531,0.59818,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,0.64514,0.61362,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.4947e-05,0.64507,0.62117,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,2.4576e-05,0.64507,0.64636,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.8997e-05,0.64424,0.59552,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.248e-05,0.64337,0.57819,1,1
2,GO CELL KILLING,2.4576e-05,0.64267,0.59131,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,3.7287e-05,0.64237,0.60292,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.4576e-05,0.64236,0.59116,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,3.0304e-05,0.64214,0.57907,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00019306,0.64131,0.58758,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,3.248e-05,0.64066,0.58617,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,2.636e-05,0.64033,0.60829,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.00014989,0.63892,0.64357,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,0.63831,0.59545,1,1
2,GO T CELL DIFFERENTIATION,7.3279e-05,0.63685,0.55968,1,1
2,GO FIBRINOLYSIS,3.248e-05,0.63618,0.65434,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00021879,0.63616,0.59402,1,1
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.8267e-05,0.63443,0.69973,1,1
2,GO INTEGRIN ACTIVATION,5.6086e-05,0.63386,0.64811,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.4805e-05,0.63376,0.59177,1,1
2,GO PHAGOCYTOSIS RECOGNITION,2.4576e-05,0.63362,0.65388,1,1
2,GO ASTROCYTE ACTIVATION,2.4576e-05,0.6335,0.58124,1,1
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.0304e-05,0.63333,0.66519,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.2907e-05,0.63321,0.58376,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.2907e-05,0.63239,0.57729,1,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00019306,0.63232,0.62451,1,1
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00014989,0.63208,0.52656,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.2907e-05,0.63149,0.59317,1,1
2,GO NEUTROPHIL EXTRAVASATION,8.9327e-05,0.63109,0.62741,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.00015974,0.63089,0.57172,1,1
2,GO REGULATION OF T CELL ACTIVATION,5.9985e-05,0.63023,0.58345,1,1
2,GO HUMORAL IMMUNE RESPONSE,2.8267e-05,0.63002,0.64573,1,1
2,GO LEUKOCYTE CHEMOTAXIS,2.4576e-05,0.62995,0.61602,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00024771,0.62969,0.54539,1,1
2,GO T CELL PROLIFERATION,3.9936e-05,0.62849,0.6119,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1347e-05,0.62826,0.58326,1,1
2,GO MACROPHAGE ACTIVATION,2.4576e-05,0.62825,0.66339,1,1
2,GO REGULATION OF PLATELET ACTIVATION,0.00020554,0.62786,0.58465,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.6059e-05,0.62769,0.58924,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,4.2763e-05,0.62699,0.58142,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,2.1347e-05,0.62692,0.59663,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.8997e-05,0.62679,0.57455,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.8997e-05,0.62652,0.5948,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.636e-05,0.62558,0.6036,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.4139e-05,0.6253,0.58564,1,1
2,GO REGULATION OF CELLULAR EXTRAVASATION,1.8524e-05,0.62503,0.67913,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,8.3461e-06,0.62417,0.67401,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.1347e-05,0.62331,0.66909,1,1
2,GO REGULATION OF BONE DEVELOPMENT,4.8997e-05,0.6231,0.60402,1,1
2,GO NATURAL KILLER CELL ACTIVATION,6.8565e-05,0.62307,0.55228,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.62301,0.55609,1,1
2,GO CD40 SIGNALING PATHWAY,3.4805e-05,0.62102,0.562,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,4.2763e-05,0.62092,0.62074,1,1
2,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,7.8298e-05,0.61927,0.68209,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00012367,0.61864,0.59619,1,1
2,GO T CELL APOPTOTIC PROCESS,2.8267e-05,0.61848,0.58317,1,1
2,GO PLASMINOGEN ACTIVATION,0.00011593,0.61677,0.57251,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00031664,0.61619,0.56108,1,1
2,GO MACROPHAGE CHEMOTAXIS,1.2035e-05,0.61536,0.61972,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,5.2428e-05,0.61532,0.55551,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.9888e-05,0.61334,0.58018,1,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.61318,0.56982,1,1
2,GO REGULATION OF MEMBRANE INVAGINATION,0.00011593,0.61282,0.66037,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.7287e-05,0.61266,0.61071,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00033648,0.61219,0.56887,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.8997e-05,0.611,0.54737,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,5.9985e-05,0.61076,0.55634,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00015974,0.60961,0.55391,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2428e-05,0.6096,0.54213,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00011593,0.60959,0.60708,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.8267e-05,0.60948,0.63809,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,5.337e-06,0.60911,0.67395,1,1
2,GO PROTEIN ACTIVATION CASCADE,6.4139e-05,0.6089,0.64773,1,1
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,6.8565e-05,0.60883,0.56265,1,1
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,5.6086e-05,0.60871,0.53802,1,1
2,GO ETHANOL METABOLIC PROCESS,3.7287e-05,0.6083,0.67563,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011593,0.60829,0.57189,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.1347e-05,0.60823,0.63377,1,1
2,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.00029789,0.60811,0.53622,1,1
2,GO AMYLOID BETA CLEARANCE,5.9985e-05,0.608,0.57513,1,1
2,GO T CELL ACTIVATION,5.2428e-05,0.60757,0.56083,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,5.9985e-05,0.60722,0.62094,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.6059e-05,0.60645,0.59759,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,2.1347e-05,0.60638,0.57897,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.4805e-05,0.60589,0.58218,1,1
2,GO INTERLEUKIN 6 PRODUCTION,3.4805e-05,0.60544,0.55368,1,1
2,GO I KAPPAB PHOSPHORYLATION,3.248e-05,0.60299,0.57211,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00020554,0.60298,0.56876,1,1
2,GO REGULATION OF CELL ACTIVATION,4.8997e-05,0.60224,0.54448,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.636e-05,0.60138,0.60424,1,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0054671,0.60137,0.48391,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0003797,0.59959,0.5357,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,3.9936e-05,0.59809,0.62867,1,1
2,GO CYTOKINE SECRETION,2.8267e-05,0.59783,0.54156,1,1
2,GO ACUTE PHASE RESPONSE,1.9888e-05,0.59743,0.56648,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.9888e-05,0.597,0.58972,1,1
2,GO NEUTROPHIL HOMEOSTASIS,1.3909e-05,0.59535,0.60654,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,3.7287e-05,0.59507,0.52201,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,1.8524e-05,0.59481,0.57773,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00010866,0.59479,0.55538,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.0304e-05,0.59439,0.6054,1,1
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,1.9888e-05,0.59437,0.65703,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.9936e-05,0.59165,0.63099,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,6.4139e-05,0.59157,0.54716,1,1
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9888e-05,0.59156,0.58749,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,3.0304e-05,0.59059,0.53944,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,1.7249e-05,0.58896,0.54794,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,6.8565e-05,0.58857,0.53294,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,1.8524e-05,0.58815,0.58737,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,1.8524e-05,0.58618,0.59086,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.2428e-05,0.58501,0.55198,1,1
2,GO T CELL LINEAGE COMMITMENT,0.00013188,0.58392,0.53572,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,4.5779e-05,0.58386,0.53937,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00019306,0.58336,0.58057,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00029789,0.58276,0.55044,1,1
2,GO BLEB ASSEMBLY,0.00045436,0.58221,0.56816,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,7.8298e-05,0.58098,0.56617,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.6086e-05,0.58077,0.60076,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,2.2907e-05,0.57871,0.59244,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.5779e-05,0.57643,0.53995,1,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.248e-05,0.57587,0.58797,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,6.4139e-05,0.57557,0.5097,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.4576e-05,0.57441,0.56233,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.2939e-05,0.57399,0.63602,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.8997e-05,0.57364,0.50677,1,1
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00010866,0.57351,0.5385,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,8.9843e-06,0.57303,0.61535,1,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00024771,0.57242,0.53645,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.248e-05,0.57206,0.6513,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,8.9327e-05,0.57144,0.51595,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00010866,0.571,0.6585,1,1
2,GO MACROPHAGE DIFFERENTIATION,4.2763e-05,0.57069,0.55584,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,2.8267e-05,0.57045,0.61298,1,1
2,GO RESPONSE TO MURAMYL DIPEPTIDE,4.8997e-05,0.57023,0.547,1,1
2,GO RESPONSE TO INTERLEUKIN 2,0.00072571,0.56997,0.54797,1,1
2,GO OSTEOCLAST DEVELOPMENT,8.3641e-05,0.56948,0.60491,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,5.2428e-05,0.56937,0.58923,1,1
2,GO INTERFERON ALPHA PRODUCTION,9.5377e-05,0.56887,0.50604,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,2.2907e-05,0.56619,0.53571,1,1
2,GO RESPIRATORY BURST,0.00010866,0.56573,0.56145,1,1
2,GO REGULATION OF IMMUNE RESPONSE,3.7287e-05,0.56336,0.50675,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00045436,0.56285,0.5528,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00018128,0.56218,0.50159,1,1
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,5.6086e-05,0.5604,0.52112,1,1
2,GO LYMPHOCYTE ACTIVATION,6.4139e-05,0.56029,0.51623,1,1
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00012367,0.55914,0.55253,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.1191e-05,0.55708,0.63956,1,1
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00024771,0.55706,0.57975,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.1347e-05,0.55698,0.54351,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.6086e-05,0.55611,0.50812,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.7287e-05,0.55541,0.5329,1,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4139e-05,0.55486,0.53859,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00035748,0.55466,0.48041,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00033648,0.55465,0.47865,1,1
2,GO PHAGOCYTOSIS,3.248e-05,0.55287,0.53318,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,5.2428e-05,0.55263,0.55701,1,1
2,GO BONE TRABECULA MORPHOGENESIS,0.0063209,0.55227,0.44507,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00014989,0.55176,0.51257,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.7287e-05,0.5511,0.52551,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.00010866,0.55089,0.65717,1,1
2,GO LEUKOCYTE HOMEOSTASIS,8.9327e-05,0.55036,0.49484,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9888e-05,0.5499,0.6582,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,0.54956,0.50555,1,1
2,GO LYMPH NODE DEVELOPMENT,0.00033648,0.54951,0.53371,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.0304e-05,0.54816,0.51436,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.8267e-05,0.54793,0.53692,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.9888e-05,0.54791,0.53644,1,1
2,GO ZYMOGEN INHIBITION,3.248e-05,0.54752,0.5746,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.5779e-05,0.54516,0.50092,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.8524e-05,0.54511,0.54365,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00014989,0.54401,0.53361,1,1
2,GO NAD BIOSYNTHETIC PROCESS,1.4947e-05,0.54313,0.51579,1,1
2,GO REGULATION OF AMYLOID BETA CLEARANCE,6.4139e-05,0.54272,0.54439,1,1
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,9.5377e-05,0.5424,0.4713,1,1
2,GO CHEMOKINE PRODUCTION,1.1191e-05,0.54219,0.56471,1,1
2,GO B CELL HOMEOSTASIS,0.00026348,0.542,0.47315,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,9.6689e-06,0.54156,0.57814,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.1347e-05,0.5415,0.52839,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.248e-05,0.54133,0.52863,1,1
2,GO CYTIDINE TO URIDINE EDITING,7.8298e-05,0.54114,0.57808,1,1
2,GO CELL CHEMOTAXIS,3.7287e-05,0.54109,0.54591,1,1
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.00024771,0.54108,0.58595,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.6086e-05,0.5397,0.49699,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.2907e-05,0.53873,0.54753,1,1
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.6059e-05,0.53743,0.61079,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,3.7287e-05,0.53583,0.65821,1,1
2,GO REGULATION OF CELL CELL ADHESION,5.6086e-05,0.53525,0.50452,1,1
2,GO LEUKOCYTE DIFFERENTIATION,4.8997e-05,0.53514,0.50324,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,7.3279e-05,0.53478,0.45948,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.00013188,0.53394,0.47185,1,1
2,GO INFLAMMATORY RESPONSE,3.0304e-05,0.53273,0.51498,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00010866,0.53193,0.49252,1,1
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00013188,0.5319,0.45725,1,1
2,GO B CELL ACTIVATION,7.3279e-05,0.53161,0.52375,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,2.8267e-05,0.5309,0.60446,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,3.9936e-05,0.53061,0.48792,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,3.7287e-05,0.5306,0.46415,1,1
2,GO INNATE IMMUNE RESPONSE,2.4576e-05,0.53059,0.50048,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,3.4805e-05,0.5291,0.4897,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7287e-05,0.52857,0.48186,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.6086e-05,0.52857,0.50973,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.8298e-05,0.52843,0.57684,1,1
2,GO LEUKOCYTE MIGRATION,4.5779e-05,0.52827,0.52824,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,8.3641e-05,0.52814,0.52969,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,3.7287e-05,0.52669,0.49015,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,1.6059e-05,0.5265,0.54687,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0304e-05,0.52575,0.49656,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,3.0304e-05,0.52428,0.47679,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00020554,0.5236,0.5211,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010181,0.52291,0.49847,1,1
2,GO IMMUNOGLOBULIN PRODUCTION,4.2763e-05,0.52276,0.51178,1,1
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.248e-05,0.52195,0.53712,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.9888e-05,0.52151,0.59126,1,1
2,GO MEMBRANE RAFT ORGANIZATION,0.00013188,0.52139,0.54146,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,1.6059e-05,0.52046,0.55191,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.00010866,0.52021,0.49008,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,6.8565e-05,0.51935,0.50516,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.8267e-05,0.51909,0.47829,1,1
2,GO HEMIDESMOSOME ASSEMBLY,0.025096,0.51853,0.4636,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00020554,0.51803,0.48462,1,1
2,GO RESPONSE TO HYDROPEROXIDE,0.00023283,0.51676,0.50702,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.248e-05,0.5157,0.46958,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.0304e-05,0.51569,0.47744,1,1
2,GO REGULATION OF INTEGRIN ACTIVATION,0.00023283,0.51522,0.49913,1,1
2,GO RESPONSE TO BACTERIUM,3.0304e-05,0.51498,0.51207,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.5377e-05,0.51457,0.60263,1,1
2,GO PEPTIDE CROSS LINKING,0.00017019,0.51417,0.52923,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,5.9985e-05,0.51303,0.47798,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.0403e-05,0.51163,0.53197,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,4.5779e-05,0.5114,0.51216,1,1
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0011418,0.51129,0.49503,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.4576e-05,0.5088,0.50547,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,5.6086e-05,0.50873,0.51732,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00010181,0.50872,0.49725,1,1
2,GO SUPEROXIDE ANION GENERATION,8.3641e-05,0.50857,0.48325,1,1
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00029789,0.50816,0.48153,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.00010181,0.50758,0.47548,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00035748,0.50604,0.4735,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,2.636e-05,0.50514,0.47225,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,4.2763e-05,0.5049,0.58574,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00015974,0.50483,0.52554,1,1
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.00045436,0.50288,0.50441,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,3.0304e-05,0.50145,0.49056,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.9985e-05,0.50118,0.49589,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,3.4805e-05,0.50056,0.52049,1,1
2,GO CYTOKINE PRODUCTION,3.4805e-05,0.49999,0.47201,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00014989,0.49906,0.49225,1,1
2,GO REGULATION OF FIBRINOLYSIS,3.7287e-05,0.49864,0.60673,1,1
2,GO MYOBLAST FUSION,9.5377e-05,0.49827,0.4944,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.0304e-05,0.49686,0.49937,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,0.49643,0.45298,1,1
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0063209,0.49638,0.38045,1,1
2,GO RESPONSE TO TUMOR CELL,9.5377e-05,0.4963,0.48504,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.7287e-05,0.49596,0.4867,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,4.5779e-05,0.49569,0.44616,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00018128,0.4952,0.45723,1,1
2,GO T CELL DIFFERENTIATION IN THYMUS,0.00014062,0.49444,0.47779,1,1
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0017696,0.49403,0.47776,1,1
2,GO IMMUNE EFFECTOR PROCESS,3.248e-05,0.4922,0.46035,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8267e-05,0.49112,0.46195,1,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00014989,0.49108,0.56386,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.248e-05,0.49008,0.48596,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,7.8298e-05,0.48953,0.42857,1,1
2,GO MULTI ORGANISM CELLULAR PROCESS,6.4139e-05,0.48904,0.55183,1,1
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,3.248e-05,0.48838,0.50366,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.00054254,0.48837,0.51522,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0012071,0.48831,0.42745,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00040321,0.48773,0.47555,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.00081392,0.48616,0.4243,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00014989,0.48582,0.49622,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00040321,0.48529,0.46756,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00010866,0.48488,0.49952,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,2.636e-05,0.48379,0.48654,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.00081392,0.48368,0.48866,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,3.9936e-05,0.48285,0.57414,1,1
2,GO OSTEOCLAST DIFFERENTIATION,7.8298e-05,0.48228,0.44798,1,1
2,GO MACROPHAGE APOPTOTIC PROCESS,0.00096503,0.48226,0.44079,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00010181,0.48193,0.47228,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00013188,0.4819,0.47982,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00014989,0.48174,0.53699,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.1347e-05,0.48164,0.53693,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,2.2907e-05,0.48154,0.48605,1,1
2,GO SEROTONIN SECRETION,0.00096503,0.48105,0.43873,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,3.4805e-05,0.48047,0.4638,1,1
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,1.7249e-05,0.48021,0.56977,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,6.4139e-05,0.48006,0.7158,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00021879,0.47943,0.51382,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00086166,0.47888,0.43904,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.00014989,0.4774,0.43259,1,1
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00024771,0.47696,0.51866,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.47679,0.43046,1,1
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0013481,0.47659,0.47204,1,1
2,GO FLUID TRANSPORT,0.00048214,0.47543,0.46087,1,1
2,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00057531,0.47522,0.41342,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.3279e-05,0.47516,0.46404,1,1
2,GO DEFENSE RESPONSE,3.4805e-05,0.47446,0.44326,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00017019,0.47442,0.47669,1,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00081392,0.47409,0.40082,1,1
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00060992,0.47366,0.50421,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.7287e-05,0.47361,0.47335,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,8.3641e-05,0.47238,0.43887,1,1
2,GO RESPONSE TO PROSTAGLANDIN,0.00035748,0.47232,0.42937,1,1
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,3.7287e-05,0.47196,0.50241,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,0.00057531,0.47156,0.47113,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013188,0.47097,0.5539,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,3.0304e-05,0.47083,0.4372,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.0011418,0.47059,0.71244,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,2.4576e-05,0.47043,0.56401,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.7249e-05,0.4703,0.53471,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,6.8565e-05,0.47019,0.58748,1,1
2,GO ASTROCYTE DEVELOPMENT,0.00010181,0.46927,0.46586,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,4.8997e-05,0.46849,0.53012,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00026348,0.46792,0.49154,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00031664,0.46747,0.42678,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.00042807,0.46713,0.40861,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,2.8267e-05,0.46645,0.47636,1,1
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00012367,0.4662,0.65655,1,1
2,GO FOAM CELL DIFFERENTIATION,8.9327e-05,0.46611,0.47587,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.0304e-05,0.46413,0.53923,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00048214,0.46401,0.47551,1,1
2,GO BONE RESORPTION,0.00017019,0.46383,0.45217,1,1
2,GO RESPONSE TO VIRUS,9.5377e-05,0.46369,0.41607,1,1
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00024771,0.46333,0.4547,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00015974,0.46224,0.47291,1,1
2,GO ACTIVATED T CELL PROLIFERATION,0.00048214,0.46164,0.40864,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.2763e-05,0.46155,0.45582,1,1
2,GO T CELL HOMEOSTASIS,0.00031664,0.46128,0.37867,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,4.8997e-05,0.46098,0.57882,1,1
2,GO B CELL DIFFERENTIATION,8.9327e-05,0.46088,0.5043,1,1
2,GO CELL ACTIVATION,5.2428e-05,0.4602,0.43512,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00020554,0.46011,0.45794,1,1
2,GO MEMBRANE INVAGINATION,0.00012367,0.45862,0.47625,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.0016767,0.45683,0.39525,1,1
2,GO SYNCYTIUM FORMATION,5.6086e-05,0.45674,0.47059,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,1.2939e-05,0.45658,0.46506,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.3279e-05,0.45608,0.41132,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,4.8997e-05,0.45583,0.50689,1,1
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,9.5377e-05,0.45579,0.47011,1,1
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00021879,0.45535,0.47787,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00023283,0.45503,0.47201,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,9.5377e-05,0.45342,0.44711,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,0.4519,0.50232,1,1
2,GO FEVER GENERATION,4.8997e-05,0.45184,0.46227,1,1
2,GO WATER TRANSPORT,0.00086166,0.45183,0.49776,1,1
2,GO MITRAL VALVE DEVELOPMENT,0.0042727,0.45166,0.36565,1,1
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00023283,0.45042,0.50416,1,1
2,GO STORE OPERATED CALCIUM ENTRY,0.00020554,0.44999,0.40098,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00014989,0.44938,0.53801,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.0003797,0.44937,0.39995,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,5.9985e-05,0.44839,0.48746,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,0.44791,0.423,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.3909e-05,0.4476,0.44721,1,1
2,GO HETEROTYPIC CELL CELL ADHESION,3.9936e-05,0.44626,0.4721,1,1
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00028019,0.44595,0.40846,1,1
2,GO AMINE CATABOLIC PROCESS,0.00010866,0.44578,0.40322,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00013188,0.44559,0.42335,1,1
2,GO ZYMOGEN ACTIVATION,5.9985e-05,0.44555,0.46886,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.8524e-05,0.44524,0.48846,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,8.9327e-05,0.44521,0.42849,1,1
2,GO RESPONSE TO FUNGUS,0.00054254,0.44512,0.43821,1,1
2,GO GAS TRANSPORT,0.0047188,0.44507,0.40175,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00020554,0.44451,0.37176,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.7287e-05,0.44395,0.4765,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0015041,0.44346,0.39612,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,7.3279e-05,0.44232,0.42028,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1347e-05,0.44166,0.45446,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00054254,0.44103,0.44536,1,1
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00042807,0.4406,0.44712,1,1
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.00026348,0.4404,0.44212,1,1
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00012367,0.43965,0.44685,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.4805e-05,0.43948,0.45918,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00011593,0.43751,0.48274,1,1
2,GO GRANULOCYTE DIFFERENTIATION,2.2907e-05,0.43724,0.50416,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.0304e-05,0.43409,0.40023,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00014989,0.43392,0.43094,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.248e-05,0.43337,0.48752,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.00018128,0.43284,0.42296,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.00031664,0.43275,0.60902,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00060992,0.43254,0.43959,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00024771,0.43174,0.41076,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00026348,0.43156,0.42036,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,8.9327e-05,0.43077,0.52889,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00033648,0.43045,0.52092,1,1
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,2.4576e-05,0.43021,0.52029,1,1
2,GO PYROPTOSIS,0.00054254,0.42978,0.4244,1,1
2,GO COLLAGEN CATABOLIC PROCESS,0.00012367,0.42972,0.50646,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00010181,0.42909,0.45752,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,1.6059e-05,0.42901,0.47218,1,1
2,GO ACTIN FILAMENT SEVERING,0.00012367,0.42772,0.48839,1,1
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0018673,0.42767,0.40958,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.7287e-05,0.42732,0.41532,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00035748,0.42695,0.42284,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,8.9327e-05,0.42692,0.46679,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00012367,0.42641,0.4579,1,1
2,GO CHOLESTEROL STORAGE,0.00014062,0.42593,0.47662,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00057531,0.4254,0.41427,1,1
2,GO POSITIVE REGULATION OF COAGULATION,2.8267e-05,0.42487,0.49125,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.1347e-05,0.42395,0.41974,1,1
2,GO REGULATION OF DEFENSE RESPONSE,3.9936e-05,0.42366,0.40207,1,1
2,GO BONE CELL DEVELOPMENT,0.00019306,0.4236,0.4434,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1191e-05,0.42302,0.44379,1,1
2,GO ENTRY INTO HOST,5.2428e-05,0.42232,0.43798,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.8524e-05,0.42193,0.45561,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00023283,0.42137,0.43142,1,1
2,GO RESPONSE TO INTERLEUKIN 1,1.4947e-05,0.42127,0.39844,1,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00026348,0.42085,0.40546,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00018128,0.42084,0.40535,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00013188,0.42061,0.37633,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.7287e-05,0.41893,0.40863,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3909e-05,0.41869,0.46964,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0021907,0.41803,0.37609,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.00096503,0.41793,0.36681,1,1
2,GO REGULATION OF CHEMOTAXIS,7.3279e-05,0.41756,0.42905,1,1
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00019306,0.41745,0.46832,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00014989,0.41714,0.44372,1,1
2,GO RESPONSE TO INTERLEUKIN 4,5.6086e-05,0.41708,0.43033,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,4.8997e-05,0.41704,0.39548,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00021879,0.41633,0.46514,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00018128,0.41585,0.37368,1,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0012071,0.41579,0.36245,1,1
2,GO SOMATIC STEM CELL DIVISION,0.0049572,0.41521,0.40119,1,1
2,GO ERK1 AND ERK2 CASCADE,3.9936e-05,0.41451,0.42944,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,5.2428e-05,0.4145,0.40318,1,1
2,GO DNA DEAMINATION,0.00068502,0.4142,0.3932,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00035748,0.41369,0.35744,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00091199,0.41347,0.40178,1,1
2,GO CELL ADHESION MOLECULE PRODUCTION,0.00020554,0.41347,0.49609,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,4.5779e-05,0.41089,0.44497,1,1
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00018128,0.41079,0.47231,1,1
2,GO RESPONSE TO INTERLEUKIN 6,0.0003797,0.41071,0.41745,1,1
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00013188,0.41066,0.4412,1,1
2,GO RETINOL METABOLIC PROCESS,2.2907e-05,0.41023,0.40895,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,6.8565e-05,0.40941,0.40826,1,1
2,GO HYALURONAN CATABOLIC PROCESS,4.8997e-05,0.40868,0.49562,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.4805e-05,0.40768,0.37936,1,1
2,GO RESPONSE TO CYTOKINE,4.2763e-05,0.40741,0.39594,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,3.0304e-05,0.40689,0.42028,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00019306,0.40656,0.41033,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00064645,0.40645,0.42883,1,1
2,GO MUCUS SECRETION,5.2428e-05,0.40541,0.46475,1,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00057531,0.40496,0.36708,1,1
2,GO OXYGEN TRANSPORT,0.058535,0.40474,0.26083,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.636e-05,0.4045,0.39682,1,1
2,GO TRANSCYTOSIS,0.0021907,0.40449,0.40308,1,1
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00096503,0.40385,0.42519,1,1
2,GO PINOCYTOSIS,0.00031664,0.40306,0.40551,1,1
2,GO LIPOXYGENASE PATHWAY,0.0023095,0.40304,0.42043,1,1
2,GO GLYCOLIPID CATABOLIC PROCESS,0.00031664,0.403,0.45278,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.7249e-05,0.40294,0.45891,1,1
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00014989,0.40281,0.42228,1,1
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.00064645,0.40257,0.56703,1,1
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00013188,0.40165,0.46604,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00086166,0.40078,0.46263,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00042807,0.39956,0.43074,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00029789,0.39937,0.44721,1,1
2,GO GAP JUNCTION ASSEMBLY,0.0010209,0.39927,0.49937,1,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00021879,0.39882,0.44881,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00024771,0.39776,0.40649,1,1
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00057531,0.39768,0.4487,1,1
2,GO SKIN MORPHOGENESIS,0.006955,0.39753,0.37316,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,4.5779e-05,0.39741,0.453,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.00068502,0.39521,0.39044,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.00023283,0.39477,0.40549,1,1
2,GO DIET INDUCED THERMOGENESIS,0.0018673,0.39475,0.34895,1,1
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,4.5779e-05,0.39417,0.50116,1,1
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.3279e-05,0.39414,0.3911,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,7.3279e-05,0.39357,0.38018,1,1
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.00014989,0.39323,0.32253,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00012367,0.39281,0.37871,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,8.3641e-05,0.39258,0.41383,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00060992,0.3921,0.40072,1,1
2,GO PROTEIN TRIMERIZATION,0.00011593,0.3914,0.47523,1,1
2,GO REGULATION OF STEROL TRANSPORT,0.00010866,0.38989,0.39555,1,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00012367,0.38985,0.54124,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.4576e-05,0.3891,0.41073,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,5.9985e-05,0.38845,0.45302,1,1
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00076864,0.38827,0.3759,1,1
2,GO AMYLOID FIBRIL FORMATION,0.00026348,0.38768,0.39591,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,7.7514e-06,0.38766,0.48411,1,1
2,GO LIVER MORPHOGENESIS,8.9327e-05,0.3875,0.39812,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00042807,0.38709,0.39981,1,1
2,GO ETHANOL CATABOLIC PROCESS,0.00017019,0.3862,0.41468,1,1
2,GO REGULATION OF BONE REMODELING,0.0010798,0.38608,0.36484,1,1
2,GO PODOSOME ASSEMBLY,0.00045436,0.38602,0.43875,1,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0013481,0.38574,0.39104,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.4947e-05,0.38556,0.41645,1,1
2,GO REGULATION OF HEMOPOIESIS,6.4139e-05,0.38543,0.38529,1,1
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00017019,0.38528,0.46334,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0038653,0.38509,0.35434,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,3.7287e-05,0.38484,0.42966,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.00054254,0.38455,0.42192,1,1
2,GO REGULATION OF COAGULATION,0.00021879,0.38438,0.4502,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00035748,0.3838,0.46897,1,1
2,GO PLATELET DEGRANULATION,0.00020554,0.38373,0.45276,1,1
2,GO COLLAGEN METABOLIC PROCESS,0.00026348,0.38316,0.45905,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00010866,0.38218,0.4444,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00026348,0.382,0.32691,1,1
2,GO ENDODERMAL CELL DIFFERENTIATION,0.0021907,0.38177,0.4319,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.4576e-05,0.3815,0.4431,1,1
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0014241,0.38074,0.35616,1,1
2,GO STEROL HOMEOSTASIS,3.248e-05,0.3805,0.3983,1,1
2,GO REGULATION OF PLATELET AGGREGATION,0.0025648,0.38023,0.38472,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00040321,0.38002,0.3017,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0034935,0.37938,0.31014,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0003797,0.3792,0.34681,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.0029965,0.379,0.30779,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.9936e-05,0.37863,0.42332,1,1
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0010209,0.37853,0.40023,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00040321,0.37805,0.41589,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00019306,0.37791,0.38616,1,1
2,GO PLATELET AGGREGATION,0.0012071,0.37778,0.38801,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00040321,0.37766,0.46013,1,1
2,GO INTERFERON BETA PRODUCTION,0.00033648,0.37732,0.38043,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.0003797,0.37719,0.3729,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.8267e-05,0.37636,0.41638,1,1
2,GO NIK NF KAPPAB SIGNALING,3.4805e-05,0.37614,0.35308,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3909e-05,0.37545,0.44605,1,1
2,GO REGULATION OF TISSUE REMODELING,0.00081392,0.37476,0.36558,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,2.636e-05,0.3747,0.48167,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,6.8565e-05,0.37463,0.43234,1,1
2,GO PLATELET ACTIVATION,0.0015882,0.37396,0.35793,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00026348,0.37369,0.40196,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.008797,0.37361,0.37169,1,1
2,GO TRABECULA FORMATION,0.0038653,0.37335,0.3447,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00060992,0.37319,0.4425,1,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.0010209,0.37271,0.38821,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.8997e-05,0.37237,0.40201,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,8.9327e-05,0.37203,0.35954,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.8298e-05,0.37148,0.35641,1,1
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00010181,0.37099,0.38734,1,1
2,GO REGULATION OF RECEPTOR BINDING,0.00054254,0.37078,0.37673,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.7287e-05,0.37077,0.38062,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00033648,0.37067,0.36992,1,1
2,GO VAGINA DEVELOPMENT,0.0019699,0.36992,0.36644,1,1
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0029965,0.3699,0.41923,1,1
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00033648,0.36964,0.39603,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00048214,0.36953,0.43107,1,1
2,GO REGULATION OF CELL ADHESION,0.00014062,0.36924,0.41025,1,1
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00014062,0.36922,0.35307,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.00024771,0.36833,0.46724,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.4947e-05,0.36804,0.43513,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.4805e-05,0.36738,0.36099,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.00060992,0.36718,0.34437,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00010181,0.36706,0.4874,1,1
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00054254,0.36687,0.39156,1,1
2,GO RENAL ABSORPTION,5.2428e-05,0.3662,0.51471,1,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00031664,0.36611,0.43466,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.6689e-06,0.36601,0.42174,1,1
2,GO RESPONSE TO FLUID SHEAR STRESS,0.00011593,0.3659,0.46504,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.7287e-05,0.36557,0.43218,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00040321,0.3651,0.3626,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,8.9327e-05,0.36477,0.38567,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0016767,0.36452,0.35764,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.9936e-05,0.3645,0.37139,1,1
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0027019,0.36407,0.33605,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00018128,0.36288,0.38427,1,1
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00035748,0.36271,0.38478,1,1
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00064645,0.3613,0.38347,1,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,5.6086e-05,0.36074,0.38299,1,1
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,8.3641e-05,0.36059,0.40507,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00051151,0.36017,0.43928,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,6.4139e-05,0.35982,0.37444,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.2907e-05,0.35971,0.43984,1,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0052065,0.3594,0.40967,1,1
2,GO P38MAPK CASCADE,2.8267e-05,0.3592,0.41471,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00023283,0.35918,0.43261,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00019306,0.35886,0.38149,1,1
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.00024771,0.35868,0.40215,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00021879,0.35814,0.36487,1,1
2,GO RESPONSE TO MINERALOCORTICOID,0.0003797,0.35798,0.32801,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00024771,0.35782,0.40323,1,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00081392,0.35656,0.39377,1,1
2,GO SEQUESTERING OF METAL ION,0.00091199,0.35591,0.35187,1,1
2,GO INTERACTION WITH SYMBIONT,1.9888e-05,0.35537,0.36391,1,1
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0024341,0.35509,0.39363,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0076456,0.35429,0.36359,1,1
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00023283,0.35396,0.42023,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00035748,0.35368,0.33222,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00012367,0.35338,0.41413,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00035748,0.35338,0.40861,1,1
2,GO RESPONSE TO MANGANESE ION,5.6086e-05,0.35314,0.36867,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021879,0.35231,0.3692,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.00010866,0.35225,0.3632,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,4.5779e-05,0.35187,0.39557,1,1
2,GO COPPER ION TRANSPORT,0.00064645,0.35173,0.32378,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,7.3279e-05,0.3516,0.37977,1,1
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0042727,0.35098,0.33182,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0027019,0.35014,0.49176,1,1
2,GO CALCIUM MEDIATED SIGNALING,0.00028019,0.35008,0.34381,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00017019,0.34978,0.36298,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.3279e-05,0.34959,0.43512,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,6.4139e-05,0.34954,0.39305,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00013188,0.34953,0.48344,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00011593,0.34947,0.35725,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0016767,0.34831,0.38237,1,1
2,GO DEFENSE RESPONSE TO FUNGUS,0.00332,0.34831,0.36288,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,0.00048214,0.34829,0.35318,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00015974,0.34822,0.34632,1,1
2,GO COLLAGEN FIBRIL ORGANIZATION,0.0049572,0.3481,0.46554,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00010181,0.34804,0.40706,1,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,3.9936e-05,0.34769,0.36839,1,1
2,GO SALIVA SECRETION,0.0040644,0.34744,0.3199,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.00035748,0.34742,0.33843,1,1
2,GO RESPONSE TO THYROID HORMONE,0.0014241,0.3469,0.30554,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021879,0.34653,0.36244,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,6.4139e-05,0.34641,0.39855,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012367,0.34616,0.43436,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00026348,0.34557,0.35427,1,1
2,GO BONE REMODELING,0.00042807,0.34539,0.38279,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0010798,0.34534,0.33918,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,6.8565e-05,0.34487,0.3815,1,1
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00048214,0.3447,0.341,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0010209,0.34457,0.37838,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0096484,0.34455,0.29828,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0028457,0.34434,0.32957,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0023095,0.34434,0.32668,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.00012367,0.34423,0.34914,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.3279e-05,0.34277,0.38336,1,1
2,GO MYELOID CELL DEVELOPMENT,0.00014989,0.34276,0.38404,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00021879,0.34255,0.35329,1,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,6.8565e-05,0.34224,0.35108,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00081392,0.34216,0.39525,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00014989,0.34178,0.29604,1,1
2,GO RESPONSE TO VITAMIN D,0.0028457,0.34165,0.31425,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00068502,0.34095,0.34551,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0014241,0.34017,0.39846,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.011063,0.33962,0.34777,1,1
2,GO RETINAL METABOLIC PROCESS,0.00015974,0.33901,0.45358,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,8.9327e-05,0.33764,0.39082,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00051151,0.33693,0.38143,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0057394,0.33587,0.31458,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,3.7287e-05,0.33482,0.39076,1,1
2,GO TISSUE REMODELING,0.0003797,0.33472,0.39661,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00029789,0.33446,0.32731,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,2.4576e-05,0.33321,0.31905,1,1
2,GO REGULATION OF LYSOSOMAL LUMEN PH,8.3641e-05,0.33285,0.36073,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00031664,0.33274,0.43134,1,1
2,GO ENDODERM FORMATION,0.00072571,0.33248,0.4231,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.00015974,0.33224,0.3847,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00015974,0.33212,0.41229,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0023095,0.33201,0.35066,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.3279e-05,0.3311,0.35411,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0027019,0.33097,0.33335,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00033648,0.33083,0.38633,1,1
2,GO STEROID ESTERIFICATION,0.00014989,0.33046,0.33691,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00054254,0.32904,0.30583,1,1
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00081392,0.32774,0.40142,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00018128,0.32681,0.34202,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,8.9327e-05,0.32642,0.33927,1,1
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.00023283,0.32589,0.37416,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.9327e-05,0.32585,0.34736,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.00026348,0.32567,0.34592,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00020554,0.32481,0.33204,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0012758,0.32455,0.32618,1,1
2,GO PULMONARY VALVE DEVELOPMENT,0.0027019,0.32452,0.3879,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,5.2428e-05,0.32376,0.36363,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00054254,0.32331,0.3214,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00057531,0.3232,0.30106,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040321,0.32278,0.31314,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0063209,0.32244,0.36253,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,6.4139e-05,0.32227,0.34609,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00068502,0.32225,0.30215,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00045436,0.32199,0.33569,1,1
2,GO RETINOIC ACID METABOLIC PROCESS,0.00026348,0.32191,0.35998,1,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.0038653,0.32181,0.33426,1,1
2,GO REGULATION OF LIPID STORAGE,0.00045436,0.32139,0.33468,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0060238,0.32138,0.28644,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0034935,0.32107,0.28569,1,1
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0028457,0.32,0.42461,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.00024771,0.31984,0.32507,1,1
2,GO PROSTAGLANDIN TRANSPORT,0.00051151,0.3198,0.38018,1,1
2,GO CHOLESTEROL EFFLUX,0.00086166,0.31977,0.31795,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.5377e-05,0.31973,0.41545,1,1
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.00042807,0.31933,0.39416,1,1
2,GO RESPONSE TO DEXAMETHASONE,0.00019306,0.31923,0.27978,1,1
2,GO REGULATION OF CALCIUM ION IMPORT,0.00033648,0.31882,0.36333,1,1
2,GO RESPONSE TO CORTICOSTERONE,0.0080134,0.31828,0.29046,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015776,0.3181,0.26165,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.013834,0.31775,0.26777,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00028019,0.3177,0.38497,1,1
2,GO CELLULAR RESPONSE TO DSRNA,0.0013481,0.31751,0.3412,1,1
2,GO MEMBRANE PROTEIN PROTEOLYSIS,8.3641e-05,0.31742,0.39717,1,1
2,GO NECROTIC CELL DEATH,0.00010181,0.31713,0.33335,1,1
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00076864,0.31712,0.32963,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00029789,0.31707,0.37237,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00029789,0.31699,0.36615,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00068502,0.3168,0.37181,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00019306,0.3168,0.3138,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0044907,0.31661,0.31755,1,1
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00014989,0.31633,0.29927,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0010209,0.31631,0.36959,1,1
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0014241,0.3157,0.42055,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00054254,0.31562,0.35688,1,1
2,GO RESPONSE TO NITRIC OXIDE,0.0024341,0.31519,0.26118,1,1
2,GO EPOXYGENASE P450 PATHWAY,0.0010209,0.31515,0.30715,1,1
2,GO REGULATION OF ISOTYPE SWITCHING,0.00060992,0.31514,0.3622,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00060992,0.31505,0.37721,1,1
2,GO GLIAL CELL PROLIFERATION,0.00057531,0.31398,0.34606,1,1
2,GO B CELL APOPTOTIC PROCESS,0.00035748,0.31392,0.33664,1,1
2,GO SEQUESTERING OF CALCIUM ION,0.00057531,0.31391,0.33313,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.013235,0.3135,0.25459,1,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00072571,0.31261,0.41799,1,1
2,GO REGULATION OF WOUND HEALING,0.0003797,0.31244,0.37007,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00010866,0.31215,0.36017,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0012071,0.31113,0.35355,1,1
2,GO RESPONSE TO DSRNA,0.00048214,0.31096,0.30062,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00028019,0.31092,0.35146,1,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0013481,0.30952,0.34087,1,1
2,GO RESPONSE TO AMYLOID BETA,0.0012758,0.30943,0.34479,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.4805e-05,0.30933,0.36089,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0018673,0.30881,0.38997,1,1
2,GO REGULATION OF PROTEIN MATURATION,6.8565e-05,0.30872,0.35365,1,1
2,GO BLOOD VESSEL REMODELING,0.0028457,0.3081,0.39557,1,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00096503,0.3078,0.29354,1,1
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00086166,0.30754,0.37264,1,1
2,GO HYALURONAN METABOLIC PROCESS,0.0012758,0.3075,0.36196,1,1
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.0029965,0.30734,0.38477,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00013188,0.30718,0.33875,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8298e-05,0.3063,0.32992,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,6.4139e-05,0.30629,0.34347,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0027019,0.30559,0.33705,1,1
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0019699,0.30546,0.34373,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0028457,0.30531,0.31674,1,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0027019,0.30523,0.30543,1,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00033648,0.30504,0.33556,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0011418,0.30436,0.31717,1,1
2,GO CELL CELL RECOGNITION,9.5377e-05,0.30341,0.2954,1,1
2,GO POSITIVE CHEMOTAXIS,0.00064645,0.30327,0.36632,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0040644,0.30306,0.25819,1,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.060677,0.30252,0.17882,1,1
2,GO OVULATION,0.00015974,0.30218,0.39424,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00045436,0.302,0.29135,1,1
2,GO CERAMIDE TRANSPORT,0.0023095,0.30195,0.29471,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.2428e-05,0.30188,0.33367,1,1
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0003797,0.30154,0.40975,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00017019,0.30145,0.42172,1,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.013834,0.30115,0.27261,1,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.0020776,0.30041,0.36147,1,1
2,GO TRABECULA MORPHOGENESIS,0.01266,0.30016,0.28333,1,1
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0029965,0.29987,0.32616,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00031664,0.29982,0.30423,1,1
2,GO LYMPH VESSEL DEVELOPMENT,0.0044907,0.29967,0.38999,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.00072571,0.29965,0.26446,1,1
2,GO POSITIVE REGULATION OF JNK CASCADE,0.00064645,0.29887,0.32513,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0076456,0.29885,0.28434,1,1
2,GO REGULATION OF BONE MINERALIZATION,0.0016767,0.29827,0.33865,1,1
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00020554,0.29815,0.3846,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0036751,0.29812,0.34367,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.00054254,0.29802,0.36199,1,1
2,GO NUCLEOSIDE CATABOLIC PROCESS,9.5377e-05,0.29787,0.31804,1,1
2,GO RESPONSE TO PROGESTERONE,0.0016767,0.29776,0.31174,1,1
2,GO REGULATION OF PINOCYTOSIS,0.008797,0.29755,0.26637,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0015041,0.2972,0.36669,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00033648,0.29702,0.32378,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0017696,0.29701,0.24231,1,1
2,GO MATERNAL PLACENTA DEVELOPMENT,0.0010209,0.29673,0.31552,1,1
2,GO ARGININE METABOLIC PROCESS,0.00011593,0.29657,0.32805,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00060992,0.29618,0.36109,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.01266,0.29612,0.25752,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00020554,0.2961,0.29673,1,1
2,GO PROSTATE GLAND GROWTH,0.0017696,0.29567,0.3016,1,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00015974,0.29551,0.36797,1,1
2,GO ICOSANOID METABOLIC PROCESS,9.5377e-05,0.2951,0.35286,1,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0023095,0.29506,0.37215,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00031664,0.29484,0.30447,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00072571,0.29469,0.27864,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0010798,0.29425,0.31584,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0076456,0.29421,0.35001,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00054254,0.29418,0.2656,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00042807,0.29405,0.26231,1,1
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0020776,0.29389,0.29381,1,1
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0015882,0.29363,0.30682,1,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0027019,0.29354,0.33521,1,1
2,GO HYPOTONIC RESPONSE,0.0036751,0.29323,0.32765,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00028019,0.29316,0.34527,1,1
2,GO INTERACTION WITH HOST,0.00013188,0.29302,0.2985,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00091199,0.29267,0.36507,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0027019,0.2926,0.2205,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00068502,0.29253,0.28056,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00029789,0.29243,0.31916,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0010798,0.29196,0.32967,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0015041,0.29186,0.31242,1,1
2,GO REGULATION OF BIOMINERALIZATION,0.0034935,0.29179,0.30098,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0019699,0.29177,0.3135,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.00096503,0.29136,0.30937,1,1
2,GO PEPTIDE CATABOLIC PROCESS,0.0003797,0.2913,0.36344,1,1
2,GO RESPONSE TO INACTIVITY,0.010572,0.29121,0.24556,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.00014062,0.29081,0.33417,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0016767,0.29046,0.28704,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0015041,0.29045,0.2841,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00068502,0.28949,0.27185,1,1
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.0010798,0.28932,0.28379,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00051151,0.28919,0.29501,1,1
2,GO COAGULATION,0.00086166,0.28837,0.32334,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.007293,0.28826,0.20911,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0054671,0.28816,0.28421,1,1
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00051151,0.288,0.29387,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.00042807,0.28735,0.28503,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00060992,0.28721,0.34023,1,1
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00033648,0.28682,0.31574,1,1
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0040644,0.28673,0.29977,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.00026348,0.2867,0.34834,1,1
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.013834,0.28642,0.30702,1,1
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.026142,0.28608,0.30199,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.024086,0.28586,0.27878,1,1
2,GO KERATINOCYTE MIGRATION,0.0047188,0.28576,0.28854,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00040321,0.28568,0.34036,1,1
2,GO POSITIVE REGULATION OF MYELINATION,0.0054671,0.28548,0.29481,1,1
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.065157,0.2854,0.19406,1,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0052065,0.28481,0.26053,1,1
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00023283,0.28475,0.34862,1,1
2,GO STEM CELL DIVISION,0.014457,0.28467,0.25853,1,1
2,GO HEAT GENERATION,0.0010209,0.28408,0.30233,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0042727,0.28408,0.34455,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0060238,0.28364,0.2585,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0092139,0.28362,0.27846,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017019,0.28285,0.2971,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0024341,0.28283,0.29935,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,5.9985e-05,0.28266,0.36275,1,1
2,GO BLOOD VESSEL MORPHOGENESIS,0.00086166,0.28248,0.35326,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00024771,0.28205,0.30091,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0021907,0.28202,0.28139,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0010798,0.28191,0.33978,1,1
2,GO PROSTAGLANDIN SECRETION,0.0023095,0.28151,0.34211,1,1
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00081392,0.28116,0.36849,1,1
2,GO RUFFLE ORGANIZATION,0.00031664,0.28096,0.32532,1,1
2,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.0036751,0.28072,0.26844,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00033648,0.28057,0.32876,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,8.9327e-05,0.28031,0.33727,1,1
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.012106,0.28001,0.24676,1,1
2,GO TISSUE MIGRATION,0.00072571,0.27993,0.32108,1,1
2,GO VASCULATURE DEVELOPMENT,0.00068502,0.27969,0.34106,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00060992,0.27968,0.32624,1,1
2,GO RESPONSE TO STEROL,0.0013481,0.27939,0.29642,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.0027019,0.27912,0.25019,1,1
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00048214,0.27891,0.34403,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.00054254,0.27885,0.34672,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0016767,0.2788,0.29792,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00076864,0.27832,0.33066,1,1
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00332,0.27822,0.3152,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.010572,0.27822,0.24227,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00028019,0.27797,0.37756,1,1
2,GO KERATINOCYTE PROLIFERATION,0.0040644,0.2778,0.28537,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.031957,0.27739,0.2071,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.018736,0.27738,0.24685,1,1
2,GO PULMONARY VALVE MORPHOGENESIS,0.010572,0.27738,0.34932,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00054254,0.27732,0.29589,1,1
2,GO TERPENOID METABOLIC PROCESS,0.00011593,0.27719,0.27369,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00010866,0.27712,0.31903,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00029789,0.27674,0.30919,1,1
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.8565e-05,0.27664,0.32019,1,1
2,GO ENAMEL MINERALIZATION,0.00026348,0.27637,0.4056,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.0018673,0.27634,0.28602,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.019548,0.27599,0.24552,1,1
2,GO RESPONSE TO ATP,0.00011593,0.27584,0.32838,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0021907,0.27582,0.3417,1,1
2,GO REGULATION OF AMYLOID BETA FORMATION,0.00068502,0.27488,0.30409,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00081392,0.27479,0.2841,1,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.0076456,0.27474,0.3211,1,1
2,GO MUSCLE CELL PROLIFERATION,0.00026348,0.27419,0.33218,1,1
2,GO GLOMERULUS DEVELOPMENT,0.0063209,0.27405,0.34345,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0028457,0.27358,0.28097,1,1
2,GO GLIAL CELL MIGRATION,0.0057394,0.27273,0.2767,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.0021907,0.27273,0.30296,1,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.0014241,0.2726,0.27157,1,1
2,GO CELL MATRIX ADHESION,0.0044907,0.2725,0.31866,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.00096503,0.27236,0.31329,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,3.4805e-05,0.27207,0.31596,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040321,0.27191,0.30775,1,1
2,GO IRON ION HOMEOSTASIS,0.00045436,0.27188,0.2749,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0018673,0.27176,0.3232,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.012106,0.27162,0.25334,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.00064645,0.27137,0.31394,1,1
2,GO ENDODERM DEVELOPMENT,0.0060238,0.27126,0.29955,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00076864,0.27085,0.27065,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00076864,0.27077,0.39679,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00010866,0.26983,0.37194,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00072571,0.26945,0.30701,1,1
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.031957,0.26914,0.21025,1,1
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.00033648,0.26831,0.31276,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.00023283,0.2677,0.2848,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0036751,0.26751,0.28679,1,1
2,GO VIRAL GENOME REPLICATION,0.0014241,0.26695,0.28298,1,1
2,GO AORTIC VALVE DEVELOPMENT,0.0054671,0.26689,0.37204,1,1
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0019699,0.26647,0.31382,1,1
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0042727,0.26629,0.23556,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00010181,0.26623,0.32688,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00021879,0.26599,0.29834,1,1
2,GO RIG I SIGNALING PATHWAY,0.00081392,0.26592,0.27596,1,1
2,GO PROTEIN KINASE B SIGNALING,0.00024771,0.26587,0.31727,1,1
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020776,0.26564,0.25186,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00031664,0.2654,0.26777,1,1
2,GO RESPONSE TO CORTICOSTEROID,0.00051151,0.26532,0.28705,1,1
2,GO SULFATION,0.0083971,0.26492,0.27034,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00076864,0.26492,0.34475,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.006955,0.26487,0.25314,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0044907,0.2645,0.36226,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0020776,0.26429,0.26623,1,1
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0019699,0.26395,0.30473,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0031545,0.26394,0.30151,1,1
2,GO PROSTATIC BUD FORMATION,0.0080134,0.26385,0.34914,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00013188,0.2637,0.27899,1,1
2,GO RESPONSE TO LIPID,0.00031664,0.26366,0.27459,1,1
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00042807,0.26351,0.30267,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,4.8997e-05,0.26333,0.36175,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00064645,0.26286,0.2926,1,1
2,GO REGULATION OF CELL SHAPE,0.00048214,0.26202,0.31994,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00033648,0.26173,0.31778,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00091199,0.26173,0.32914,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0028457,0.26169,0.26986,1,1
2,GO MYOTUBE DIFFERENTIATION,0.0014241,0.26136,0.27377,1,1
2,GO SEQUESTERING OF TRIGLYCERIDE,0.0047188,0.26126,0.2779,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.0015882,0.2612,0.30415,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.00081392,0.26106,0.30253,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00045436,0.26083,0.28699,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.0021907,0.26034,0.34044,1,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.0052065,0.26005,0.27928,1,1
2,GO PANCREATIC JUICE SECRETION,0.014457,0.25993,0.25762,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,3.248e-05,0.25935,0.29131,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00015974,0.25903,0.28359,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0012758,0.25883,0.27953,1,1
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00011593,0.25843,0.29421,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0023095,0.25792,0.24145,1,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0057394,0.25787,0.37326,1,1
2,GO EXOCYTOSIS,0.00072571,0.25751,0.26235,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.00051151,0.2574,0.27905,1,1
2,GO CELLULAR RESPONSE TO NUTRIENT,0.035953,0.25694,0.21534,1,1
2,GO REGULATION OF TRANSPOSITION,0.025096,0.25693,0.19572,1,1
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.052482,0.25661,0.29346,1,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.0054671,0.25631,0.30059,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.00086166,0.25619,0.26158,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.0023095,0.25617,0.32139,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0025648,0.25603,0.24003,1,1
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.021265,0.25551,0.29315,1,1
2,GO VIRAL LIFE CYCLE,0.00031664,0.25543,0.28042,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.011063,0.25534,0.24548,1,1
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.016475,0.25519,0.23622,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0083971,0.25485,0.26944,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0012758,0.25477,0.2318,1,1
2,GO BONE MATURATION,0.0096484,0.25452,0.2696,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0034935,0.25422,0.2984,1,1
2,GO ARTERY MORPHOGENESIS,0.0021907,0.25402,0.32724,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0014241,0.2539,0.26475,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00033648,0.25326,0.3063,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0031545,0.25296,0.27001,1,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0023095,0.25265,0.30934,1,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.0034935,0.2523,0.27527,1,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.0044907,0.25223,0.2903,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0012758,0.25222,0.32372,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.046961,0.2522,0.23999,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.00081392,0.25191,0.27472,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.0003797,0.2519,0.30685,1,1
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00091199,0.2515,0.23036,1,1
2,GO SALIVARY GLAND DEVELOPMENT,0.010101,0.25148,0.30805,1,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0010209,0.25109,0.28292,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0042727,0.25078,0.30081,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0025648,0.25039,0.22183,1,1
2,GO ARTERY DEVELOPMENT,0.0038653,0.25021,0.3164,1,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0010209,0.24982,0.29034,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.2763e-05,0.24944,0.2729,1,1
2,GO CORNIFICATION,0.060677,0.24928,0.17093,1,1
2,GO BRONCHUS DEVELOPMENT,0.012106,0.24894,0.32423,1,1
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.022172,0.24854,0.23918,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0036751,0.24811,0.25941,1,1
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,5.6086e-05,0.24809,0.27756,1,1
2,GO EMBRYO IMPLANTATION,0.00081392,0.24809,0.31883,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.00012367,0.24773,0.2372,1,1
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.013235,0.24771,0.24393,1,1
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0024341,0.24728,0.27412,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028457,0.24694,0.23343,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00021879,0.24655,0.25183,1,1
2,GO TISSUE REGENERATION,0.00072571,0.24637,0.24679,1,1
2,GO REPLACEMENT OSSIFICATION,0.0063209,0.24622,0.29878,1,1
2,GO MIDGUT DEVELOPMENT,0.027226,0.24603,0.25065,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00023283,0.24557,0.28475,1,1
2,GO MANGANESE ION TRANSPORT,0.0057394,0.24556,0.2283,1,1
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.026142,0.24549,0.27679,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00051151,0.24522,0.26557,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.008797,0.2451,0.2664,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0034935,0.24477,0.27445,1,1
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.018736,0.24438,0.261,1,1
2,GO HEART VALVE DEVELOPMENT,0.0066311,0.24433,0.31772,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045436,0.24422,0.28756,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00020554,0.24399,0.25631,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.00024771,0.24381,0.24815,1,1
2,GO RESPONSE TO HYPEROXIA,0.00081392,0.24298,0.30201,1,1
2,GO REGULATION OF GASTRULATION,0.0012758,0.24288,0.28876,1,1
2,GO FIBROBLAST ACTIVATION,0.0054671,0.24284,0.27957,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0080134,0.24283,0.26913,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00072571,0.24264,0.25588,1,1
2,GO SECRETION BY TISSUE,0.00091199,0.24205,0.251,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0012071,0.24203,0.24003,1,1
2,GO RESPONSE TO GROWTH HORMONE,0.00048214,0.24182,0.26862,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00042807,0.24116,0.24613,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.013834,0.24109,0.2148,1,1
2,GO LUNG MORPHOGENESIS,0.0057394,0.24104,0.28881,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.0020776,0.24102,0.2567,1,1
2,GO RESPONSE TO RETINOIC ACID,0.0016767,0.24101,0.26534,1,1
2,GO BIOMINERALIZATION,0.0038653,0.24098,0.25479,1,1
2,GO TAXIS,0.0017696,0.24081,0.26859,1,1
2,GO BONE DEVELOPMENT,0.0016767,0.24072,0.2848,1,1
2,GO RESPONSE TO FATTY ACID,0.00060992,0.23988,0.25358,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0066311,0.23937,0.33092,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.013235,0.23917,0.29556,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0028457,0.23823,0.2478,1,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.0076456,0.23781,0.20977,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.007293,0.23778,0.28126,1,1
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.043559,0.23655,0.26193,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00042807,0.23649,0.27202,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0044907,0.23634,0.24985,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.23614,0.28814,1,1
2,GO PLASMA MEMBRANE FUSION,0.0042727,0.23613,0.28137,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00054254,0.23608,0.25555,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00060992,0.23565,0.25155,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00019306,0.23564,0.27268,1,1
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0080134,0.23507,0.26233,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.026142,0.23459,0.21304,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0063209,0.23447,0.22055,1,1
2,GO TRANSPOSITION,0.034576,0.23429,0.17236,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.0028457,0.23404,0.25775,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00031664,0.23398,0.26658,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023283,0.23383,0.25636,1,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0021907,0.23378,0.24619,1,1
2,GO RESPONSE TO ESTROGEN,0.0015041,0.23364,0.2643,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.00023283,0.23362,0.25156,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.006955,0.23292,0.26901,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0019699,0.23281,0.28428,1,1
2,GO CELL CELL ADHESION,0.00096503,0.23278,0.2875,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0014241,0.23258,0.30319,1,1
2,GO MEGAKARYOCYTE DEVELOPMENT,0.0060238,0.23252,0.26171,1,1
2,GO ODONTOGENESIS,0.0031545,0.2325,0.25694,1,1
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0018673,0.23236,0.2586,1,1
2,GO DRUG METABOLIC PROCESS,0.0020776,0.2323,0.27827,1,1
2,GO COPPER ION HOMEOSTASIS,0.0010209,0.23166,0.232,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.040368,0.23123,0.20467,1,1
2,GO DETOXIFICATION,0.00011593,0.23119,0.24179,1,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.046961,0.23105,0.18464,1,1
2,GO STEROL TRANSPORT,0.00054254,0.23077,0.28312,1,1
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0027019,0.23063,0.25974,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00072571,0.23053,0.24965,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0047188,0.22942,0.26175,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0038653,0.2292,0.2408,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.01266,0.2292,0.2996,1,1
2,GO AMYLOID BETA FORMATION,0.0013481,0.22913,0.25967,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0057394,0.22843,0.26093,1,1
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0010209,0.22834,0.28426,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.018736,0.22804,0.19545,1,1
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.016475,0.22791,0.24218,1,1
2,GO BROWN FAT CELL DIFFERENTIATION,0.0027019,0.22759,0.23499,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00081392,0.2271,0.2601,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.007293,0.22698,0.2419,1,1
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0020776,0.22687,0.23905,1,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.0014241,0.22666,0.24661,1,1
2,GO ENDOCARDIAL CUSHION FORMATION,0.040368,0.22666,0.27338,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00081392,0.22608,0.28529,1,1
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0021907,0.22607,0.20785,1,1
2,GO FACE DEVELOPMENT,0.035953,0.22561,0.23418,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.00045436,0.22498,0.241,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,3.4805e-05,0.22478,0.25642,1,1
2,GO MRNA TRANSCRIPTION,0.011063,0.22473,0.26167,1,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.01266,0.22455,0.29252,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.031957,0.22451,0.22314,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00045436,0.22431,0.25306,1,1
2,GO LIPID STORAGE,0.00076864,0.22378,0.27083,1,1
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.00019306,0.22362,0.25813,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.00072571,0.22361,0.26314,1,1
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0027019,0.22348,0.23706,1,1
2,GO FATTY ACID TRANSPORT,0.00017019,0.22311,0.27545,1,1
2,GO LIPID HOMEOSTASIS,0.00031664,0.22219,0.25917,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00045436,0.22209,0.24362,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.040368,0.22153,0.28033,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014062,0.2215,0.25658,1,1
2,GO BIOLOGICAL ADHESION,0.0015882,0.22108,0.28469,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.0017696,0.22101,0.24034,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.0012071,0.22071,0.24299,1,1
2,GO AMELOGENESIS,0.00096503,0.22042,0.31601,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0019699,0.22027,0.23875,1,1
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0011418,0.2195,0.21929,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00064645,0.2195,0.24704,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00096503,0.21872,0.29102,1,1
2,GO DRUG CATABOLIC PROCESS,0.015104,0.21863,0.20754,1,1
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.0063209,0.21845,0.28551,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0013481,0.21781,0.25332,1,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00048214,0.21762,0.29284,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0021907,0.21725,0.21504,1,1
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0024341,0.21681,0.27776,1,1
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0036751,0.21652,0.2601,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0012758,0.21622,0.26454,1,1
2,GO TRACHEA MORPHOGENESIS,0.033245,0.2161,0.30768,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0049572,0.21599,0.23402,1,1
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.020391,0.21581,0.23793,1,1
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0016767,0.2158,0.25501,1,1
2,GO REGULATION OF MAPK CASCADE,0.00086166,0.21569,0.26657,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.016475,0.21537,0.29124,1,1
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.0003797,0.21534,0.2784,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00096503,0.21526,0.2711,1,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0018673,0.21499,0.29173,1,1
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.011574,0.21447,0.3093,1,1
2,GO NEPHRON TUBULE FORMATION,0.0083971,0.21384,0.24798,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0017696,0.21365,0.2049,1,1
2,GO BILE ACID METABOLIC PROCESS,0.00086166,0.21358,0.21879,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00031664,0.21354,0.2406,1,1
2,GO AORTA DEVELOPMENT,0.0047188,0.21344,0.2957,1,1
2,GO HEPARIN METABOLIC PROCESS,0.015776,0.21292,0.26666,1,1
2,GO ANIMAL ORGAN REGENERATION,0.00029789,0.21203,0.24756,1,1
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0172,0.21199,0.23122,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0031545,0.21197,0.24184,1,1
2,GO PROTEIN AUTOPROCESSING,0.015104,0.21191,0.19025,1,1
2,GO BICARBONATE TRANSPORT,0.037377,0.21173,0.18123,1,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.0024341,0.21164,0.23053,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0027019,0.21138,0.22482,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0054671,0.21131,0.24625,1,1
2,GO ACTIVATION OF MAPK ACTIVITY,0.0025648,0.21109,0.22604,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.0010798,0.21108,0.25699,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.008797,0.21065,0.20894,1,1
2,GO PRIMARY MIRNA PROCESSING,0.01266,0.21029,0.26462,1,1
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.017954,0.21011,0.25261,1,1
2,GO TISSUE HOMEOSTASIS,0.00054254,0.21011,0.25297,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.025096,0.21002,0.20394,1,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0172,0.2098,0.1899,1,1
2,GO METAL ION HOMEOSTASIS,0.0031545,0.20977,0.22939,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0016767,0.20971,0.24646,1,1
2,GO ESTROUS CYCLE,0.031957,0.20934,0.24928,1,1
2,GO RESPONSE TO SALT STRESS,0.030713,0.20906,0.20227,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0024341,0.20878,0.24626,1,1
2,GO ERBB SIGNALING PATHWAY,0.0017696,0.20877,0.23921,1,1
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0020776,0.2085,0.24588,1,1
2,GO ETHER METABOLIC PROCESS,0.0014241,0.20833,0.22429,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0080134,0.20832,0.29422,1,1
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0083971,0.20828,0.20336,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014989,0.20827,0.26128,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.00060992,0.20803,0.24909,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.018736,0.20801,0.22195,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066311,0.20789,0.21745,1,1
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0036751,0.20766,0.23843,1,1
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.008797,0.20693,0.23526,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.007293,0.20684,0.25432,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.0054671,0.20675,0.20745,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.011063,0.20668,0.20603,1,1
2,GO FAT CELL DIFFERENTIATION,0.00332,0.20651,0.23882,1,1
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0010798,0.20635,0.20929,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.00060992,0.20622,0.23695,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.0015041,0.20584,0.24966,1,1
2,GO PLATELET MORPHOGENESIS,0.0034935,0.20573,0.28931,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0016767,0.20541,0.24312,1,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0016767,0.2053,0.22311,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00057531,0.2051,0.34747,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0049572,0.20501,0.26142,1,1
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0063209,0.20479,0.28398,1,1
2,GO CELLULAR RESPONSE TO CAMP,0.00081392,0.20464,0.24316,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.041938,0.20462,0.23663,1,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.00096503,0.20456,0.27517,1,1
2,GO CELL MOTILITY,0.0028457,0.20445,0.2398,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00081392,0.20438,0.22801,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.011063,0.2043,0.32159,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0016767,0.20424,0.22119,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0021907,0.20414,0.24185,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0047188,0.20337,0.2078,1,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.0012071,0.20272,0.23877,1,1
2,GO CELLULAR RESPONSE TO ATP,0.0025648,0.20268,0.26105,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.012106,0.20232,0.19129,1,1
2,GO CELLULAR ION HOMEOSTASIS,0.0038653,0.20197,0.21215,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0012758,0.20173,0.25992,1,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.00024771,0.20171,0.25072,1,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.008797,0.20168,0.24574,1,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025648,0.20161,0.23664,1,1
2,GO FOREGUT MORPHOGENESIS,0.024086,0.2016,0.24546,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0038653,0.20103,0.2348,1,1
2,GO RESPONSE TO CAMP,0.0016767,0.20059,0.26263,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.006955,0.20022,0.23724,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0010209,0.19912,0.24119,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.0044907,0.19902,0.19242,1,1
2,GO CELLULAR RESPONSE TO STEROL,0.038848,0.19897,0.19983,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0015882,0.19894,0.23299,1,1
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0018673,0.19883,0.23778,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0038653,0.19871,0.22247,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0096484,0.19829,0.22705,1,1
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.045233,0.19799,0.18601,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.037377,0.19785,0.24066,1,1
2,GO PROTEIN PROCESSING,0.00060992,0.19772,0.26149,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0060238,0.19755,0.2318,1,1
2,GO XENOBIOTIC TRANSPORT,0.060677,0.19673,0.18217,1,1
2,GO LIPID CATABOLIC PROCESS,0.00057531,0.19667,0.21502,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0063209,0.19656,0.22864,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00086166,0.19651,0.23304,1,1
2,GO PERICARDIUM DEVELOPMENT,0.0038653,0.19624,0.29346,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.007293,0.19612,0.22203,1,1
2,GO RESPONSE TO KETONE,0.0016767,0.19608,0.2255,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.015776,0.19599,0.22469,1,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00091199,0.19597,0.25638,1,1
2,GO ANIMAL ORGAN MATURATION,0.0172,0.19596,0.23317,1,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.006955,0.19527,0.20637,1,1
2,GO RNA DECAPPING,0.0096484,0.19462,0.21173,1,1
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0054671,0.19449,0.21279,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0011418,0.19386,0.34689,1,1
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0012758,0.19378,0.24599,1,1
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.021265,0.19361,0.19107,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00096503,0.19321,0.24951,1,1
2,GO REGULATION OF PROTEOLYSIS,0.00064645,0.19294,0.21982,1,1
2,GO NUCLEOTIDE SALVAGE,0.0057394,0.19288,0.20091,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0027019,0.19232,0.23127,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0003797,0.19187,0.23161,1,1
2,GO MYOBLAST PROLIFERATION,0.0060238,0.19163,0.2893,1,1
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0024341,0.1916,0.22109,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.031957,0.19141,0.20434,1,1
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0092139,0.19112,0.2287,1,1
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0029965,0.19094,0.2038,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0031545,0.1906,0.18304,1,1
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0054671,0.19032,0.24166,1,1
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0044907,0.19011,0.25678,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.02951,0.18994,0.19157,1,1
2,GO MAINTENANCE OF LOCATION,0.0016767,0.18982,0.22096,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.0040644,0.18982,0.22377,1,1
2,GO CELLULAR RESPONSE TO FATTY ACID,0.0076456,0.18963,0.20069,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.013235,0.18946,0.18978,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00096503,0.18941,0.19204,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,0.0031545,0.18936,0.17994,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.015104,0.18902,0.25425,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0010209,0.18892,0.23973,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00064645,0.18889,0.23644,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.00028019,0.18841,0.2215,1,1
2,GO ION HOMEOSTASIS,0.0031545,0.18809,0.20936,1,1
2,GO GLYCOSIDE METABOLIC PROCESS,0.0003797,0.18799,0.21216,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0010798,0.18781,0.18158,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0014241,0.18773,0.2144,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0010798,0.18741,0.21572,1,1
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.015104,0.18716,0.21094,1,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0020776,0.18639,0.22357,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0096484,0.18584,0.20779,1,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.0096484,0.18542,0.25215,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.017954,0.18541,0.17372,1,1
2,GO PROTEIN HOMOTETRAMERIZATION,0.0036751,0.18496,0.21822,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.0025648,0.18492,0.22817,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016475,0.18484,0.24898,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.011063,0.18482,0.20856,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0015882,0.18473,0.26509,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.015104,0.18456,0.24497,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.00064645,0.18433,0.20811,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0044907,0.18402,0.18167,1,1
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0040644,0.18367,0.23551,1,1
2,GO JNK CASCADE,0.0036751,0.18319,0.2265,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.018736,0.18305,0.14488,1,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0029965,0.18304,0.18583,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.021265,0.18296,0.18923,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.017954,0.18262,0.17684,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.018736,0.18261,0.20523,1,1
2,GO AUTOPHAGOSOME MATURATION,0.0057394,0.18165,0.17464,1,1
2,GO SECRETION,0.0044907,0.18136,0.20594,1,1
2,GO IMP BIOSYNTHETIC PROCESS,0.062884,0.18124,0.10971,1,1
2,GO DIGESTION,0.013235,0.18122,0.18015,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.011574,0.18116,0.21221,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0057394,0.18115,0.20203,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00040321,0.18112,0.20204,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.00014062,0.18085,0.23544,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.00076864,0.18046,0.23429,1,1
2,GO PLACENTA DEVELOPMENT,0.0083971,0.18006,0.19899,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.013235,0.17987,0.19886,1,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.013834,0.17966,0.23375,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0021907,0.17952,0.20955,1,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0015882,0.17927,0.21445,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0025648,0.1792,0.22742,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00091199,0.17894,0.20947,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0092139,0.17866,0.1662,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00045436,0.17863,0.23766,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0017696,0.1784,0.27442,1,1
2,GO RESPONSE TO UV B,0.0063209,0.17801,0.21168,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0063209,0.17746,0.19929,1,1
2,GO ENDOCYTOSIS,0.0052065,0.17716,0.22264,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0016767,0.17706,0.22756,1,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0076456,0.1769,0.23565,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.034576,0.17682,0.24013,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0031545,0.17675,0.23227,1,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.021265,0.17669,0.21212,1,1
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.023112,0.17646,0.17721,1,1
2,GO CELLULAR RESPONSE TO KETONE,0.0076456,0.17644,0.18478,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0020776,0.17616,0.21891,1,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037377,0.17607,0.20762,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00068502,0.17576,0.21269,1,1
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.060677,0.17574,0.16397,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0003797,0.17561,0.22352,1,1
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.017954,0.17553,0.21043,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.031957,0.17525,0.10757,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.0012071,0.17524,0.1877,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0096484,0.1749,0.18754,1,1
2,GO STEROL METABOLIC PROCESS,0.0016767,0.17451,0.20963,1,1
2,GO LIPID OXIDATION,0.013834,0.17438,0.14819,1,1
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.010101,0.17435,0.24586,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0021907,0.17428,0.20652,1,1
2,GO RESPONSE TO ALCOHOL,0.00332,0.17424,0.20627,1,1
2,GO HEME METABOLIC PROCESS,0.00045436,0.17395,0.20355,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0057394,0.17349,0.19002,1,1
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.031957,0.17202,0.17598,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0036751,0.17164,0.19676,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.015104,0.17071,0.17909,1,1
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.040368,0.17043,0.20496,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0083971,0.1697,0.21419,1,1
2,GO STEROID METABOLIC PROCESS,0.0012758,0.16949,0.18661,1,1
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.006955,0.16915,0.18632,1,1
2,GO POSITIVE REGULATION OF SIGNALING,0.0076456,0.16819,0.18121,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.0080134,0.16815,0.2104,1,1
2,GO RESPONSE TO MUSCLE STRETCH,0.052482,0.16813,0.22936,1,1
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.069906,0.16793,0.15082,1,1
2,GO INACTIVATION OF MAPK ACTIVITY,0.011574,0.16758,0.23073,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0066311,0.16706,0.21318,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034935,0.16703,0.19826,1,1
2,GO RUFFLE ASSEMBLY,0.0054671,0.16699,0.21498,1,1
2,GO CELL RECOGNITION,0.008797,0.16668,0.19679,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0025648,0.16601,0.22942,1,1
2,GO LIVER REGENERATION,0.00096503,0.16595,0.23025,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.030713,0.16526,0.21402,1,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0066311,0.16523,0.20186,1,1
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.026142,0.16463,0.17692,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.016475,0.16432,0.18718,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.00096503,0.1642,0.23737,1,1
2,GO REGENERATION,0.0029965,0.1639,0.20035,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.034576,0.16348,0.20927,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.028348,0.16338,0.14458,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.016475,0.16333,0.16257,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.026142,0.1631,0.15925,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0017696,0.1631,0.21741,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.011063,0.16307,0.17935,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.041938,0.16299,0.20889,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0042727,0.16258,0.18342,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.031957,0.16246,0.1594,1,1
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.060677,0.1623,0.14595,1,1
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.043559,0.1623,0.19603,1,1
2,GO SYMBIOTIC PROCESS,0.0015882,0.16208,0.17607,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.021265,0.16177,0.21864,1,1
2,GO CARTILAGE DEVELOPMENT,0.011574,0.16156,0.23392,1,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0052065,0.16148,0.28217,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.008797,0.16115,0.24584,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.0010798,0.16111,0.20169,1,1
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.01266,0.16099,0.23758,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0016767,0.1609,0.21662,1,1
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.013235,0.16068,0.16896,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.011574,0.16026,0.19314,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0016767,0.16015,0.19598,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0047188,0.15987,0.18884,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0012071,0.15952,0.19792,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0040644,0.15903,0.21218,1,1
2,GO REGULATION OF CELL DEATH,0.0012071,0.15894,0.19895,1,1
2,GO GDP METABOLIC PROCESS,0.021265,0.15878,0.21218,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.01266,0.15822,0.17297,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0023095,0.15788,0.23289,1,1
2,GO VACUOLAR ACIDIFICATION,0.0031545,0.15787,0.20136,1,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.008797,0.15768,0.18313,1,1
2,GO RESPONSE TO SALT,0.065157,0.15766,0.12642,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00068502,0.15766,0.22667,1,1
2,GO RNA DESTABILIZATION,0.058535,0.15739,0.19834,1,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.010101,0.15736,0.17654,1,1
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.058535,0.15695,0.1368,1,1
2,GO PROTEIN MATURATION,0.0015041,0.1566,0.20201,1,1
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0049572,0.15651,0.22523,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.046961,0.1563,0.16238,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049572,0.15598,0.19441,1,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038653,0.15576,0.19572,1,1
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.043559,0.15548,0.16026,1,1
2,GO BLASTODERM SEGMENTATION,0.0028457,0.15502,0.23719,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.010101,0.15474,0.1696,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.01266,0.15434,0.20851,1,1
2,GO REGULATION OF CELLULAR PH,0.041938,0.1543,0.13649,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00018128,0.15395,0.20271,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.010572,0.15373,0.17563,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0076456,0.15367,0.15757,1,1
2,GO ESTROGEN METABOLIC PROCESS,0.0060238,0.15367,0.16515,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0047188,0.15322,0.17004,1,1
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.012106,0.15272,0.15655,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0083971,0.15171,0.19989,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0021907,0.15168,0.16611,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0014241,0.15131,0.22407,1,1
2,GO RESPONSE TO X RAY,0.037377,0.15125,0.19309,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.011574,0.1509,0.16571,1,1
2,GO LIPID METABOLIC PROCESS,0.0024341,0.15051,0.17737,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00064645,0.15021,0.20972,1,1
2,GO EPIDERMIS DEVELOPMENT,0.045233,0.14989,0.14595,1,1
2,GO DNA DEMETHYLATION,0.060677,0.14983,0.15102,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,0.013834,0.14959,0.14929,1,1
2,GO BODY FLUID SECRETION,0.030713,0.14922,0.14711,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.041938,0.14908,0.1515,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.022172,0.14832,0.18155,1,1
2,GO IRON ION TRANSPORT,0.0076456,0.14832,0.17846,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.0092139,0.1483,0.16137,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.027226,0.14788,0.18316,1,1
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.037377,0.14773,0.14525,1,1
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.027226,0.14747,0.19142,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.011063,0.14704,0.22153,1,1
2,GO MESODERMAL CELL FATE COMMITMENT,0.026142,0.14643,0.13692,1,1
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0040644,0.14635,0.25823,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0049572,0.14627,0.20597,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0049572,0.14583,0.16445,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0096484,0.14536,0.14494,1,1
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.0049572,0.1452,0.19107,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0013481,0.14496,0.17461,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.010572,0.14476,0.19869,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.067497,0.14381,0.13391,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.007293,0.14358,0.16298,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.010101,0.1435,0.17784,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.024086,0.14325,0.18631,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.025096,0.14299,0.13627,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.034576,0.14292,0.1737,1,1
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0023095,0.14255,0.19243,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0027019,0.14205,0.155,1,1
2,GO MITOCHONDRIAL DEPOLARIZATION,0.016475,0.14197,0.21947,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.0060238,0.14173,0.18287,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0014241,0.14164,0.23145,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012758,0.14161,0.15522,1,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.0092139,0.14155,0.19801,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0012758,0.14146,0.16547,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.040368,0.14135,0.14975,1,1
2,GO SLEEP,0.013235,0.14078,0.16598,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0019699,0.14019,0.1924,1,1
2,GO NADP METABOLIC PROCESS,0.019548,0.13978,0.15327,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.024086,0.13919,0.19457,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,0.015776,0.13915,0.16352,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.016475,0.13883,0.19253,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.007293,0.13877,0.16864,1,1
2,GO GASTRIC ACID SECRETION,0.069906,0.13875,0.1331,1,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.023112,0.13862,0.16599,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.007293,0.13846,0.18417,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0023095,0.13703,0.14863,1,1
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.040368,0.13667,0.16503,1,1
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.030713,0.13584,0.20174,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.033245,0.13532,0.193,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0076456,0.1353,0.16074,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.0036751,0.13528,0.1921,1,1
2,GO CELLULAR HOMEOSTASIS,0.0066311,0.1351,0.16891,1,1
2,GO VESICLE CARGO LOADING,0.038848,0.13506,0.14853,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0096484,0.13399,0.17121,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0076456,0.13296,0.23313,1,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0034935,0.13286,0.17054,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.037377,0.13278,0.1346,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036751,0.1327,0.16046,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0047188,0.13239,0.15648,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.050584,0.13202,0.14119,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0028457,0.13177,0.19269,1,1
2,GO BLASTOCYST FORMATION,0.0049572,0.13167,0.15671,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0044907,0.13154,0.17804,1,1
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.043559,0.13052,0.20324,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0036751,0.1304,0.15694,1,1
2,GO GTP METABOLIC PROCESS,0.0049572,0.13002,0.16085,1,1
2,GO HOMEOSTATIC PROCESS,0.0076456,0.12997,0.16994,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.067497,0.12992,0.14629,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.037377,0.12905,0.16029,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.007293,0.12892,0.15402,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.048745,0.12871,0.15236,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.013834,0.12851,0.15296,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.020391,0.1285,0.16382,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.024086,0.1284,0.15907,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.040368,0.12683,0.1292,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.0049572,0.1267,0.13856,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0031545,0.12649,0.15778,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.045233,0.1263,0.12161,1,1
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.02951,0.12613,0.18184,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.045233,0.12517,0.14448,1,1
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.018736,0.12494,0.14215,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.048745,0.12459,0.11576,1,1
2,GO MICROVILLUS ORGANIZATION,0.067497,0.12332,0.13847,1,1
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.040368,0.12317,0.14028,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0047188,0.12312,0.17789,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.015104,0.12289,0.1716,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.019548,0.12261,0.14918,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.023112,0.12215,0.15931,1,1
2,GO RESPONSE TO PEPTIDE,0.016475,0.12209,0.1642,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.019548,0.12203,0.14226,1,1
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023095,0.12036,0.17556,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.013834,0.12006,0.15902,1,1
2,GO PROTEIN TETRAMERIZATION,0.014457,0.11985,0.16726,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.0066311,0.11793,0.16155,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.008797,0.11773,0.16526,1,1
2,GO REGULATION OF PH,0.056456,0.11634,0.12065,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.037377,0.11633,0.14174,1,1
2,GO ACTIN NUCLEATION,0.008797,0.11631,0.1665,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE,0.041938,0.11622,0.15417,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0096484,0.1156,0.16357,1,1
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.016475,0.11427,0.1532,1,1
2,GO AMP METABOLIC PROCESS,0.031957,0.11323,0.14036,1,1
2,GO COPII COATED VESICLE BUDDING,0.045233,0.11321,0.13396,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0063209,0.11263,0.16026,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.054439,0.11249,0.1393,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0076456,0.11137,0.14967,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.0052065,0.11121,0.1398,1,1
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.065157,0.11119,0.13035,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.020391,0.11108,0.13341,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.006955,0.10961,0.16748,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0023095,0.1091,0.16023,1,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.052482,0.10817,0.12793,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.026142,0.10802,0.15833,1,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.060677,0.108,0.14003,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.011063,0.10715,0.18851,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.052482,0.10205,0.11893,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.052482,0.10157,0.12552,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.069906,0.10148,0.10944,1,1
2,GO GOLGI VESICLE BUDDING,0.045233,0.10131,0.13343,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0036751,0.10059,0.13939,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.028348,0.098073,0.16519,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.097961,0.10889,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0096484,0.097728,0.14244,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.069906,0.097302,0.1251,1,1
2,GO REGULATION OF LIGASE ACTIVITY,0.038848,0.097268,0.12944,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.065157,0.096585,0.11586,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.010101,0.096158,0.1299,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.030713,0.095326,0.11028,1,1
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.02951,0.094703,0.16224,1,1
2,GO PROTEIN DESTABILIZATION,0.022172,0.094451,0.15496,1,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.050584,0.092188,0.18168,1,1
2,GO THIOESTER METABOLIC PROCESS,0.038848,0.090659,0.13636,1,1
2,GO REGULATION OF ERAD PATHWAY,0.048745,0.089587,0.15544,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.010101,0.089322,0.13575,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.034576,0.089208,0.12162,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0092139,0.087023,0.13624,1,1
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.065157,0.086843,0.12299,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.067497,0.08391,0.14237,1,1
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.069906,0.082938,0.13855,1,1
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.050584,0.082346,0.1422,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.023112,0.079362,0.13129,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.050584,0.076029,0.13864,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.038848,0.072567,0.13438,1,1
3,GO OUTER DYNEIN ARM ASSEMBLY,0.0016767,0.78155,0.67742,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00010181,0.74171,0.66715,1,1
3,GO RESPONSE TO POTASSIUM ION,6.6813e-06,0.7205,0.69981,1,1
3,GO NEURON CELL CELL ADHESION,1.2939e-05,0.70031,0.74462,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.5779e-05,0.69195,0.73166,1,1
3,GO INNER DYNEIN ARM ASSEMBLY,0.006955,0.68756,0.56731,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00017019,0.68474,0.65109,1,1
3,GO SYNAPTIC VESICLE DOCKING,1.6059e-05,0.68102,0.8091,1,1
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00091199,0.67389,0.5943,1,1
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,5.9985e-05,0.67104,0.65759,1,1
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00035748,0.64875,0.55325,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00014989,0.63281,0.6673,1,1
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00035748,0.63225,0.51743,1,1
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,2.636e-05,0.63112,0.79534,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.6059e-05,0.62761,0.61144,1,1
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00014062,0.62293,0.57303,1,1
3,GO SYNAPTIC MEMBRANE ADHESION,5.9985e-05,0.61574,0.5937,1,1
3,GO PREPULSE INHIBITION,8.3641e-05,0.6121,0.61698,1,1
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,9.5377e-05,0.60263,0.71021,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,8.9327e-05,0.59323,0.55681,1,1
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00057531,0.59188,0.57425,1,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0024341,0.58344,0.4637,1,1
3,GO STARTLE RESPONSE,2.8267e-05,0.58154,0.54016,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,1.9888e-05,0.57614,0.69064,1,1
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,2.2907e-05,0.57595,0.62262,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00045436,0.5733,0.63774,1,1
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00035748,0.56669,0.54256,1,1
3,GO DIVALENT METAL ION EXPORT,0.0012071,0.56391,0.46343,1,1
3,GO COLLECTING DUCT DEVELOPMENT,0.00029789,0.56307,0.57986,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00011593,0.56267,0.53114,1,1
3,GO VOCALIZATION BEHAVIOR,0.00017019,0.55873,0.49441,1,1
3,GO SYNAPSE MATURATION,0.00042807,0.54698,0.50601,1,1
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,6.8565e-05,0.54598,0.54216,1,1
3,GO REGULATION OF SYNAPSE MATURATION,0.0011418,0.54349,0.47787,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0029965,0.5253,0.62178,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,6.8565e-05,0.52508,0.68847,1,1
3,GO RETINA LAYER FORMATION,3.7287e-05,0.52494,0.57013,1,1
3,GO CENTRIOLE CENTRIOLE COHESION,0.00014989,0.52339,0.51042,1,1
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,6.4139e-05,0.52195,0.47729,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00026348,0.51991,0.46993,1,1
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00035748,0.51961,0.53681,1,1
3,GO POSTSYNAPSE ASSEMBLY,5.9985e-05,0.51926,0.60209,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,8.3641e-05,0.51636,0.51174,1,1
3,GO MICROTUBULE DEPOLYMERIZATION,0.00010181,0.51538,0.49197,1,1
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00018128,0.51225,0.4692,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,5.2428e-05,0.51178,0.51389,1,1
3,GO AXONEME ASSEMBLY,0.00040321,0.50903,0.50995,1,1
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,5.6086e-05,0.5088,0.53256,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00031664,0.50304,0.3917,1,1
3,GO ASTRAL MICROTUBULE ORGANIZATION,8.9327e-05,0.50274,0.51084,1,1
3,GO MALE SEX DETERMINATION,0.0023095,0.49922,0.38265,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00035748,0.49906,0.52017,1,1
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,3.4805e-05,0.49819,0.49482,1,1
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.8298e-05,0.49712,0.44955,1,1
3,GO MICROTUBULE BUNDLE FORMATION,7.3279e-05,0.49615,0.4786,1,1
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00017019,0.49549,0.48081,1,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,5.6086e-05,0.49528,0.49996,1,1
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,4.5779e-05,0.48991,0.50688,1,1
3,GO REGULATION OF NEURON MIGRATION,5.6086e-05,0.48691,0.53576,1,1
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00010866,0.48674,0.51693,1,1
3,GO NEURONAL ION CHANNEL CLUSTERING,1.1191e-05,0.48651,0.54951,1,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00064645,0.48618,0.44571,1,1
3,GO BEHAVIORAL RESPONSE TO COCAINE,3.0304e-05,0.48604,0.50607,1,1
3,GO REGULATION OF COLLATERAL SPROUTING,0.00033648,0.48527,0.48743,1,1
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00015974,0.48468,0.48964,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00010866,0.48247,0.4758,1,1
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0011418,0.48133,0.52274,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.7249e-05,0.47908,0.52812,1,1
3,GO LONG TERM SYNAPTIC DEPRESSION,4.2763e-05,0.47901,0.45721,1,1
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0031545,0.47881,0.56375,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00054254,0.47837,0.44645,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.0020776,0.4781,0.45654,1,1
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0031545,0.47801,0.42445,1,1
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,3.9936e-05,0.47714,0.52998,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00029789,0.47502,0.4231,1,1
3,GO MICROTUBULE ANCHORING AT CENTROSOME,4.2763e-05,0.47461,0.54825,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0010798,0.4733,0.42415,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.00035748,0.47046,0.43115,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.9985e-05,0.47038,0.48961,1,1
3,GO PONS DEVELOPMENT,0.0010798,0.46986,0.55285,1,1
3,GO DENDRITIC TRANSPORT,0.00068502,0.46932,0.47272,1,1
3,GO HISTONE H3 K36 METHYLATION,4.2763e-05,0.4686,0.50339,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.00042807,0.4682,0.49292,1,1
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00048214,0.46747,0.55724,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00068502,0.4668,0.52225,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00010181,0.4663,0.44518,1,1
3,GO MAGNESIUM ION HOMEOSTASIS,0.00060992,0.46509,0.44527,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00028019,0.46504,0.51861,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00019306,0.46429,0.51985,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00020554,0.46313,0.46908,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.00026348,0.46234,0.47271,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00020554,0.46205,0.54093,1,1
3,GO NUCLEAR MIGRATION,3.0304e-05,0.46198,0.52161,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,9.5377e-05,0.46065,0.37502,1,1
3,GO MOTILE CILIUM ASSEMBLY,0.0010798,0.45956,0.42188,1,1
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,5.2428e-05,0.45878,0.47005,1,1
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,3.9936e-05,0.45878,0.51507,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00035748,0.4581,0.54685,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,7.8298e-05,0.45657,0.43647,1,1
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00013188,0.45636,0.48119,1,1
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00042807,0.45544,0.49648,1,1
3,GO COLLATERAL SPROUTING,0.00015974,0.45451,0.47882,1,1
3,GO NUCLEUS LOCALIZATION,2.636e-05,0.45281,0.52298,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.3909e-05,0.45002,0.45471,1,1
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.00014062,0.44751,0.42395,1,1
3,GO INNERVATION,0.00033648,0.4463,0.52358,1,1
3,GO EXPLORATION BEHAVIOR,0.00045436,0.44604,0.41636,1,1
3,GO REGULATION OF SYNAPSE ASSEMBLY,5.6086e-05,0.44505,0.44645,1,1
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0017696,0.44461,0.44096,1,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00054254,0.44291,0.45334,1,1
3,GO CELL JUNCTION MAINTENANCE,2.2907e-05,0.4429,0.46494,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0020776,0.44272,0.58784,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0013481,0.44198,0.42099,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00029789,0.4403,0.48876,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0013481,0.43911,0.38846,1,1
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.00024771,0.43905,0.50162,1,1
3,GO SYNAPTIC VESICLE MATURATION,0.00023283,0.43888,0.55357,1,1
3,GO PRESYNAPSE ORGANIZATION,7.8298e-05,0.43838,0.46314,1,1
3,GO SYNAPTIC VESICLE CLUSTERING,0.00017019,0.43836,0.60433,1,1
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0016767,0.43705,0.43243,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,7.3279e-05,0.43668,0.51441,1,1
3,GO SYNAPSE ASSEMBLY,1.8524e-05,0.43577,0.5047,1,1
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00031664,0.43482,0.40198,1,1
3,GO RESPONSE TO AUDITORY STIMULUS,0.00012367,0.43389,0.46851,1,1
3,GO SECONDARY PALATE DEVELOPMENT,0.0020776,0.4337,0.41096,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0020776,0.43356,0.40831,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,7.8298e-05,0.43333,0.45169,1,1
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,7.3279e-05,0.43322,0.42979,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.636e-05,0.43162,0.46687,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,8.3641e-05,0.43162,0.43966,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,1.1191e-05,0.43149,0.46992,1,1
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.4576e-05,0.43078,0.48729,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,4.5779e-05,0.43019,0.78608,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00019306,0.42945,0.53669,1,1
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0023095,0.42873,0.40691,1,1
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,7.3279e-05,0.4287,0.44027,1,1
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,6.4139e-05,0.42814,0.42319,1,1
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00010866,0.42779,0.38739,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00042807,0.4267,0.4408,1,1
3,GO EXTRACELLULAR TRANSPORT,0.00076864,0.42622,0.42616,1,1
3,GO CILIUM MOVEMENT,0.00014062,0.42595,0.42803,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,4.5779e-05,0.42542,0.48703,1,1
3,GO MEIOTIC CHROMOSOME SEPARATION,0.0012071,0.42494,0.37772,1,1
3,GO SUCKLING BEHAVIOR,9.5377e-05,0.4242,0.4223,1,1
3,GO FOREBRAIN REGIONALIZATION,0.024086,0.42316,0.29618,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,6.8565e-05,0.42228,0.55161,1,1
3,GO REGULATION OF CILIUM ASSEMBLY,1.7249e-05,0.42169,0.42695,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00040321,0.42145,0.49447,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.0003797,0.42115,0.39677,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00023283,0.42104,0.38431,1,1
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.00042807,0.42047,0.40258,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.0403e-05,0.41909,0.47596,1,1
3,GO HISTONE H3 K27 METHYLATION,2.8267e-05,0.41875,0.50506,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,2.8267e-05,0.41861,0.42613,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0010209,0.41824,0.42629,1,1
3,GO TUBULIN DEACETYLATION,4.2763e-05,0.41712,0.45218,1,1
3,GO RESPONSE TO COCAINE,1.1191e-05,0.41449,0.43624,1,1
3,GO MATING BEHAVIOR,7.3279e-05,0.41376,0.42348,1,1
3,GO GLUTAMATE SECRETION,0.00042807,0.41113,0.39869,1,1
3,GO DENSE CORE GRANULE TRANSPORT,0.0020776,0.41078,0.52086,1,1
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,8.3641e-05,0.41054,0.43942,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0003797,0.41022,0.39835,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0044907,0.4092,0.39991,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,3.0304e-05,0.40817,0.5038,1,1
3,GO NEURAL TUBE PATTERNING,0.00010866,0.40693,0.36944,1,1
3,GO PEPTIDYL LYSINE TRIMETHYLATION,3.248e-05,0.40688,0.42072,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0012071,0.40598,0.55113,1,1
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0036751,0.40541,0.49311,1,1
3,GO REPRODUCTIVE BEHAVIOR,3.7287e-05,0.40482,0.44473,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00017019,0.40449,0.56173,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00060992,0.40436,0.32762,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,7.3279e-05,0.40369,0.488,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.00021879,0.40321,0.53935,1,1
3,GO AXONAL FASCICULATION,0.00051151,0.40217,0.44264,1,1
3,GO HISTONE H3 K4 TRIMETHYLATION,0.00014062,0.40208,0.47379,1,1
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.01266,0.40184,0.34309,1,1
3,GO EMBRYONIC BODY MORPHOGENESIS,0.00013188,0.4013,0.42291,1,1
3,GO BRAIN MORPHOGENESIS,5.6086e-05,0.40115,0.40149,1,1
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00018128,0.40038,0.3937,1,1
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.00012367,0.39909,0.52864,1,1
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00096503,0.39897,0.39536,1,1
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,9.5377e-05,0.39889,0.41304,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00076864,0.39867,0.4313,1,1
3,GO RECEPTOR CLUSTERING,0.00014062,0.39858,0.40648,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00057531,0.39848,0.55106,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,5.2428e-05,0.39822,0.43509,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00048214,0.397,0.39211,1,1
3,GO ACROSOME ASSEMBLY,0.00021879,0.3966,0.3766,1,1
3,GO ADULT BEHAVIOR,4.9495e-06,0.39654,0.45319,1,1
3,GO SCHWANN CELL DEVELOPMENT,0.00015974,0.39597,0.39491,1,1
3,GO HAIR CELL DIFFERENTIATION,0.00012367,0.39576,0.4168,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,2.4576e-05,0.39551,0.51287,1,1
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00015974,0.39547,0.39037,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.9888e-05,0.39524,0.43471,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00010181,0.39523,0.47981,1,1
3,GO INOSITOL METABOLIC PROCESS,4.5779e-05,0.39505,0.44186,1,1
3,GO REGULATION OF MICROTUBULE BINDING,0.00010866,0.39406,0.43981,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,2.2907e-05,0.39334,0.41044,1,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00012367,0.39251,0.41231,1,1
3,GO SPINAL CORD PATTERNING,0.0015882,0.39199,0.41169,1,1
3,GO PROTEIN POLYGLUTAMYLATION,0.00031664,0.39168,0.40101,1,1
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0038653,0.39134,0.31465,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.4139e-05,0.39125,0.43242,1,1
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00018128,0.3912,0.45481,1,1
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,8.3641e-05,0.39089,0.34416,1,1
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00031664,0.39008,0.42253,1,1
3,GO NERVE DEVELOPMENT,0.00029789,0.3898,0.39777,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,6.4139e-05,0.38881,0.39503,1,1
3,GO FORELIMB MORPHOGENESIS,0.0012071,0.38865,0.34459,1,1
3,GO SEX DETERMINATION,8.3641e-05,0.38779,0.37334,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00017019,0.38769,0.42178,1,1
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,1.2035e-05,0.38705,0.45563,1,1
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,9.5377e-05,0.38669,0.4208,1,1
3,GO NEURON CELLULAR HOMEOSTASIS,0.00068502,0.38642,0.40664,1,1
3,GO NEGATIVE REGULATION OF AXONOGENESIS,3.248e-05,0.38618,0.45863,1,1
3,GO RESPONSE TO FORSKOLIN,0.0019699,0.386,0.40237,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00023283,0.38576,0.42528,1,1
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00013188,0.38575,0.39302,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0060238,0.3857,0.37443,1,1
3,GO HISTONE H3 K9 TRIMETHYLATION,1.8524e-05,0.3855,0.41957,1,1
3,GO DENDRITE MORPHOGENESIS,2.8267e-05,0.38507,0.43392,1,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.007293,0.38487,0.38618,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.017954,0.38475,0.29579,1,1
3,GO HISTONE H3 K9 METHYLATION,4.8997e-05,0.38473,0.42317,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00031664,0.38455,0.53665,1,1
3,GO MEMBRANE HYPERPOLARIZATION,0.0025648,0.38401,0.40072,1,1
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00096503,0.38337,0.38496,1,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,5.9985e-05,0.38271,0.41791,1,1
3,GO NEGATIVE REGULATION OF AXON EXTENSION,4.5779e-05,0.38262,0.4466,1,1
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.01266,0.38228,0.37578,1,1
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00028019,0.38198,0.4228,1,1
3,GO CHROMATIN SILENCING AT TELOMERE,7.3279e-05,0.3818,0.36459,1,1
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.00081392,0.38152,0.42573,1,1
3,GO NOREPINEPHRINE SECRETION,0.0016767,0.38137,0.42322,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0023095,0.38061,0.4247,1,1
3,GO FEAR RESPONSE,2.8267e-05,0.38038,0.38831,1,1
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0027019,0.3802,0.40982,1,1
3,GO CARDIAC MYOFIBRIL ASSEMBLY,5.2428e-05,0.38013,0.42726,1,1
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0012758,0.38008,0.35462,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00048214,0.37997,0.38006,1,1
3,GO DOPAMINE TRANSPORT,0.00028019,0.37982,0.45435,1,1
3,GO MECHANOSENSORY BEHAVIOR,0.00057531,0.37966,0.45855,1,1
3,GO PROTEIN LOCALIZATION TO CILIUM,7.8298e-05,0.37932,0.39432,1,1
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0016767,0.37905,0.38857,1,1
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.0016767,0.37897,0.3793,1,1
3,GO MICROTUBULE ANCHORING,1.8524e-05,0.37892,0.4641,1,1
3,GO CENTRIOLE ASSEMBLY,0.00035748,0.37885,0.35154,1,1
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00040321,0.3788,0.47412,1,1
3,GO RETROGRADE AXONAL TRANSPORT,0.00033648,0.37858,0.45563,1,1
3,GO CHEMOSENSORY BEHAVIOR,5.9985e-05,0.37847,0.42474,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.00010181,0.37838,0.4293,1,1
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0003797,0.37813,0.41534,1,1
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,3.4805e-05,0.37807,0.43354,1,1
3,GO DRUG CATABOLIC PROCESS,0.025096,0.37715,0.27031,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,3.9936e-05,0.37708,0.41369,1,1
3,GO CEREBELLAR CORTEX FORMATION,0.00012367,0.37683,0.40862,1,1
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0012071,0.37682,0.32007,1,1
3,GO MICROTUBULE SEVERING,0.00015974,0.37667,0.37033,1,1
3,GO DOSAGE COMPENSATION,0.00020554,0.37619,0.37732,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00081392,0.37592,0.41762,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0047188,0.37359,0.42067,1,1
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00029789,0.37264,0.39461,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00013188,0.37222,0.41409,1,1
3,GO MICROTUBULE NUCLEATION,2.4576e-05,0.37191,0.40851,1,1
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00048214,0.37151,0.40088,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0076456,0.37103,0.35951,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,7.3279e-05,0.37069,0.43388,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.00010866,0.37032,0.57552,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00011593,0.3703,0.41452,1,1
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0015882,0.37025,0.37576,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.024086,0.36994,0.56498,1,1
3,GO REGULATION OF AMINO ACID TRANSPORT,0.00048214,0.36984,0.35107,1,1
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,8.9327e-05,0.36937,0.49171,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,4.5779e-05,0.36906,0.40404,1,1
3,GO UV DAMAGE EXCISION REPAIR,7.3279e-05,0.36901,0.35924,1,1
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0018673,0.36901,0.40134,1,1
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00021879,0.36868,0.36918,1,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0018673,0.36853,0.38048,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00018128,0.3681,0.43538,1,1
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,3.0304e-05,0.3681,0.43835,1,1
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00017019,0.36809,0.39951,1,1
3,GO RESPONSE TO INSECTICIDE,0.0017696,0.36781,0.33977,1,1
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.9936e-05,0.36755,0.40185,1,1
3,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,2.636e-05,0.36749,0.44455,1,1
3,GO LEARNING,1.2939e-05,0.36733,0.43832,1,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,2.1347e-05,0.36723,0.41591,1,1
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.8524e-05,0.36711,0.41578,1,1
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00010181,0.36697,0.40257,1,1
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,2.8267e-05,0.36691,0.40698,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0040644,0.36627,0.46618,1,1
3,GO CILIUM ORGANIZATION,1.7249e-05,0.36618,0.38799,1,1
3,GO REGULATION OF AXON GUIDANCE,0.00051151,0.36587,0.39398,1,1
3,GO NEURON MATURATION,2.4576e-05,0.36583,0.40544,1,1
3,GO ACTIN CROSSLINK FORMATION,7.8298e-05,0.36583,0.41123,1,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0034935,0.36571,0.41452,1,1
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,8.9327e-05,0.3648,0.49842,1,1
3,GO SECRETORY GRANULE LOCALIZATION,0.0027019,0.36421,0.39448,1,1
3,GO POSTSYNAPSE ORGANIZATION,3.248e-05,0.36421,0.41165,1,1
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.00028019,0.36409,0.39125,1,1
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00015974,0.36391,0.42843,1,1
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,8.3641e-05,0.36386,0.35868,1,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0054671,0.36353,0.37821,1,1
3,GO MUSCLE FIBER DEVELOPMENT,7.8298e-05,0.36352,0.34842,1,1
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.011063,0.36332,0.35458,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00072571,0.36285,0.37432,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,0.00015974,0.36193,0.40304,1,1
3,GO RESPONSE TO GLUCAGON,6.8565e-05,0.36096,0.39041,1,1
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00031664,0.36064,0.46273,1,1
3,GO SYNAPTIC VESICLE EXOCYTOSIS,4.8997e-05,0.35991,0.50045,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00026348,0.35987,0.39161,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00011593,0.35955,0.40646,1,1
3,GO REGULATION OF TUBULIN DEACETYLATION,6.8565e-05,0.35941,0.44409,1,1
3,GO METENCEPHALON DEVELOPMENT,1.7249e-05,0.35915,0.37575,1,1
3,GO NEUROTRANSMITTER REUPTAKE,9.5377e-05,0.3588,0.38345,1,1
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.00086166,0.35868,0.43872,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00010866,0.35855,0.39238,1,1
3,GO SHORT TERM MEMORY,0.00054254,0.3585,0.41825,1,1
3,GO CATECHOLAMINE SECRETION,3.248e-05,0.35781,0.45823,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,9.5377e-05,0.35755,0.36906,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.7287e-05,0.35748,0.39429,1,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,1.8524e-05,0.35736,0.40767,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,4.5779e-05,0.35668,0.50376,1,1
3,GO REGULATION OF ACTION POTENTIAL,4.2763e-05,0.35632,0.42389,1,1
3,GO NEUROTRANSMITTER TRANSPORT,2.2907e-05,0.35509,0.45284,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.00045436,0.35431,0.39286,1,1
3,GO FOREBRAIN NEURON DEVELOPMENT,0.00096503,0.3543,0.34395,1,1
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,8.3461e-06,0.35411,0.38577,1,1
3,GO ASSOCIATIVE LEARNING,1.7249e-05,0.35374,0.40971,1,1
3,GO REPLICATION FORK PROCESSING,0.0025648,0.35373,0.34525,1,1
3,GO AMINE TRANSPORT,3.4805e-05,0.35328,0.38988,1,1
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.00031664,0.35314,0.33645,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.1347e-05,0.35311,0.39663,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.013235,0.35293,0.29887,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00019306,0.35289,0.36184,1,1
3,GO REGULATION OF RECEPTOR CLUSTERING,0.00060992,0.35225,0.43615,1,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00035748,0.35212,0.40576,1,1
3,GO SCHWANN CELL DIFFERENTIATION,0.00021879,0.35204,0.33905,1,1
3,GO LONG TERM MEMORY,0.00033648,0.35202,0.38427,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00029789,0.3518,0.36348,1,1
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,7.8298e-05,0.35086,0.3879,1,1
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0010209,0.35068,0.43232,1,1
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,8.9327e-05,0.35053,0.4902,1,1
3,GO HISTONE METHYLATION,1.9888e-05,0.35021,0.38177,1,1
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0012758,0.34953,0.38626,1,1
3,GO CATECHOLAMINE UPTAKE,0.00035748,0.34947,0.43762,1,1
3,GO OTIC VESICLE DEVELOPMENT,0.0040644,0.34914,0.29658,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00010181,0.34872,0.45628,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,3.248e-05,0.34837,0.3925,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00013188,0.34829,0.3933,1,1
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00035748,0.34823,0.3297,1,1
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.00010866,0.34799,0.40385,1,1
3,GO NEUROTRANSMITTER SECRETION,2.636e-05,0.34798,0.48606,1,1
3,GO MICROTUBULE BASED MOVEMENT,2.2907e-05,0.34788,0.37637,1,1
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.0304e-05,0.34776,0.4645,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00014062,0.34726,0.37299,1,1
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00033648,0.34716,0.3558,1,1
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.6059e-05,0.347,0.4099,1,1
3,GO GOLGI RIBBON FORMATION,0.00018128,0.34677,0.40329,1,1
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00057531,0.34628,0.35293,1,1
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00010181,0.34601,0.38197,1,1
3,GO FUCOSYLATION,4.2763e-05,0.34589,0.37729,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00018128,0.34586,0.39463,1,1
3,GO REGULATION OF EXTENT OF CELL GROWTH,3.7287e-05,0.34557,0.42219,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.2907e-05,0.34542,0.35908,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00081392,0.345,0.33858,1,1
3,GO DENDRITE DEVELOPMENT,2.8267e-05,0.34497,0.39884,1,1
3,GO SYNAPSE ORGANIZATION,1.9888e-05,0.34488,0.43315,1,1
3,GO NEURAL CREST CELL MIGRATION,0.00072571,0.34465,0.32503,1,1
3,GO RESPONSE TO ACETYLCHOLINE,0.00013188,0.34438,0.43806,1,1
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,1.7249e-05,0.344,0.38912,1,1
3,GO OOCYTE MATURATION,0.00029789,0.34387,0.32698,1,1
3,GO MICROTUBULE BASED TRANSPORT,5.9985e-05,0.34355,0.33851,1,1
3,GO CELL JUNCTION ASSEMBLY,8.9327e-05,0.34324,0.35776,1,1
3,GO MICROTUBULE POLYMERIZATION,2.4576e-05,0.34244,0.41478,1,1
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,2.1347e-05,0.34244,0.36635,1,1
3,GO PROTEIN DEMETHYLATION,3.248e-05,0.34198,0.43869,1,1
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.8524e-05,0.34193,0.44404,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00054254,0.34185,0.39924,1,1
3,GO CRANIAL NERVE DEVELOPMENT,0.00064645,0.34181,0.36078,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,5.2428e-05,0.34161,0.4122,1,1
3,GO CELLULAR RESPONSE TO VITAMIN D,0.027226,0.34153,0.23661,1,1
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,9.5377e-05,0.34138,0.34591,1,1
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.8565e-05,0.34092,0.35985,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0012071,0.34091,0.3438,1,1
3,GO FEEDING BEHAVIOR,2.8267e-05,0.34057,0.3579,1,1
3,GO MONOAMINE TRANSPORT,4.8997e-05,0.34056,0.40023,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,1.8524e-05,0.34037,0.39978,1,1
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0013481,0.34024,0.29661,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.031957,0.33999,0.2654,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00014062,0.33975,0.39924,1,1
3,GO NEUROMUSCULAR PROCESS,3.4805e-05,0.3396,0.40025,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.2907e-05,0.33919,0.44053,1,1
3,GO POSITIVE REGULATION OF AXONOGENESIS,6.8565e-05,0.33902,0.41085,1,1
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00023283,0.33882,0.38742,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.00026348,0.33874,0.43915,1,1
3,GO GENETIC IMPRINTING,0.00076864,0.33847,0.33796,1,1
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,4.5779e-05,0.33834,0.37465,1,1
3,GO SYNAPTIC VESICLE RECYCLING,0.00010181,0.33806,0.42313,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,1.6059e-05,0.33792,0.42401,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0080134,0.3377,0.34328,1,1
3,GO LOCOMOTORY BEHAVIOR,8.3461e-06,0.3377,0.42212,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,5.2428e-05,0.33733,0.41338,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,7.3279e-05,0.33731,0.3654,1,1
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,6.8565e-05,0.3373,0.3837,1,1
3,GO NON MOTILE CILIUM ASSEMBLY,2.4576e-05,0.33701,0.3605,1,1
3,GO ACIDIC AMINO ACID TRANSPORT,4.2763e-05,0.33691,0.38151,1,1
3,GO REGULATION OF AXONOGENESIS,4.2763e-05,0.3368,0.41893,1,1
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0029965,0.33635,0.3093,1,1
3,GO HYPEROSMOTIC RESPONSE,0.0003797,0.33632,0.37813,1,1
3,GO CAMP METABOLIC PROCESS,0.0015041,0.3363,0.35411,1,1
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00332,0.33581,0.30769,1,1
3,GO SPERM MOTILITY,0.00011593,0.33574,0.36767,1,1
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,4.5779e-05,0.33473,0.45516,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.00011593,0.33471,0.34935,1,1
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.038848,0.33439,0.30178,1,1
3,GO POSITIVE REGULATION OF BEHAVIOR,0.0034935,0.33419,0.26687,1,1
3,GO ADHERENS JUNCTION ASSEMBLY,8.3641e-05,0.33371,0.39812,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00054254,0.33342,0.39724,1,1
3,GO NEUROTRANSMITTER UPTAKE,7.8298e-05,0.3333,0.32003,1,1
3,GO ANTEROGRADE AXONAL TRANSPORT,0.00010866,0.33308,0.38749,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0029965,0.333,0.44826,1,1
3,GO PROTEIN PALMITOYLATION,3.7287e-05,0.33279,0.39595,1,1
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0060238,0.33256,0.51718,1,1
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,5.9985e-05,0.33181,0.33592,1,1
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,4.2763e-05,0.33181,0.40439,1,1
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,6.8565e-05,0.33176,0.3308,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.0042727,0.33158,0.3137,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,3.248e-05,0.33139,0.38372,1,1
3,GO NEURON RECOGNITION,0.0015041,0.33037,0.3593,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0027019,0.33029,0.34526,1,1
3,GO HINDLIMB MORPHOGENESIS,5.9985e-05,0.33027,0.35655,1,1
3,GO ATRIAL SEPTUM DEVELOPMENT,0.00057531,0.33006,0.38619,1,1
3,GO STEM CELL DIVISION,0.0016767,0.32985,0.30172,1,1
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.00010181,0.32966,0.39853,1,1
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.015776,0.3296,0.29476,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0010209,0.32908,0.35916,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,4.2763e-05,0.32899,0.41243,1,1
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,1.8524e-05,0.32869,0.36024,1,1
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,6.8565e-05,0.32841,0.368,1,1
3,GO INSEMINATION,0.0034935,0.32829,0.35282,1,1
3,GO NEURAL RETINA DEVELOPMENT,8.9327e-05,0.32802,0.37192,1,1
3,GO REGULATION OF RESPONSE TO FOOD,0.00064645,0.32783,0.37218,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00029789,0.32747,0.36556,1,1
3,GO CARDIAC CONDUCTION,7.3279e-05,0.32726,0.40203,1,1
3,GO URETER DEVELOPMENT,0.050584,0.32686,0.27733,1,1
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0020776,0.32679,0.31839,1,1
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00076864,0.32674,0.3841,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,3.0304e-05,0.32672,0.38194,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,0.00021879,0.32574,0.37775,1,1
3,GO ADHERENS JUNCTION ORGANIZATION,4.5779e-05,0.32548,0.38381,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00031664,0.32533,0.33743,1,1
3,GO NEURON PROJECTION GUIDANCE,0.00010181,0.32524,0.37752,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.0015882,0.3252,0.44175,1,1
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00057531,0.32513,0.29728,1,1
3,GO MEMBRANE DISASSEMBLY,0.00024771,0.32506,0.35263,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.00060992,0.3246,0.31217,1,1
3,GO SODIUM ION HOMEOSTASIS,0.00081392,0.32459,0.33933,1,1
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0031545,0.32454,0.35723,1,1
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.00031664,0.32449,0.33668,1,1
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0010209,0.32432,0.35783,1,1
3,GO VENTRICULAR SYSTEM DEVELOPMENT,4.5779e-05,0.32398,0.3884,1,1
3,GO FAT CELL PROLIFERATION,0.0034935,0.32231,0.34569,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,5.6086e-05,0.32184,0.37878,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,3.248e-05,0.32178,0.4363,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,2.2907e-05,0.32157,0.44051,1,1
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,7.8298e-05,0.32142,0.39557,1,1
3,GO RESPONSE TO L GLUTAMATE,0.0021907,0.32097,0.2718,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,6.4139e-05,0.32069,0.37018,1,1
3,GO PEPTIDYL LYSINE METHYLATION,2.2907e-05,0.32063,0.39081,1,1
3,GO LIPID TRANSLOCATION,0.00051151,0.3206,0.34961,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00064645,0.32053,0.37624,1,1
3,GO EATING BEHAVIOR,0.0012071,0.32044,0.30601,1,1
3,GO HISTONE H3 K4 METHYLATION,0.00010181,0.32044,0.3451,1,1
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.1347e-05,0.31969,0.33286,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.010572,0.31957,0.26383,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,3.7287e-05,0.31945,0.40305,1,1
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.038848,0.31837,0.25614,1,1
3,GO MATING,0.00010181,0.31814,0.33425,1,1
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00017019,0.31806,0.33944,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.01266,0.31794,0.25083,1,1
3,GO HINDBRAIN DEVELOPMENT,1.3909e-05,0.31765,0.33872,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00014062,0.31763,0.37421,1,1
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.00033648,0.3173,0.32221,1,1
3,GO LEFT RIGHT PATTERN FORMATION,0.0010209,0.31726,0.30212,1,1
3,GO SEGMENT SPECIFICATION,0.0036751,0.3172,0.33289,1,1
3,GO SYNAPTIC VESICLE LOCALIZATION,0.00019306,0.31697,0.41444,1,1
3,GO CYSTEINE METABOLIC PROCESS,0.023112,0.31677,0.24459,1,1
3,GO COCHLEA DEVELOPMENT,0.00033648,0.31672,0.33463,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,4.5779e-05,0.3166,0.3966,1,1
3,GO PHOTOPERIODISM,1.1191e-05,0.31651,0.34716,1,1
3,GO REGULATION OF MICROTUBULE BASED PROCESS,1.8524e-05,0.31638,0.33753,1,1
3,GO PHOTORECEPTOR CELL DEVELOPMENT,8.3641e-05,0.31624,0.34639,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,4.5779e-05,0.316,0.33821,1,1
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00014062,0.31556,0.37425,1,1
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00064645,0.31554,0.30571,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0015882,0.31533,0.35673,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00051151,0.31514,0.42961,1,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.9888e-05,0.31509,0.34309,1,1
3,GO CARNITINE SHUTTLE,0.00013188,0.31508,0.36549,1,1
3,GO SPINAL CORD DEVELOPMENT,0.00017019,0.31506,0.3741,1,1
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,4.8997e-05,0.31491,0.39425,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,8.3641e-05,0.31486,0.37099,1,1
3,GO POSITIVE REGULATION OF AXON EXTENSION,7.8298e-05,0.31485,0.39424,1,1
3,GO REGULATION OF BLOOD CIRCULATION,0.00023283,0.31478,0.31632,1,1
3,GO DEFINITIVE HEMOPOIESIS,0.00081392,0.31469,0.38059,1,1
3,GO TORC1 SIGNALING,4.2763e-05,0.31435,0.38192,1,1
3,GO SOMATIC STEM CELL DIVISION,0.0096484,0.31414,0.34428,1,1
3,GO BEHAVIOR,1.1191e-05,0.31414,0.37061,1,1
3,GO REGULATION OF MRNA PROCESSING,1.8524e-05,0.314,0.33496,1,1
3,GO BASEMENT MEMBRANE ASSEMBLY,0.0092139,0.31396,0.3932,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0172,0.31381,0.26605,1,1
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00057531,0.3137,0.32038,1,1
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,7.3279e-05,0.3134,0.38123,1,1
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.034576,0.31305,0.27388,1,1
3,GO MYELIN ASSEMBLY,0.00010866,0.31305,0.38965,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00072571,0.3129,0.41404,1,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.00012367,0.31244,0.41105,1,1
3,GO SODIUM ION TRANSPORT,8.3641e-05,0.3123,0.37,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00013188,0.31161,0.33366,1,1
3,GO CELL PART MORPHOGENESIS,2.8267e-05,0.31146,0.36767,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,5.9985e-05,0.31037,0.41519,1,1
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0024341,0.31031,0.37795,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00012367,0.31029,0.34833,1,1
3,GO POTASSIUM ION HOMEOSTASIS,8.9327e-05,0.31028,0.36371,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0010798,0.31006,0.38101,1,1
3,GO AXON EXTENSION,2.636e-05,0.3089,0.41765,1,1
3,GO AXO DENDRITIC TRANSPORT,0.00024771,0.30862,0.36164,1,1
3,GO CELLULAR COMPONENT MAINTENANCE,1.8524e-05,0.30845,0.3784,1,1
3,GO PROTEIN METHYLATION,2.2907e-05,0.30824,0.35285,1,1
3,GO OSTEOBLAST DEVELOPMENT,0.017954,0.30821,0.23707,1,1
3,GO HINDBRAIN MORPHOGENESIS,0.00010181,0.30753,0.34402,1,1
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0057394,0.30752,0.28907,1,1
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0014241,0.30741,0.34023,1,1
3,GO MULTICELLULAR ORGANISMAL SIGNALING,3.248e-05,0.3074,0.40778,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.00011593,0.30727,0.36109,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,0.00014062,0.30705,0.44152,1,1
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,2.8267e-05,0.30705,0.3365,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00040321,0.30686,0.38941,1,1
3,GO ADULT LOCOMOTORY BEHAVIOR,5.6086e-05,0.3067,0.34502,1,1
3,GO MYOTUBE CELL DEVELOPMENT,0.00011593,0.30668,0.29883,1,1
3,GO SYNAPTIC SIGNALING,1.2939e-05,0.30636,0.43286,1,1
3,GO CELLULAR COMPONENT MORPHOGENESIS,3.0304e-05,0.30632,0.3598,1,1
3,GO EMBRYONIC PATTERN SPECIFICATION,2.4576e-05,0.30628,0.33134,1,1
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0015882,0.30618,0.36789,1,1
3,GO ACID SECRETION,0.00029789,0.30601,0.30233,1,1
3,GO NEURON MIGRATION,0.00014989,0.30569,0.38241,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,4.2763e-05,0.30549,0.37404,1,1
3,GO NEURON PROJECTION ARBORIZATION,0.00031664,0.30541,0.38454,1,1
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.00040321,0.305,0.32716,1,1
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,2.4576e-05,0.30494,0.39294,1,1
3,GO TRANSPORT ALONG MICROTUBULE,6.4139e-05,0.30492,0.32232,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,7.3279e-05,0.3048,0.3991,1,1
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.0010798,0.30465,0.28776,1,1
3,GO OOGENESIS,2.636e-05,0.30439,0.3036,1,1
3,GO REGULATION OF APPETITE,0.0096484,0.30438,0.31804,1,1
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,4.2763e-05,0.30425,0.34598,1,1
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,3.7287e-05,0.30425,0.36583,1,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00013188,0.30413,0.29881,1,1
3,GO POTASSIUM ION TRANSPORT,5.9985e-05,0.30411,0.37783,1,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0010209,0.30408,0.29809,1,1
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0016767,0.30394,0.31673,1,1
3,GO AXON DEVELOPMENT,4.2763e-05,0.30392,0.36627,1,1
3,GO VISUAL BEHAVIOR,3.9936e-05,0.30387,0.35314,1,1
3,GO NEURON PROJECTION EXTENSION,3.0304e-05,0.30349,0.40288,1,1
3,GO AXONAL TRANSPORT,0.00021879,0.30288,0.36457,1,1
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,1.6059e-05,0.30243,0.37761,1,1
3,GO HISTONE H4 K5 ACETYLATION,4.5779e-05,0.30233,0.35057,1,1
3,GO CELL MIGRATION IN HINDBRAIN,0.0036751,0.3023,0.38045,1,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.00057531,0.30212,0.30894,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00057531,0.30203,0.37844,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.0020776,0.3013,0.30143,1,1
3,GO MISMATCH REPAIR,0.00018128,0.30093,0.30549,1,1
3,GO MEMBRANE DEPOLARIZATION,0.0015882,0.30092,0.35716,1,1
3,GO MICROTUBULE BASED PROCESS,1.3909e-05,0.30089,0.33928,1,1
3,GO REGULATION OF TORC1 SIGNALING,4.2763e-05,0.30054,0.36683,1,1
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.00014989,0.30031,0.3924,1,1
3,GO RESPONSE TO INACTIVITY,0.0019699,0.30029,0.3082,1,1
3,GO KINETOCHORE ORGANIZATION,0.019548,0.30021,0.26969,1,1
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00012367,0.30019,0.3725,1,1
3,GO CELL JUNCTION ORGANIZATION,4.2763e-05,0.29991,0.36226,1,1
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.00012367,0.29972,0.3182,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00081392,0.29961,0.28897,1,1
3,GO MEMBRANE DOCKING,1.9888e-05,0.29952,0.31952,1,1
3,GO LONG TERM SYNAPTIC POTENTIATION,0.00029789,0.29935,0.38523,1,1
3,GO PRO B CELL DIFFERENTIATION,0.007293,0.29923,0.33425,1,1
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00010181,0.29916,0.35095,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00048214,0.29887,0.331,1,1
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0025648,0.2984,0.31482,1,1
3,GO G2 DNA DAMAGE CHECKPOINT,0.00033648,0.29823,0.32299,1,1
3,GO ASYMMETRIC CELL DIVISION,0.00018128,0.29794,0.32653,1,1
3,GO REGULATION OF HIPPO SIGNALING,0.0016767,0.29767,0.31782,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,2.636e-05,0.29758,0.35064,1,1
3,GO REGULATION OF TELOMERE CAPPING,0.00014062,0.29743,0.32557,1,1
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.015776,0.29732,0.20864,1,1
3,GO FUCOSE METABOLIC PROCESS,0.00010181,0.29729,0.30211,1,1
3,GO ACROSOME REACTION,0.0003797,0.29677,0.30653,1,1
3,GO DIACYLGLYCEROL METABOLIC PROCESS,8.9327e-05,0.29677,0.39298,1,1
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.00076864,0.29652,0.32224,1,1
3,GO MAINTENANCE OF CELL POLARITY,0.0015882,0.29636,0.32899,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0036751,0.29634,0.29413,1,1
3,GO NEURON PROJECTION ORGANIZATION,0.00011593,0.29623,0.39096,1,1
3,GO MEIOTIC SPINDLE ORGANIZATION,0.00081392,0.2962,0.36927,1,1
3,GO RENAL WATER HOMEOSTASIS,0.0016767,0.29589,0.35668,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00072571,0.29526,0.30924,1,1
3,GO MEIOSIS I CELL CYCLE PROCESS,0.00086166,0.29488,0.28335,1,1
3,GO REGULATION OF RNA SPLICING,1.6059e-05,0.2948,0.32131,1,1
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.030713,0.29475,0.23615,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.00014989,0.29459,0.3722,1,1
3,GO THYROID GLAND DEVELOPMENT,0.0003797,0.29457,0.35225,1,1
3,GO EMBRYONIC AXIS SPECIFICATION,2.8267e-05,0.29454,0.32922,1,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00045436,0.29452,0.32197,1,1
3,GO RENAL SODIUM EXCRETION,0.011063,0.29452,0.30703,1,1
3,GO APICAL PROTEIN LOCALIZATION,0.0017696,0.29415,0.31939,1,1
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,1.3909e-05,0.29391,0.42912,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00048214,0.29369,0.3379,1,1
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.0076456,0.2936,0.281,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.020391,0.29302,0.24115,1,1
3,GO PROTEIN KINASE C SIGNALING,0.0066311,0.29291,0.3149,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00015974,0.29244,0.39878,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.00021879,0.2924,0.3473,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0024341,0.29218,0.39262,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS,0.0027019,0.29208,0.35397,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.018736,0.29205,0.29059,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,1.6059e-05,0.29189,0.38679,1,1
3,GO NOTCH RECEPTOR PROCESSING,0.035953,0.29181,0.27687,1,1
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0018673,0.29174,0.31646,1,1
3,GO NEUROBLAST PROLIFERATION,0.0018673,0.29137,0.28536,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.041938,0.29106,0.23443,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.00023283,0.29099,0.29169,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.0010209,0.29067,0.2891,1,1
3,GO NEURAL CREST CELL DIFFERENTIATION,0.00076864,0.29061,0.28881,1,1
3,GO RESPONSE TO ALKALOID,5.9985e-05,0.29049,0.29068,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,3.7287e-05,0.29037,0.36089,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0025648,0.2898,0.34528,1,1
3,GO LOCALIZATION WITHIN MEMBRANE,0.00029789,0.28963,0.33904,1,1
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,6.8565e-05,0.28942,0.33812,1,1
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0021907,0.28938,0.27,1,1
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,4.8997e-05,0.28904,0.3386,1,1
3,GO REGULATION OF SYNAPTIC PLASTICITY,5.2428e-05,0.28889,0.42573,1,1
3,GO ACTION POTENTIAL,0.00010866,0.28882,0.38163,1,1
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00014062,0.28835,0.45,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0060238,0.28824,0.296,1,1
3,GO STRIATUM DEVELOPMENT,0.0024341,0.28822,0.31959,1,1
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,5.2428e-05,0.28813,0.38248,1,1
3,GO SPERM CAPACITATION,0.0042727,0.28793,0.25152,1,1
3,GO POST ANAL TAIL MORPHOGENESIS,0.0015882,0.28784,0.31632,1,1
3,GO DETECTION OF VISIBLE LIGHT,5.2428e-05,0.28783,0.25393,1,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00064645,0.28781,0.32062,1,1
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.021265,0.2876,0.2185,1,1
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,4.5779e-05,0.28749,0.36808,1,1
3,GO CELL FATE SPECIFICATION,0.0021907,0.28746,0.27157,1,1
3,GO DEVELOPMENTAL CELL GROWTH,6.8565e-05,0.28745,0.36955,1,1
3,GO GERM CELL DEVELOPMENT,1.2939e-05,0.28744,0.31056,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0060238,0.28732,0.33675,1,1
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00012367,0.28717,0.3341,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0015882,0.28669,0.31596,1,1
3,GO METANEPHROS MORPHOGENESIS,0.00026348,0.28668,0.32777,1,1
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0003797,0.28627,0.30014,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0060238,0.28624,0.3006,1,1
3,GO ORGANIC CATION TRANSPORT,6.8565e-05,0.28587,0.3434,1,1
3,GO POSITIVE REGULATION OF TOR SIGNALING,7.3279e-05,0.28557,0.30083,1,1
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.0063209,0.28547,0.26641,1,1
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00020554,0.28546,0.31145,1,1
3,GO TRANSMISSION OF NERVE IMPULSE,1.8524e-05,0.28521,0.45302,1,1
3,GO ACTIVATION OF JNKK ACTIVITY,0.00091199,0.28516,0.32417,1,1
3,GO CELL PROJECTION ORGANIZATION,2.2907e-05,0.28509,0.32749,1,1
3,GO HISTONE H2A MONOUBIQUITINATION,0.00011593,0.28504,0.36287,1,1
3,GO HEART PROCESS,0.00012367,0.28453,0.31228,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0015041,0.28418,0.3409,1,1
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,5.6086e-05,0.28417,0.33667,1,1
3,GO SMOOTHENED SIGNALING PATHWAY,3.7287e-05,0.28398,0.32392,1,1
3,GO RESPONSE TO NICOTINE,0.00021879,0.28375,0.35571,1,1
3,GO NEURON FATE SPECIFICATION,0.016475,0.28373,0.3134,1,1
3,GO SECONDARY METABOLIC PROCESS,0.00033648,0.28351,0.27967,1,1
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.00013188,0.28315,0.32427,1,1
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.010572,0.28279,0.26528,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.030713,0.28251,0.24117,1,1
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,2.8267e-05,0.28236,0.40629,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.7287e-05,0.28231,0.33256,1,1
3,GO RESPONSE TO HYDROXYUREA,0.00029789,0.28222,0.30173,1,1
3,GO HISTONE H3 DEACETYLATION,1.7249e-05,0.28213,0.37881,1,1
3,GO HISTONE DEUBIQUITINATION,0.00019306,0.28211,0.35635,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0014241,0.28207,0.34813,1,1
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.00014989,0.28183,0.32868,1,1
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00024771,0.28137,0.33206,1,1
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0017696,0.2809,0.32556,1,1
3,GO LENS FIBER CELL DIFFERENTIATION,0.0003797,0.28079,0.30367,1,1
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.015104,0.28079,0.24433,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,6.4139e-05,0.28074,0.36027,1,1
3,GO MESONEPHROS DEVELOPMENT,0.0063209,0.28071,0.2288,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0172,0.28068,0.26565,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00064645,0.28033,0.32491,1,1
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0029965,0.28014,0.3188,1,1
3,GO REGULATION OF GLUCONEOGENESIS,2.8267e-05,0.28002,0.36511,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,2.8267e-05,0.28002,0.30628,1,1
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0003797,0.27993,0.37681,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.248e-05,0.27982,0.33653,1,1
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0029965,0.27968,0.34358,1,1
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,8.9327e-05,0.27941,0.30291,1,1
3,GO COVALENT CHROMATIN MODIFICATION,2.4576e-05,0.27908,0.33544,1,1
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.016475,0.27889,0.27278,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,0.0021907,0.27873,0.34012,1,1
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.00010181,0.27871,0.33003,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,1.6059e-05,0.27854,0.32835,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.015104,0.27839,0.31779,1,1
3,GO REGULATION OF SISTER CHROMATID COHESION,0.0015041,0.27838,0.29959,1,1
3,GO FOREGUT MORPHOGENESIS,0.0076456,0.27823,0.27073,1,1
3,GO SPERM AXONEME ASSEMBLY,0.00096503,0.2781,0.28805,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0018673,0.27735,0.2309,1,1
3,GO POST EMBRYONIC DEVELOPMENT,0.00012367,0.27709,0.30619,1,1
3,GO MITOTIC CHROMOSOME CONDENSATION,0.030713,0.27707,0.30097,1,1
3,GO NEURON DEVELOPMENT,2.4576e-05,0.27702,0.35383,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00023283,0.27698,0.33393,1,1
3,GO CHROMOSOME CONDENSATION,0.0076456,0.27675,0.2741,1,1
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00014062,0.27666,0.31884,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00064645,0.27663,0.31482,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00018128,0.27655,0.32478,1,1
3,GO RESPONSE TO PAIN,0.0042727,0.27625,0.31767,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0021907,0.27603,0.32856,1,1
3,GO REGULATION OF EXCRETION,0.020391,0.27592,0.25245,1,1
3,GO IMPORT INTO CELL,0.00029789,0.27585,0.29627,1,1
3,GO OOCYTE DIFFERENTIATION,0.00011593,0.27582,0.28934,1,1
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.00010181,0.27581,0.31587,1,1
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,3.7287e-05,0.27555,0.32362,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.00011593,0.2752,0.28021,1,1
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00014062,0.27513,0.27122,1,1
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.027226,0.27506,0.26608,1,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,2.8267e-05,0.27502,0.34839,1,1
3,GO REGULATION OF SPINDLE ORGANIZATION,0.00045436,0.27447,0.28094,1,1
3,GO MEMORY,0.00014062,0.27446,0.34652,1,1
3,GO HISTONE DEACETYLATION,2.4576e-05,0.27441,0.33173,1,1
3,GO CELL PROJECTION ASSEMBLY,3.9936e-05,0.27394,0.3029,1,1
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.00048214,0.27391,0.31134,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.0047188,0.2739,0.3028,1,1
3,GO REGULATION OF HISTONE METHYLATION,2.8267e-05,0.27379,0.35655,1,1
3,GO PEPTIDE HORMONE SECRETION,1.6059e-05,0.2737,0.33382,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.00096503,0.27363,0.30425,1,1
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0023095,0.27362,0.32036,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00012367,0.27353,0.35949,1,1
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0012071,0.2734,0.32046,1,1
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0018673,0.27328,0.28951,1,1
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.00096503,0.27324,0.34188,1,1
3,GO DORSAL VENTRAL PATTERN FORMATION,0.00020554,0.27273,0.30917,1,1
3,GO POSITIVE REGULATION OF DNA REPAIR,3.248e-05,0.2727,0.31445,1,1
3,GO SPECIFICATION OF SYMMETRY,5.2428e-05,0.27256,0.32037,1,1
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,3.9936e-05,0.27249,0.32572,1,1
3,GO REGULATION OF LYASE ACTIVITY,5.6086e-05,0.27246,0.32751,1,1
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.013235,0.27229,0.22869,1,1
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0010209,0.27226,0.33088,1,1
3,GO HISTONE H4 ACETYLATION,2.636e-05,0.2722,0.32672,1,1
3,GO MYELIN MAINTENANCE,0.015104,0.27207,0.26969,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.00014989,0.27187,0.32153,1,1
3,GO REGULATION OF HEART RATE,0.00051151,0.2717,0.32344,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.00012367,0.27169,0.28916,1,1
3,GO SPINDLE ORGANIZATION,0.0010798,0.27158,0.28154,1,1
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.00028019,0.27127,0.29758,1,1
3,GO REGULATION OF FEEDING BEHAVIOR,0.0016767,0.27117,0.25163,1,1
3,GO RESPONSE TO CATECHOLAMINE,0.00021879,0.27116,0.30014,1,1
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.7287e-05,0.27106,0.3653,1,1
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.045233,0.27091,0.23353,1,1
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00017019,0.27059,0.30938,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0025648,0.2705,0.35118,1,1
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00057531,0.27046,0.28288,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,7.8298e-05,0.27014,0.33982,1,1
3,GO LEFT RIGHT AXIS SPECIFICATION,0.0025648,0.27009,0.28492,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0023095,0.27008,0.24837,1,1
3,GO DOPAMINE METABOLIC PROCESS,0.0054671,0.27008,0.28453,1,1
3,GO SECONDARY HEART FIELD SPECIFICATION,0.0047188,0.27001,0.38326,1,1
3,GO WATER HOMEOSTASIS,0.00332,0.26964,0.282,1,1
3,GO UV PROTECTION,8.3641e-05,0.2696,0.33632,1,1
3,GO CATECHOLAMINE METABOLIC PROCESS,0.0027019,0.26942,0.2852,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0019699,0.26921,0.29129,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00013188,0.26912,0.35449,1,1
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0044907,0.26906,0.25833,1,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0023095,0.26902,0.28193,1,1
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.8997e-05,0.26891,0.36747,1,1
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00018128,0.26819,0.29084,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00035748,0.26806,0.38561,1,1
3,GO REGULATION OF NEURON DIFFERENTIATION,5.6086e-05,0.26806,0.33781,1,1
3,GO EXCRETION,0.00012367,0.26791,0.33603,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0019699,0.26789,0.2795,1,1
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,3.7287e-05,0.26775,0.34934,1,1
3,GO DIOL METABOLIC PROCESS,0.0021907,0.26765,0.26243,1,1
3,GO CHROMOSOME SEPARATION,0.0052065,0.26756,0.2407,1,1
3,GO GROOMING BEHAVIOR,0.0027019,0.26756,0.36012,1,1
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0023095,0.26754,0.36368,1,1
3,GO SEGMENTATION,0.00013188,0.26719,0.28268,1,1
3,GO REGULATION OF CELL SIZE,4.5779e-05,0.26717,0.352,1,1
3,GO NEURON DIFFERENTIATION,2.1347e-05,0.26714,0.33547,1,1
3,GO TOOTH MINERALIZATION,0.0054671,0.2669,0.36764,1,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.052482,0.26678,0.28985,1,1
3,GO CELLULAR RESPONSE TO PH,0.00026348,0.26678,0.28955,1,1
3,GO ALANINE TRANSPORT,0.026142,0.26673,0.25883,1,1
3,GO CIRCADIAN RHYTHM,2.4576e-05,0.26664,0.28489,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.045233,0.26659,0.20513,1,1
3,GO INNER EAR MORPHOGENESIS,0.00014989,0.26655,0.30011,1,1
3,GO SOMITE DEVELOPMENT,6.8565e-05,0.26639,0.30725,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.0013481,0.26629,0.26492,1,1
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.0027019,0.26621,0.31924,1,1
3,GO CHROMATIN ORGANIZATION,4.2763e-05,0.26621,0.3226,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,1.8524e-05,0.26614,0.30137,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.00042807,0.26587,0.28248,1,1
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0040644,0.26568,0.30234,1,1
3,GO PROTEIN O LINKED MANNOSYLATION,0.00023283,0.26562,0.29037,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,7.3279e-05,0.26552,0.34489,1,1
3,GO HISTONE H2A UBIQUITINATION,0.00017019,0.2655,0.31325,1,1
3,GO ESTROUS CYCLE,0.011063,0.26535,0.2718,1,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.019548,0.26475,0.2745,1,1
3,GO PEPTIDYL LYSINE MODIFICATION,3.7287e-05,0.2645,0.29915,1,1
3,GO PEPTIDYL THREONINE MODIFICATION,3.7287e-05,0.26434,0.3265,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.0049572,0.26429,0.33729,1,1
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.00018128,0.26423,0.30074,1,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,3.9936e-05,0.26417,0.31642,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00019306,0.26413,0.33374,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,4.5779e-05,0.26412,0.3171,1,1
3,GO GLUTAMATE METABOLIC PROCESS,3.248e-05,0.26411,0.3092,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.0083971,0.2639,0.26579,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0031545,0.26356,0.33359,1,1
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0036751,0.26335,0.28282,1,1
3,GO CAMERA TYPE EYE DEVELOPMENT,3.4805e-05,0.26335,0.3079,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,2.4576e-05,0.2633,0.32709,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.00096503,0.26325,0.25863,1,1
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00033648,0.26323,0.2951,1,1
3,GO CARNITINE METABOLIC PROCESS,0.00029789,0.26267,0.30003,1,1
3,GO EYE MORPHOGENESIS,0.00021879,0.26253,0.29694,1,1
3,GO PROTEIN MANNOSYLATION,2.8267e-05,0.26232,0.33227,1,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0010209,0.26217,0.30123,1,1
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00029789,0.26216,0.29573,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0031545,0.26216,0.26715,1,1
3,GO CHROMATIN REMODELING,5.9985e-05,0.26194,0.30736,1,1
3,GO INSULIN SECRETION,1.9888e-05,0.26189,0.33596,1,1
3,GO RNA POLYADENYLATION,8.3641e-05,0.2614,0.3148,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,9.5377e-05,0.26118,0.31464,1,1
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0028457,0.26117,0.28984,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00048214,0.26082,0.34418,1,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.0028457,0.26079,0.28864,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.024086,0.26064,0.25386,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00014062,0.26042,0.33376,1,1
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0003797,0.26014,0.34217,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.031957,0.26013,0.20825,1,1
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0016767,0.26007,0.29522,1,1
3,GO MITOCHONDRION LOCALIZATION,0.00021879,0.26005,0.32225,1,1
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.00014062,0.25999,0.32178,1,1
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.00332,0.25975,0.28172,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.00021879,0.25968,0.286,1,1
3,GO SENSORY ORGAN MORPHOGENESIS,0.00015974,0.25966,0.27378,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.0054671,0.25963,0.24981,1,1
3,GO SOMITOGENESIS,0.00010866,0.25913,0.30469,1,1
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0016767,0.25874,0.26819,1,1
3,GO CALCINEURIN MEDIATED SIGNALING,0.00057531,0.25872,0.27434,1,1
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.019548,0.25865,0.26235,1,1
3,GO PARAXIAL MESODERM DEVELOPMENT,0.038848,0.25836,0.18542,1,1
3,GO PROTEIN ACYLATION,2.4576e-05,0.25823,0.30892,1,1
3,GO HETEROCHROMATIN ORGANIZATION,0.00010866,0.25817,0.32597,1,1
3,GO STRIATED MUSCLE CONTRACTION,0.00045436,0.25802,0.31089,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0029965,0.25798,0.2597,1,1
3,GO DICARBOXYLIC ACID TRANSPORT,0.00019306,0.25797,0.32199,1,1
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1.6059e-05,0.25796,0.2891,1,1
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00017019,0.25786,0.34861,1,1
3,GO HISTONE H3 K9 ACETYLATION,0.0018673,0.25764,0.24671,1,1
3,GO REGULATION OF ORGANELLE ASSEMBLY,2.8267e-05,0.25731,0.29841,1,1
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,4.8997e-05,0.25727,0.35027,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.065157,0.25708,0.18334,1,1
3,GO SIALYLATION,0.0057394,0.25682,0.30727,1,1
3,GO REGULATION OF SPINDLE ASSEMBLY,0.0060238,0.25673,0.22464,1,1
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.00017019,0.25658,0.32627,1,1
3,GO NEURONAL ACTION POTENTIAL,0.0020776,0.25644,0.37012,1,1
3,GO SPINDLE ASSEMBLY,0.0017696,0.25644,0.26037,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0010798,0.25615,0.3918,1,1
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00018128,0.25614,0.2905,1,1
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.013834,0.25603,0.29227,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00015974,0.25591,0.32748,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.0011418,0.25581,0.29514,1,1
3,GO REGULATION OF HORMONE SECRETION,4.8997e-05,0.25577,0.29035,1,1
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.040368,0.25567,0.20274,1,1
3,GO NADH METABOLIC PROCESS,0.0012071,0.25551,0.23866,1,1
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,7.8298e-05,0.25541,0.32617,1,1
3,GO REGULATION OF CHROMATIN ORGANIZATION,3.4805e-05,0.25531,0.29647,1,1
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.024086,0.25516,0.21046,1,1
3,GO SPINDLE LOCALIZATION,0.00014062,0.25493,0.29687,1,1
3,GO MEMBRANE BIOGENESIS,0.00072571,0.25489,0.35263,1,1
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.4139e-05,0.25482,0.3124,1,1
3,GO PEPTIDYL LYSINE ACETYLATION,3.4805e-05,0.25464,0.30785,1,1
3,GO REGULATION OF POTASSIUM ION TRANSPORT,8.9327e-05,0.25458,0.34316,1,1
3,GO SENSORY SYSTEM DEVELOPMENT,5.2428e-05,0.25448,0.29872,1,1
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0040644,0.25427,0.23345,1,1
3,GO SPERMATID DIFFERENTIATION,2.2907e-05,0.25406,0.29206,1,1
3,GO MIDGUT DEVELOPMENT,0.0066311,0.25403,0.32441,1,1
3,GO TELOMERE CAPPING,0.00015974,0.25399,0.29469,1,1
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,6.8565e-05,0.2539,0.41564,1,1
3,GO MITOTIC SPINDLE ORGANIZATION,0.0063209,0.25373,0.24387,1,1
3,GO OVULATION CYCLE,0.00045436,0.25373,0.3166,1,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.011574,0.25366,0.26006,1,1
3,GO DEVELOPMENTAL MATURATION,6.8565e-05,0.25354,0.29907,1,1
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012071,0.25343,0.4224,1,1
3,GO NEURAL TUBE DEVELOPMENT,0.00096503,0.25332,0.27592,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,5.9985e-05,0.25322,0.27834,1,1
3,GO REFLEX,0.025096,0.25316,0.29806,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00042807,0.25309,0.28516,1,1
3,GO NEUROGENESIS,2.8267e-05,0.25308,0.31541,1,1
3,GO PHOTORECEPTOR CELL MAINTENANCE,8.9327e-05,0.25308,0.33593,1,1
3,GO POSITIVE REGULATION OF ACROSOME REACTION,0.0014241,0.253,0.27344,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0044907,0.25294,0.22469,1,1
3,GO METHYLATION,3.248e-05,0.2528,0.26657,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00051151,0.25277,0.33202,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0040644,0.25272,0.26894,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.00060992,0.2527,0.28875,1,1
3,GO HEAD DEVELOPMENT,2.2907e-05,0.25269,0.30392,1,1
3,GO RENAL SYSTEM PROCESS,0.0021907,0.25228,0.26988,1,1
3,GO CHLORIDE TRANSPORT,0.00033648,0.25225,0.3161,1,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00017019,0.25225,0.44479,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.027226,0.25217,0.19321,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0038653,0.25208,0.26916,1,1
3,GO PROTEIN ACETYLATION,4.2763e-05,0.25197,0.29525,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00096503,0.25195,0.27891,1,1
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.636e-05,0.25183,0.29251,1,1
3,GO REGULATION OF CHROMOSOME SEPARATION,0.011063,0.25157,0.19972,1,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0049572,0.25149,0.23816,1,1
3,GO SEXUAL REPRODUCTION,8.9843e-06,0.25142,0.28089,1,1
3,GO RESPONSE TO DOPAMINE,6.8565e-05,0.25122,0.30289,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00042807,0.25121,0.27329,1,1
3,GO BIOLOGICAL PHASE,0.033245,0.25085,0.25083,1,1
3,GO PROTEIN DEPOLYMERIZATION,6.4139e-05,0.25065,0.35099,1,1
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,3.0304e-05,0.25051,0.30217,1,1
3,GO REGULATION OF HISTONE MODIFICATION,2.4576e-05,0.25045,0.29374,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.00048214,0.25045,0.27643,1,1
3,GO CARDIAC MUSCLE CONTRACTION,0.00054254,0.25032,0.30366,1,1
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0047188,0.25004,0.23126,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,9.5377e-05,0.24972,0.4003,1,1
3,GO MEIOTIC CELL CYCLE,0.00019306,0.24952,0.28452,1,1
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0036751,0.24932,0.3042,1,1
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.00020554,0.24873,0.30442,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.0034935,0.24865,0.30726,1,1
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.037377,0.24842,0.18645,1,1
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.0036751,0.24824,0.22882,1,1
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0011418,0.2481,0.26099,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00024771,0.24806,0.28798,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0066311,0.248,0.25717,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00072571,0.24782,0.28132,1,1
3,GO PATTERN SPECIFICATION PROCESS,3.248e-05,0.24781,0.28936,1,1
3,GO METHIONINE METABOLIC PROCESS,0.00031664,0.24776,0.29575,1,1
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,8.3641e-05,0.24773,0.28401,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0034935,0.24768,0.24752,1,1
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.01266,0.24742,0.27276,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00014989,0.24736,0.26902,1,1
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0018673,0.24716,0.30945,1,1
3,GO DETECTION OF CALCIUM ION,0.010572,0.24707,0.33554,1,1
3,GO PANCREATIC JUICE SECRETION,0.058535,0.24706,0.21362,1,1
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.01266,0.2466,0.24603,1,1
3,GO SINGLE STRAND BREAK REPAIR,5.2428e-05,0.24652,0.34944,1,1
3,GO MELANOCYTE DIFFERENTIATION,0.00072571,0.24647,0.29617,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.0025648,0.24646,0.28924,1,1
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.022172,0.24628,0.23063,1,1
3,GO PARTURITION,0.0031545,0.24609,0.25982,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.4576e-05,0.2459,0.29739,1,1
3,GO REGULATION OF INSULIN SECRETION,1.8524e-05,0.24589,0.33268,1,1
3,GO AMINO ACID TRANSPORT,7.8298e-05,0.24583,0.29159,1,1
3,GO REGULATION OF MITOPHAGY,0.00010181,0.24529,0.37987,1,1
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.021265,0.24522,0.24007,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014989,0.24503,0.34061,1,1
3,GO ACTIVATION OF MAPKK ACTIVITY,0.00048214,0.24499,0.32639,1,1
3,GO RHYTHMIC PROCESS,1.8524e-05,0.24466,0.28704,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,3.0304e-05,0.24457,0.32489,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.8524e-05,0.24456,0.33761,1,1
3,GO MRNA METHYLATION,0.00057531,0.24438,0.29083,1,1
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00060992,0.24434,0.31542,1,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.00031664,0.24427,0.3371,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0031545,0.24421,0.30356,1,1
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00045436,0.24409,0.27842,1,1
3,GO MULTICELLULAR ORGANISM GROWTH,5.9985e-05,0.24396,0.30856,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.011574,0.24391,0.19117,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.00026348,0.24382,0.28448,1,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0047188,0.24379,0.33838,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.037377,0.24367,0.29238,1,1
3,GO POLYOL CATABOLIC PROCESS,5.9985e-05,0.24363,0.33492,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.008797,0.2436,0.26329,1,1
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.031957,0.24344,0.33494,1,1
3,GO LOCOMOTOR RHYTHM,0.0010209,0.24341,0.4189,1,1
3,GO REGULATION OF DNA REPAIR,5.2428e-05,0.24338,0.29275,1,1
3,GO COGNITION,1.8524e-05,0.24313,0.33521,1,1
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0029965,0.24307,0.31003,1,1
3,GO BODY MORPHOGENESIS,0.016475,0.24304,0.25413,1,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0014241,0.243,0.25013,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.00086166,0.24269,0.26699,1,1
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0010798,0.24267,0.30759,1,1
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.011574,0.24266,0.19732,1,1
3,GO REGULATION OF CYTOKINESIS,0.00019306,0.2423,0.28969,1,1
3,GO REGULATION OF GOLGI ORGANIZATION,0.0047188,0.24212,0.32039,1,1
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.007293,0.24211,0.21814,1,1
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00020554,0.24205,0.33341,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00054254,0.24204,0.24833,1,1
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.062884,0.2419,0.23552,1,1
3,GO MAGNESIUM ION TRANSPORT,0.00057531,0.24186,0.32672,1,1
3,GO OVULATION CYCLE PROCESS,0.00020554,0.24179,0.3297,1,1
3,GO REGIONALIZATION,0.00018128,0.24174,0.26268,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0013481,0.2414,0.27557,1,1
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00018128,0.24134,0.28629,1,1
3,GO MEMBRANE REPOLARIZATION,0.0031545,0.24132,0.33338,1,1
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012106,0.24118,0.28544,1,1
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00060992,0.24116,0.27751,1,1
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.011574,0.24097,0.2308,1,1
3,GO RESPONSE TO MISFOLDED PROTEIN,7.8298e-05,0.24077,0.31572,1,1
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.6086e-05,0.24074,0.30547,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0063209,0.24071,0.18476,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.007293,0.24066,0.23612,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.00060992,0.24065,0.24263,1,1
3,GO REGULATION OF MEMBRANE POTENTIAL,2.8267e-05,0.2406,0.36945,1,1
3,GO HEART FORMATION,0.0027019,0.24058,0.26706,1,1
3,GO ENAMEL MINERALIZATION,0.0023095,0.24045,0.37843,1,1
3,GO RESPONSE TO LIGHT STIMULUS,1.9888e-05,0.24037,0.26991,1,1
3,GO DEMETHYLATION,7.3279e-05,0.24031,0.31096,1,1
3,GO SENSORY ORGAN DEVELOPMENT,8.3641e-05,0.24015,0.28042,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.017954,0.24011,0.22179,1,1
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.037377,0.2401,0.25614,1,1
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,7.8298e-05,0.23979,0.33726,1,1
3,GO DETECTION OF LIGHT STIMULUS,5.2428e-05,0.23974,0.24745,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0076456,0.23971,0.23392,1,1
3,GO HISTONE H3 ACETYLATION,0.00028019,0.23956,0.25814,1,1
3,GO MACROMOLECULE DEACYLATION,2.636e-05,0.23954,0.31272,1,1
3,GO MOTOR NEURON AXON GUIDANCE,0.0054671,0.23941,0.27714,1,1
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0083971,0.23922,0.21625,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00021879,0.2392,0.33757,1,1
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0036751,0.23894,0.25782,1,1
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0029965,0.23893,0.31211,1,1
3,GO CHROMOSOME SEGREGATION,0.0042727,0.23851,0.22556,1,1
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00014989,0.23835,0.3098,1,1
3,GO ENERGY HOMEOSTASIS,0.00012367,0.2383,0.32511,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.00091199,0.2383,0.28255,1,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00010866,0.23827,0.32385,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0042727,0.23821,0.28223,1,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0034935,0.2382,0.23604,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00029789,0.23811,0.36878,1,1
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0010209,0.23805,0.29038,1,1
3,GO NON RECOMBINATIONAL REPAIR,0.00010181,0.23794,0.27156,1,1
3,GO RECEPTOR RECYCLING,0.0025648,0.23777,0.23955,1,1
3,GO GAMETE GENERATION,1.2939e-05,0.2375,0.28301,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00040321,0.2374,0.29855,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00060992,0.23726,0.28665,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00091199,0.23705,0.25463,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00096503,0.2368,0.26591,1,1
3,GO MITOPHAGY,0.00010181,0.2367,0.32011,1,1
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.00020554,0.23663,0.27301,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00064645,0.23661,0.28418,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.067497,0.2362,0.20361,1,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,1.8524e-05,0.2361,0.27064,1,1
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0038653,0.23576,0.28146,1,1
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.065157,0.23558,0.27323,1,1
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0044907,0.2354,0.25626,1,1
3,GO REGULATION OF OOGENESIS,0.0010209,0.23529,0.24378,1,1
3,GO ENDOCARDIUM DEVELOPMENT,0.0096484,0.23519,0.24712,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,0.0015041,0.23508,0.24616,1,1
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00014989,0.23482,0.31809,1,1
3,GO REGULATION OF SYSTEM PROCESS,3.7287e-05,0.23481,0.29926,1,1
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.0021907,0.23441,0.28447,1,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.011063,0.23438,0.22395,1,1
3,GO DENDRITE EXTENSION,0.0028457,0.23438,0.38879,1,1
3,GO MEIOTIC CELL CYCLE PROCESS,0.00057531,0.23434,0.27276,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00060992,0.23415,0.25618,1,1
3,GO AORTA MORPHOGENESIS,0.0172,0.23412,0.28152,1,1
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00020554,0.234,0.33051,1,1
3,GO CELL VOLUME HOMEOSTASIS,0.0038653,0.23359,0.26615,1,1
3,GO HORMONE TRANSPORT,4.2763e-05,0.23354,0.28272,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.014457,0.23327,0.28776,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00054254,0.23323,0.36882,1,1
3,GO REGULATION OF BEHAVIOR,0.00081392,0.23319,0.23604,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0017696,0.23313,0.22434,1,1
3,GO COPULATION,0.030713,0.23296,0.30416,1,1
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.031957,0.23286,0.211,1,1
3,GO AXIS SPECIFICATION,0.00011593,0.23285,0.25038,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.00086166,0.23267,0.25761,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0025648,0.23246,0.25645,1,1
3,GO ALCOHOL CATABOLIC PROCESS,0.0012071,0.23237,0.23152,1,1
3,GO ANIMAL ORGAN FORMATION,0.013235,0.23235,0.19361,1,1
3,GO PROTEIN AUTOUBIQUITINATION,2.2907e-05,0.23231,0.28705,1,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,6.4139e-05,0.23225,0.33177,1,1
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00040321,0.232,0.27444,1,1
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,6.8565e-05,0.23169,0.29109,1,1
3,GO CENTROMERE COMPLEX ASSEMBLY,0.023112,0.2313,0.21885,1,1
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00029789,0.23117,0.28736,1,1
3,GO LIPOPROTEIN LOCALIZATION,0.00332,0.23111,0.3138,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0027019,0.23092,0.28138,1,1
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.00029789,0.23088,0.26704,1,1
3,GO FOCAL ADHESION ASSEMBLY,0.0029965,0.23063,0.3005,1,1
3,GO RESPONSE TO AMINE,0.00018128,0.2306,0.26507,1,1
3,GO VESICLE CYTOSKELETAL TRAFFICKING,9.5377e-05,0.2305,0.33118,1,1
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00028019,0.23037,0.2671,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.018736,0.23035,0.28811,1,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0010209,0.23019,0.32477,1,1
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,7.3279e-05,0.23019,0.28263,1,1
3,GO LACTATION,0.00068502,0.23005,0.26207,1,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,1.8524e-05,0.23004,0.29117,1,1
3,GO DNA PACKAGING,0.00068502,0.22994,0.28543,1,1
3,GO EAR DEVELOPMENT,0.00029789,0.22989,0.26325,1,1
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00040321,0.22975,0.28347,1,1
3,GO PROTEIN KINASE A SIGNALING,0.0010209,0.22967,0.28475,1,1
3,GO HAIR FOLLICLE MATURATION,0.0016767,0.22944,0.28786,1,1
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.0080134,0.22943,0.26414,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00017019,0.2294,0.26068,1,1
3,GO SENSORY PERCEPTION OF SMELL,0.00015974,0.22935,0.24491,1,1
3,GO RESPONSE TO AMPHETAMINE,0.00096503,0.22927,0.26794,1,1
3,GO MRNA 3 END PROCESSING,0.00019306,0.2291,0.26178,1,1
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00010181,0.22886,0.3527,1,1
3,GO NODAL SIGNALING PATHWAY,0.013834,0.22879,0.27087,1,1
3,GO POSITIVE REGULATION OF MITOPHAGY,0.00064645,0.22877,0.37178,1,1
3,GO MANGANESE ION TRANSPORT,0.007293,0.22871,0.21809,1,1
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.00076864,0.22861,0.32011,1,1
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00042807,0.22859,0.27737,1,1
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.00048214,0.22842,0.3214,1,1
3,GO REGULATION OF TOR SIGNALING,4.5779e-05,0.22835,0.28335,1,1
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00081392,0.22817,0.42429,1,1
3,GO MRNA PROCESSING,5.9985e-05,0.22815,0.26241,1,1
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.013834,0.22801,0.2254,1,1
3,GO EAR MORPHOGENESIS,0.00031664,0.22783,0.27278,1,1
3,GO FERTILIZATION,1.4947e-05,0.22776,0.24951,1,1
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00064645,0.2277,0.28832,1,1
3,GO STEROID HORMONE SECRETION,0.056456,0.22764,0.17372,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.3279e-05,0.22746,0.29078,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,0.014457,0.22735,0.22936,1,1
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.010101,0.22718,0.20455,1,1
3,GO ACTIN MEDIATED CELL CONTRACTION,0.0020776,0.22714,0.26271,1,1
3,GO RESPONSE TO PARATHYROID HORMONE,0.0080134,0.22674,0.24268,1,1
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.00072571,0.2267,0.26331,1,1
3,GO MUSCLE CONTRACTION,0.00086166,0.22666,0.26575,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.0029965,0.22663,0.31475,1,1
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,5.2428e-05,0.22658,0.32885,1,1
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00020554,0.22649,0.27927,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,4.8997e-05,0.22644,0.26305,1,1
3,GO CELL DIVISION,0.00051151,0.22641,0.23757,1,1
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,5.6086e-05,0.22612,0.26175,1,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0012071,0.22592,0.24791,1,1
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00042807,0.22573,0.2761,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.030713,0.22563,0.23161,1,1
3,GO REGULATION OF GASTRIC ACID SECRETION,0.046961,0.22556,0.2291,1,1
3,GO SISTER CHROMATID SEGREGATION,0.0066311,0.22554,0.21242,1,1
3,GO REGULATION OF TUBE SIZE,0.0076456,0.22554,0.21099,1,1
3,GO CHROMATIN REMODELING AT CENTROMERE,0.065157,0.22534,0.15558,1,1
3,GO DNA METHYLATION,0.00081392,0.22519,0.241,1,1
3,GO C4 DICARBOXYLATE TRANSPORT,0.0011418,0.22518,0.2444,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.010101,0.22514,0.21879,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.010572,0.22512,0.21232,1,1
3,GO ERYTHROCYTE MATURATION,0.0003797,0.22505,0.36413,1,1
3,GO ORGANELLE ASSEMBLY,1.1191e-05,0.22504,0.28068,1,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00091199,0.22502,0.28999,1,1
3,GO DEVELOPMENTAL GROWTH,7.3279e-05,0.22499,0.28588,1,1
3,GO WALKING BEHAVIOR,0.0172,0.22495,0.24927,1,1
3,GO CONVERGENT EXTENSION,0.028348,0.22494,0.24398,1,1
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0054671,0.22486,0.26684,1,1
3,GO CLATHRIN COAT ASSEMBLY,5.2428e-05,0.22485,0.36819,1,1
3,GO RESPONSE TO LEAD ION,0.00060992,0.22475,0.28497,1,1
3,GO RNA DESTABILIZATION,0.00096503,0.22465,0.29797,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0011418,0.22464,0.26737,1,1
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,7.3279e-05,0.22462,0.30565,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.065157,0.22449,0.21275,1,1
3,GO NERVOUS SYSTEM PROCESS,2.1347e-05,0.22439,0.29893,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00042807,0.22433,0.32131,1,1
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0023095,0.22419,0.34419,1,1
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,6.4139e-05,0.22407,0.27381,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,8.9327e-05,0.22407,0.26626,1,1
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00064645,0.22399,0.32154,1,1
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0025648,0.22396,0.23859,1,1
3,GO REGULATION OF EXOCYTOSIS,0.00028019,0.2238,0.3134,1,1
3,GO RNA SPLICING,8.9327e-05,0.22366,0.24919,1,1
3,GO MALE GAMETE GENERATION,1.6059e-05,0.22359,0.27163,1,1
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.019548,0.22349,0.22493,1,1
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00031664,0.22348,0.25718,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.018736,0.22337,0.21124,1,1
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.011063,0.22315,0.28225,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0040644,0.22287,0.39515,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0021907,0.22275,0.18792,1,1
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.010572,0.22273,0.20125,1,1
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0018673,0.22254,0.32296,1,1
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0172,0.2225,0.21203,1,1
3,GO HEART FIELD SPECIFICATION,0.015104,0.22244,0.26489,1,1
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.025096,0.22232,0.1882,1,1
3,GO FEMALE GAMETE GENERATION,0.00010866,0.2223,0.26069,1,1
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0063209,0.22226,0.24191,1,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.0020776,0.22225,0.33102,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.010101,0.22197,0.30632,1,1
3,GO CHROMOSOME ORGANIZATION,8.9327e-05,0.22194,0.27886,1,1
3,GO KIDNEY MORPHOGENESIS,0.0036751,0.22183,0.2513,1,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00051151,0.22182,0.26316,1,1
3,GO REGULATION OF CELL MATURATION,0.00017019,0.22174,0.23608,1,1
3,GO SKELETAL MUSCLE ADAPTATION,0.0092139,0.22154,0.29031,1,1
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.00012367,0.22149,0.2975,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.00013188,0.22139,0.32933,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0080134,0.22134,0.25075,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,0.00017019,0.22102,0.22822,1,1
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00026348,0.22087,0.2816,1,1
3,GO CELL MORPHOGENESIS,9.5377e-05,0.22072,0.31513,1,1
3,GO REGULATION OF MRNA 3 END PROCESSING,7.3279e-05,0.22054,0.2947,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00010181,0.22037,0.29792,1,1
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.008797,0.22026,0.25251,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0024341,0.22017,0.32489,1,1
3,GO NEURAL NUCLEUS DEVELOPMENT,0.00035748,0.22015,0.31716,1,1
3,GO HISTONE MONOUBIQUITINATION,0.00042807,0.22005,0.29464,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.01266,0.21997,0.20798,1,1
3,GO ORGANELLE LOCALIZATION,2.636e-05,0.21977,0.2737,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.011063,0.21961,0.25495,1,1
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.00332,0.21949,0.28291,1,1
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0042727,0.21913,0.26155,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,6.8565e-05,0.21909,0.28695,1,1
3,GO POLYOL METABOLIC PROCESS,3.0304e-05,0.21909,0.27858,1,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.01266,0.21905,0.27925,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.00033648,0.21898,0.25704,1,1
3,GO ATP TRANSPORT,0.00048214,0.21897,0.23432,1,1
3,GO REGULATION OF DEVELOPMENTAL GROWTH,6.8565e-05,0.21894,0.30458,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,5.9985e-05,0.21893,0.27883,1,1
3,GO FATTY ACID BETA OXIDATION,0.00010181,0.21873,0.2606,1,1
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00023283,0.2187,0.30338,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0038653,0.21866,0.27786,1,1
3,GO CORONARY VASCULATURE DEVELOPMENT,0.006955,0.21865,0.27773,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.00017019,0.2183,0.22091,1,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.9985e-05,0.21813,0.32307,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.034576,0.21782,0.21663,1,1
3,GO CELL MATURATION,0.00031664,0.21778,0.25043,1,1
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00045436,0.21769,0.29677,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,0.00017019,0.21743,0.26025,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0054671,0.21722,0.24433,1,1
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00026348,0.2171,0.30112,1,1
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0025648,0.21696,0.34396,1,1
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0076456,0.21696,0.21419,1,1
3,GO LIPID OXIDATION,0.00028019,0.21682,0.23507,1,1
3,GO REGULATION OF NEURON MATURATION,0.0014241,0.21679,0.30447,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00013188,0.21666,0.24608,1,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.0034935,0.21664,0.20809,1,1
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.00072571,0.2165,0.25359,1,1
3,GO MANNOSYLATION,0.00033648,0.21617,0.23631,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00021879,0.21609,0.21993,1,1
3,GO NEUROBLAST DIVISION,0.00332,0.21609,0.27524,1,1
3,GO OUTFLOW TRACT MORPHOGENESIS,0.024086,0.216,0.206,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00017019,0.21573,0.28481,1,1
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0028457,0.21552,0.26829,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0096484,0.21544,0.19941,1,1
3,GO DETECTION OF ABIOTIC STIMULUS,3.4805e-05,0.21538,0.25771,1,1
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0012758,0.21533,0.25878,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0057394,0.2153,0.28057,1,1
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,4.5779e-05,0.21525,0.2823,1,1
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.00029789,0.21505,0.29986,1,1
3,GO MESENCHYME DEVELOPMENT,0.0063209,0.21504,0.2252,1,1
3,GO CARDIAC CELL DEVELOPMENT,0.0010798,0.21498,0.24761,1,1
3,GO NEPHRON MORPHOGENESIS,0.008797,0.21484,0.22844,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.027226,0.2147,0.20218,1,1
3,GO GANGLION DEVELOPMENT,0.022172,0.21466,0.25449,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00023283,0.21455,0.25501,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.022172,0.21438,0.26794,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00064645,0.21437,0.30295,1,1
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.00012367,0.21427,0.25948,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.065157,0.21422,0.16443,1,1
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,5.9985e-05,0.21417,0.32264,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0010209,0.21405,0.24131,1,1
3,GO MRNA TRANSCRIPTION,0.052482,0.21398,0.2038,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0018673,0.21374,0.23267,1,1
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0060238,0.2137,0.23837,1,1
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0044907,0.21367,0.24166,1,1
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.00013188,0.21316,0.25247,1,1
3,GO CYTOSKELETON ORGANIZATION,5.9985e-05,0.21315,0.27524,1,1
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00012367,0.21311,0.29531,1,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0038653,0.21285,0.25765,1,1
3,GO LIPID DROPLET ORGANIZATION,0.00060992,0.21265,0.22889,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,9.5377e-05,0.2126,0.26195,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00019306,0.21209,0.24464,1,1
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0015041,0.21204,0.26154,1,1
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.00014062,0.21198,0.30174,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.00060992,0.2118,0.21226,1,1
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.056456,0.21173,0.17594,1,1
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.00026348,0.21161,0.24891,1,1
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.026142,0.21159,0.22362,1,1
3,GO REGULATION OF HAIR CYCLE,0.0010798,0.21137,0.28118,1,1
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.025096,0.21118,0.23962,1,1
3,GO VESICLE DOCKING,0.00015974,0.21111,0.3301,1,1
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,2.2907e-05,0.21075,0.28126,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0012758,0.21073,0.28204,1,1
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00026348,0.21072,0.2685,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00028019,0.21064,0.24327,1,1
3,GO COPII COATED VESICLE CARGO LOADING,0.0034935,0.21051,0.27061,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00014989,0.21044,0.26361,1,1
3,GO SECRETORY GRANULE ORGANIZATION,0.0019699,0.21032,0.27157,1,1
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.00023283,0.21012,0.32094,1,1
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0018673,0.21004,0.35081,1,1
3,GO HISTONE H2A ACETYLATION,0.00028019,0.21,0.28506,1,1
3,GO LYMPH VESSEL MORPHOGENESIS,0.023112,0.2099,0.2718,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0034935,0.20967,0.23577,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.3279e-05,0.20954,0.23302,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00332,0.20934,0.29304,1,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.014457,0.20928,0.22067,1,1
3,GO REGULATION OF CELL DIVISION,0.00015974,0.20922,0.23873,1,1
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0047188,0.20908,0.22583,1,1
3,GO PIGMENTATION,0.00028019,0.20889,0.27121,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,5.6086e-05,0.20878,0.22624,1,1
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0012758,0.20842,0.23403,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00045436,0.20835,0.31086,1,1
3,GO DEVELOPMENTAL PIGMENTATION,0.00072571,0.20832,0.26012,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.00076864,0.20796,0.32938,1,1
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0023095,0.20796,0.27521,1,1
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0020776,0.20781,0.26893,1,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00019306,0.2078,0.2234,1,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.00010866,0.2072,0.31464,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.016475,0.20716,0.28466,1,1
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0047188,0.20708,0.27832,1,1
3,GO MIDDLE EAR MORPHOGENESIS,0.023112,0.20707,0.16534,1,1
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,8.9327e-05,0.20706,0.27687,1,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.041938,0.20704,0.23581,1,1
3,GO NOTCH SIGNALING PATHWAY,0.00045436,0.20689,0.26529,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,5.6086e-05,0.20679,0.23792,1,1
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.010101,0.20669,0.1917,1,1
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.00019306,0.20654,0.21959,1,1
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00010181,0.20636,0.33292,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00011593,0.20636,0.26678,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0063209,0.20635,0.24071,1,1
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,3.7287e-05,0.20611,0.22526,1,1
3,GO REGULATION OF CHROMOSOME ORGANIZATION,9.5377e-05,0.20604,0.25959,1,1
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.00045436,0.20598,0.27366,1,1
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,4.8997e-05,0.20593,0.31851,1,1
3,GO CALCIUM ION IMPORT,0.0012758,0.20585,0.30521,1,1
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0021907,0.20579,0.26828,1,1
3,GO CARDIAC SEPTUM DEVELOPMENT,0.01266,0.20578,0.24705,1,1
3,GO INORGANIC ANION TRANSPORT,0.0025648,0.20573,0.24507,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0020776,0.20572,0.22602,1,1
3,GO GASTRIC ACID SECRETION,0.0092139,0.20567,0.2249,1,1
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.040368,0.20567,0.15126,1,1
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00054254,0.20566,0.25878,1,1
3,GO SENSORY PERCEPTION,5.6086e-05,0.20563,0.24762,1,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0042727,0.20561,0.21612,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.0017696,0.20541,0.24401,1,1
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00086166,0.2053,0.26099,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.0003797,0.2052,0.25035,1,1
3,GO PROTEIN SUMOYLATION,0.00010866,0.20511,0.25936,1,1
3,GO NEGATIVE REGULATION OF CELL AGING,0.0025648,0.20509,0.22791,1,1
3,GO REGULATION OF ACROSOME REACTION,0.017954,0.20507,0.19085,1,1
3,GO LYSOSOMAL TRANSPORT,7.3279e-05,0.20495,0.31549,1,1
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00068502,0.20489,0.24618,1,1
3,GO HISTONE H2B UBIQUITINATION,0.0042727,0.20485,0.19861,1,1
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,3.9936e-05,0.20438,0.23167,1,1
3,GO REGULATION OF CELL DEVELOPMENT,9.5377e-05,0.20433,0.27958,1,1
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00018128,0.2043,0.25434,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.00012367,0.2042,0.28279,1,1
3,GO TRANSFERRIN TRANSPORT,0.0044907,0.20416,0.22767,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00021879,0.20403,0.28421,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00031664,0.20379,0.2517,1,1
3,GO MEMBRANE FISSION,0.011063,0.20367,0.26307,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.054439,0.20335,0.22087,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,3.0304e-05,0.20319,0.28911,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0076456,0.20312,0.22502,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00057531,0.20297,0.2542,1,1
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.00076864,0.20287,0.24741,1,1
3,GO CELL CYCLE DNA REPLICATION,0.052482,0.20282,0.17801,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00064645,0.20267,0.22742,1,1
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.008797,0.20254,0.20482,1,1
3,GO LENS FIBER CELL DEVELOPMENT,0.01266,0.20245,0.22773,1,1
3,GO ROOF OF MOUTH DEVELOPMENT,0.0028457,0.20212,0.2536,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.041938,0.20202,0.16529,1,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00042807,0.20191,0.22791,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00029789,0.20176,0.31689,1,1
3,GO RNA 3 END PROCESSING,0.00029789,0.20164,0.22204,1,1
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,5.9985e-05,0.20157,0.23288,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0012071,0.20138,0.24513,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.034576,0.20131,0.26537,1,1
3,GO NEPHRON DEVELOPMENT,0.0044907,0.20116,0.2486,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,0.00010866,0.20106,0.27984,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0015882,0.20103,0.21912,1,1
3,GO REGULATION OF MUSCLE CONTRACTION,0.00081392,0.20089,0.24454,1,1
3,GO MIRNA METABOLIC PROCESS,0.00051151,0.20082,0.27383,1,1
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,4.2763e-05,0.2008,0.26207,1,1
3,GO MULTI ORGANISM PROCESS,1.7249e-05,0.20078,0.24196,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0083971,0.20069,0.2648,1,1
3,GO REGULATION OF HORMONE LEVELS,7.8298e-05,0.20069,0.25367,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.007293,0.20043,0.21001,1,1
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.023112,0.20036,0.17404,1,1
3,GO TOR SIGNALING,5.6086e-05,0.20025,0.26332,1,1
3,GO PEPTIDYL SERINE MODIFICATION,5.6086e-05,0.20015,0.28109,1,1
3,GO GLUCOSE METABOLIC PROCESS,0.00012367,0.20006,0.23571,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.00021879,0.20002,0.24112,1,1
3,GO BILE ACID METABOLIC PROCESS,0.00332,0.19993,0.20628,1,1
3,GO PHOTOTRANSDUCTION,7.3279e-05,0.19977,0.20668,1,1
3,GO ACTIN FILAMENT BASED MOVEMENT,0.0010798,0.19971,0.27668,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0096484,0.1997,0.22385,1,1
3,GO REGULATION OF CATION CHANNEL ACTIVITY,9.5377e-05,0.1991,0.35226,1,1
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.0024341,0.1988,0.23896,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.007293,0.19865,0.20629,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00033648,0.19857,0.25239,1,1
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.0066311,0.1984,0.24522,1,1
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.040368,0.19838,0.20454,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.0066311,0.19835,0.224,1,1
3,GO MRNA CLEAVAGE,0.00045436,0.19811,0.25039,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0080134,0.19802,0.28849,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0063209,0.19793,0.24676,1,1
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.069906,0.19782,0.14178,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,8.9327e-05,0.19774,0.29217,1,1
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00014989,0.19766,0.24944,1,1
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.033245,0.19744,0.27733,1,1
3,GO EMBRYO DEVELOPMENT,0.00018128,0.19717,0.24687,1,1
3,GO MRNA EXPORT FROM NUCLEUS,0.00023283,0.19697,0.25995,1,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0040644,0.19694,0.21337,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00013188,0.19676,0.37512,1,1
3,GO PIGMENT CELL DIFFERENTIATION,0.0012071,0.19674,0.26151,1,1
3,GO AORTA DEVELOPMENT,0.024086,0.19645,0.24484,1,1
3,GO CELLULAR PIGMENTATION,0.0049572,0.19627,0.21255,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00018128,0.19618,0.27464,1,1
3,GO SPHINGOID METABOLIC PROCESS,0.0076456,0.19616,0.26003,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.0003797,0.19613,0.27802,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0015041,0.19595,0.25575,1,1
3,GO DEVELOPMENTAL INDUCTION,0.00332,0.19573,0.22181,1,1
3,GO RESPONSE TO CALCIUM ION,0.0017696,0.19564,0.26921,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,2.8267e-05,0.19555,0.24156,1,1
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0012071,0.19539,0.25028,1,1
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.008797,0.19475,0.22224,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.0057394,0.19473,0.18864,1,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0025648,0.19437,0.28436,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00081392,0.19437,0.30513,1,1
3,GO DNA MODIFICATION,0.00042807,0.19434,0.20951,1,1
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,7.3279e-05,0.19424,0.21695,1,1
3,GO NUCLEAR BODY ORGANIZATION,0.00064645,0.19407,0.26229,1,1
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00026348,0.19405,0.26142,1,1
3,GO PROTEIN TARGETING TO VACUOLE,0.00024771,0.19404,0.27557,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.9985e-05,0.19393,0.21837,1,1
3,GO MUSCLE SYSTEM PROCESS,0.0012071,0.19392,0.24593,1,1
3,GO RESPONSE TO CAFFEINE,0.00048214,0.19377,0.28198,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.045233,0.19352,0.14094,1,1
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00332,0.19344,0.23901,1,1
3,GO REPRODUCTION,3.7287e-05,0.19338,0.23997,1,1
3,GO GLOMERULUS DEVELOPMENT,0.060677,0.19329,0.2404,1,1
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00081392,0.19323,0.26482,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00018128,0.1932,0.24721,1,1
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0076456,0.19302,0.22048,1,1
3,GO STEM CELL PROLIFERATION,0.0011418,0.19301,0.25865,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0028457,0.193,0.25306,1,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.01266,0.19294,0.21104,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00013188,0.19291,0.22124,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.00072571,0.19279,0.29013,1,1
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.018736,0.19265,0.21862,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.00033648,0.19263,0.23053,1,1
3,GO SINGLE FERTILIZATION,1.8524e-05,0.19252,0.24081,1,1
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.00010181,0.19244,0.30035,1,1
3,GO HEART MORPHOGENESIS,0.0025648,0.19233,0.23932,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.00014062,0.19231,0.22022,1,1
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.00013188,0.1923,0.28296,1,1
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00013188,0.19222,0.23099,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.010572,0.1921,0.24037,1,1
3,GO RESPONSE TO AMINO ACID STARVATION,0.00012367,0.19207,0.25161,1,1
3,GO ARTERY DEVELOPMENT,0.025096,0.19194,0.21526,1,1
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.00029789,0.19185,0.23447,1,1
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00057531,0.19176,0.23415,1,1
3,GO ARTERY MORPHOGENESIS,0.037377,0.19175,0.21301,1,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.043559,0.19168,0.25933,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0054671,0.19114,0.34052,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,7.8298e-05,0.19107,0.23091,1,1
3,GO FATTY ACID CATABOLIC PROCESS,6.8565e-05,0.19107,0.25332,1,1
3,GO OXIDATIVE DEMETHYLATION,0.00072571,0.19099,0.34322,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0080134,0.19098,0.25213,1,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.0040644,0.19081,0.20785,1,1
3,GO DNA REPAIR,0.00020554,0.19075,0.24868,1,1
3,GO HORMONE METABOLIC PROCESS,0.0017696,0.19072,0.20396,1,1
3,GO RESPONSE TO REDOX STATE,0.007293,0.1907,0.27979,1,1
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.018736,0.19067,0.27064,1,1
3,GO REGULATION OF PROTEIN ACETYLATION,0.00023283,0.19053,0.24665,1,1
3,GO ANION TRANSPORT,0.00068502,0.19027,0.23187,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.046961,0.19013,0.22247,1,1
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.010572,0.19006,0.20204,1,1
3,GO CELL GROWTH,0.00021879,0.19005,0.26142,1,1
3,GO REGULATION OF ANION TRANSPORT,0.0076456,0.18976,0.20081,1,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0172,0.18968,0.18407,1,1
3,GO EMBRYONIC MORPHOGENESIS,0.00096503,0.18958,0.2391,1,1
3,GO LIMBIC SYSTEM DEVELOPMENT,0.00029789,0.18931,0.25749,1,1
3,GO CELL FATE DETERMINATION,0.018736,0.18929,0.19467,1,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00011593,0.18919,0.28125,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.00023283,0.18898,0.21895,1,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00042807,0.18885,0.213,1,1
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0060238,0.18883,0.26537,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.0028457,0.18878,0.27809,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.010101,0.18874,0.27906,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0063209,0.1887,0.20884,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.025096,0.18854,0.23758,1,1
3,GO EXOCYTIC PROCESS,0.00096503,0.1884,0.30874,1,1
3,GO POSITIVE REGULATION OF GROWTH,0.00081392,0.1884,0.2596,1,1
3,GO GROWTH,0.00020554,0.18824,0.23711,1,1
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.00010181,0.18823,0.32687,1,1
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00040321,0.18764,0.21048,1,1
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00072571,0.18743,0.23018,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.069906,0.1873,0.18275,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00051151,0.18716,0.27821,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,3.7287e-05,0.18709,0.24782,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011063,0.18705,0.18594,1,1
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0019699,0.18697,0.24113,1,1
3,GO ENDOCYTIC RECYCLING,0.00048214,0.18684,0.30785,1,1
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00014062,0.18672,0.26283,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0012758,0.18664,0.20091,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.033245,0.18649,0.15898,1,1
3,GO ESTABLISHMENT OF CELL POLARITY,0.00029789,0.18648,0.27158,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.038848,0.18641,0.20797,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0063209,0.18637,0.27423,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00026348,0.18593,0.23086,1,1
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00011593,0.18589,0.22749,1,1
3,GO NUCLEUS ORGANIZATION,5.2428e-05,0.18575,0.23983,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00045436,0.18562,0.27879,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00057531,0.18561,0.20775,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.0028457,0.18557,0.20183,1,1
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.00054254,0.18555,0.27104,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00035748,0.18545,0.2383,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00019306,0.1852,0.21816,1,1
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.013834,0.18516,0.24951,1,1
3,GO RESPONSE TO RADIATION,7.3279e-05,0.18513,0.21787,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.023112,0.18513,0.17718,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,0.027226,0.18512,0.19093,1,1
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.00064645,0.18489,0.21454,1,1
3,GO ENDOCARDIAL CUSHION FORMATION,0.060677,0.18476,0.17921,1,1
3,GO VESICLE LOCALIZATION,9.5377e-05,0.18455,0.28514,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010572,0.18455,0.23461,1,1
3,GO PHOSPHOLIPID TRANSPORT,0.015104,0.18449,0.20916,1,1
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.0047188,0.18449,0.27417,1,1
3,GO HEART VALVE DEVELOPMENT,0.054439,0.18449,0.22525,1,1
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00017019,0.18447,0.29797,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00076864,0.18417,0.21352,1,1
3,GO TOXIN TRANSPORT,0.0019699,0.18416,0.23854,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.0027019,0.18386,0.25254,1,1
3,GO REGULATION OF CELL MORPHOGENESIS,0.00014989,0.18379,0.29526,1,1
3,GO SMOOTH MUSCLE CONTRACTION,0.0012758,0.18365,0.22413,1,1
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0052065,0.18364,0.20642,1,1
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.007293,0.18358,0.21425,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.00096503,0.18356,0.25536,1,1
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.00020554,0.18354,0.23848,1,1
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0025648,0.18341,0.24647,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.020391,0.18341,0.21556,1,1
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.010572,0.18323,0.18483,1,1
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.010101,0.18307,0.33142,1,1
3,GO METAL ION TRANSPORT,0.00051151,0.18284,0.25678,1,1
3,GO RRNA 3 END PROCESSING,0.010101,0.18278,0.15902,1,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0024341,0.18249,0.24581,1,1
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.00048214,0.18235,0.23359,1,1
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00017019,0.18224,0.22958,1,1
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0013481,0.18223,0.19013,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0027019,0.1822,0.20379,1,1
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.00011593,0.1822,0.23842,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.015104,0.1822,0.20762,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00033648,0.18215,0.22575,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.015104,0.18215,0.25,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.00045436,0.18197,0.20636,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0063209,0.18176,0.2504,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,8.3641e-05,0.18174,0.225,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.9985e-05,0.18167,0.27127,1,1
3,GO STRESS FIBER ASSEMBLY,0.008797,0.18131,0.24661,1,1
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00096503,0.18127,0.22346,1,1
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00086166,0.18123,0.2303,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.038848,0.18109,0.26567,1,1
3,GO ION TRANSPORT,0.00048214,0.18107,0.24539,1,1
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,5.6086e-05,0.18099,0.23117,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0029965,0.18099,0.24565,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.00011593,0.18092,0.22557,1,1
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0012758,0.18084,0.23841,1,1
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0076456,0.18067,0.22217,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.0042727,0.18043,0.23035,1,1
3,GO CELL CELL SIGNALING BY WNT,0.00019306,0.18029,0.23911,1,1
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0060238,0.18022,0.22471,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.013834,0.18021,0.18087,1,1
3,GO PLATELET MORPHOGENESIS,0.028348,0.18009,0.21934,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00012367,0.17969,0.20797,1,1
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.012106,0.17957,0.20937,1,1
3,GO CYTOSOLIC TRANSPORT,5.6086e-05,0.17955,0.30551,1,1
3,GO TRANSMEMBRANE TRANSPORT,0.00024771,0.1795,0.24031,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0172,0.1794,0.2938,1,1
3,GO BASE EXCISION REPAIR,0.00072571,0.17938,0.22413,1,1
3,GO SIGNAL RELEASE,0.00017019,0.17931,0.26727,1,1
3,GO STEROL TRANSPORT,0.0083971,0.17913,0.22608,1,1
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.030713,0.17908,0.20523,1,1
3,GO ERBB SIGNALING PATHWAY,0.015104,0.17907,0.20558,1,1
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00076864,0.17904,0.28925,1,1
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,5.9985e-05,0.179,0.29975,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,7.3279e-05,0.17894,0.25706,1,1
3,GO CELL CELL SIGNALING,7.3279e-05,0.17875,0.27308,1,1
3,GO AMINO ACID IMPORT,0.018736,0.1783,0.18861,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0024341,0.17827,0.16534,1,1
3,GO MITOTIC CYTOKINESIS,0.0024341,0.17822,0.20945,1,1
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.0011418,0.17821,0.23399,1,1
3,GO VIRAL RNA GENOME REPLICATION,0.0080134,0.17792,0.2071,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,0.037377,0.17787,0.20943,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.0096484,0.17782,0.24738,1,1
3,GO MESENCHYME MORPHOGENESIS,0.067497,0.17773,0.18638,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.00042807,0.17769,0.20522,1,1
3,GO LACTATE METABOLIC PROCESS,0.0023095,0.17726,0.19306,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.027226,0.17718,0.27428,1,1
3,GO SULFATE TRANSPORT,0.0063209,0.17712,0.22731,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0031545,0.17711,0.27693,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,9.5377e-05,0.17701,0.23906,1,1
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.010572,0.17682,0.2281,1,1
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00026348,0.17676,0.2783,1,1
3,GO RESPONSE TO STARVATION,0.00012367,0.17676,0.22166,1,1
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0010798,0.17649,0.22961,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.00091199,0.17628,0.23774,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0016767,0.17627,0.23305,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.00051151,0.1762,0.25628,1,1
3,GO RESPONSE TO ISCHEMIA,0.052482,0.17617,0.17814,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.0028457,0.17607,0.20727,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0031545,0.17602,0.24172,1,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.00021879,0.176,0.21238,1,1
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0028457,0.17593,0.19829,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.038848,0.17592,0.16635,1,1
3,GO CRISTAE FORMATION,0.0063209,0.17592,0.1978,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0003797,0.17591,0.28127,1,1
3,GO REGULATION OF PROTEIN BINDING,0.0015041,0.17585,0.22926,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00091199,0.17584,0.20052,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0044907,0.17582,0.22732,1,1
3,GO MODIFIED AMINO ACID TRANSPORT,0.0096484,0.1758,0.23442,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0036751,0.17569,0.25649,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00014989,0.1755,0.28283,1,1
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.012106,0.17546,0.27957,1,1
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.0052065,0.17535,0.22448,1,1
3,GO ORGANIC ACID TRANSPORT,0.0012071,0.17518,0.21945,1,1
3,GO CATION TRANSPORT,0.00028019,0.17517,0.25384,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0012758,0.17512,0.25915,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00021879,0.17506,0.2985,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0044907,0.17505,0.28022,1,1
3,GO GOLGI ORGANIZATION,0.00026348,0.17497,0.28553,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0029965,0.17491,0.29619,1,1
3,GO LIPID PHOSPHORYLATION,0.00076864,0.17471,0.26398,1,1
3,GO CELL CYCLE ARREST,0.00024771,0.1747,0.22244,1,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00051151,0.1747,0.18633,1,1
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00091199,0.17461,0.23437,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.020391,0.17437,0.18701,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.8298e-05,0.17436,0.24933,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00033648,0.17434,0.22979,1,1
3,GO PROSTATE GLAND GROWTH,0.013834,0.17433,0.19778,1,1
3,GO REGULATION OF ORGANELLE ORGANIZATION,5.2428e-05,0.17422,0.24282,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.02951,0.17412,0.18157,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,0.015104,0.17403,0.18861,1,1
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00031664,0.174,0.25654,1,1
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.00024771,0.17396,0.25903,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0040644,0.17386,0.21041,1,1
3,GO NEURON PROJECTION REGENERATION,0.0015882,0.17384,0.29423,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0063209,0.17383,0.19144,1,1
3,GO ORGANIC ANION TRANSPORT,0.0014241,0.17375,0.21453,1,1
3,GO KETONE BODY METABOLIC PROCESS,0.0038653,0.17371,0.18945,1,1
3,GO RRNA TRANSCRIPTION,0.00026348,0.17369,0.23495,1,1
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0003797,0.17367,0.26352,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0029965,0.17358,0.27313,1,1
3,GO POSITIVE REGULATION OF CELL DIVISION,0.0031545,0.17351,0.19278,1,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0049572,0.17344,0.19709,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00054254,0.17344,0.25661,1,1
3,GO ANIMAL ORGAN MORPHOGENESIS,0.0011418,0.17341,0.23141,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.023112,0.1734,0.19876,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.0060238,0.1734,0.27288,1,1
3,GO EPITHELIUM DEVELOPMENT,0.0025648,0.17336,0.20215,1,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.046961,0.17285,0.18569,1,1
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0052065,0.17283,0.22721,1,1
3,GO REGULATION OF MYELINATION,0.030713,0.17271,0.20253,1,1
3,GO REGULATION OF CELLULAR PH,0.0172,0.17271,0.17707,1,1
3,GO REGULATION OF ION TRANSPORT,0.00081392,0.17268,0.2591,1,1
3,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0092139,0.17261,0.19663,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0014241,0.17255,0.25292,1,1
3,GO PERICARDIUM DEVELOPMENT,0.027226,0.17249,0.25658,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00057531,0.17242,0.18926,1,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00086166,0.17232,0.21246,1,1
3,GO ENDOCRINE HORMONE SECRETION,0.010101,0.17229,0.18083,1,1
3,GO ENSHEATHMENT OF NEURONS,0.00086166,0.17223,0.24119,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0034935,0.17217,0.24761,1,1
3,GO REGULATION OF PROTEIN TARGETING,0.00045436,0.17206,0.23353,1,1
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.041938,0.17197,0.16166,1,1
3,GO REGULATION OF PH,0.0096484,0.17188,0.17869,1,1
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00064645,0.17177,0.16727,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.019548,0.17155,0.24688,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0052065,0.17144,0.19125,1,1
3,GO MUSCLE ORGAN DEVELOPMENT,0.0012758,0.17138,0.23447,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.011574,0.17108,0.26855,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0027019,0.17108,0.24014,1,1
3,GO REGULATION OF PROTON TRANSPORT,0.0049572,0.17103,0.19649,1,1
3,GO L AMINO ACID TRANSPORT,0.0076456,0.17069,0.1918,1,1
3,GO SELECTIVE AUTOPHAGY,0.00060992,0.1706,0.25642,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00014989,0.1705,0.26299,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.006955,0.17048,0.16388,1,1
3,GO MOLTING CYCLE,0.0017696,0.17045,0.25762,1,1
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.038848,0.17042,0.19098,1,1
3,GO ERYTHROCYTE DEVELOPMENT,0.0025648,0.17041,0.24257,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.018736,0.17034,0.21302,1,1
3,GO NEURON APOPTOTIC PROCESS,0.00026348,0.17028,0.22717,1,1
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.0042727,0.17021,0.24855,1,1
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0012758,0.1701,0.19931,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0017696,0.16964,0.1976,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0034935,0.16963,0.31875,1,1
3,GO ANIMAL ORGAN MATURATION,0.012106,0.16962,0.25569,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0038653,0.16955,0.23375,1,1
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.00033648,0.16952,0.25585,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.00091199,0.16946,0.21279,1,1
3,GO RESPONSE TO ESTRADIOL,0.0015041,0.16935,0.21851,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,0.00026348,0.16909,0.20498,1,1
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0060238,0.16906,0.23606,1,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.00045436,0.16898,0.17435,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.027226,0.16897,0.22482,1,1
3,GO ENDOSOMAL TRANSPORT,0.00010866,0.16884,0.25565,1,1
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.018736,0.16851,0.24406,1,1
3,GO REGULATION OF BLOOD PRESSURE,0.017954,0.16816,0.19043,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00040321,0.16816,0.27925,1,1
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.006955,0.16816,0.1969,1,1
3,GO MYOFIBRIL ASSEMBLY,0.006955,0.16816,0.2341,1,1
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00011593,0.16804,0.24516,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.01266,0.16801,0.18575,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0029965,0.16755,0.24184,1,1
3,GO RESPONSE TO BMP,0.0080134,0.16746,0.24359,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.0010798,0.16741,0.24846,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0025648,0.16737,0.22678,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.16737,0.25506,1,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0010798,0.1672,0.27129,1,1
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0028457,0.16712,0.23249,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.011063,0.16702,0.19116,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.037377,0.16696,0.22287,1,1
3,GO SKELETAL MUSCLE CONTRACTION,0.0063209,0.16663,0.30661,1,1
3,GO RESPONSE TO PH,0.0066311,0.16654,0.2317,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0011418,0.16652,0.18875,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.00019306,0.16642,0.24475,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.013834,0.16631,0.26218,1,1
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0083971,0.16623,0.22553,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.035953,0.16623,0.19432,1,1
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0096484,0.16609,0.19172,1,1
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.02951,0.16603,0.22517,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.037377,0.16596,0.24929,1,1
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.028348,0.16595,0.2127,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.025096,0.16578,0.18163,1,1
3,GO COENZYME A METABOLIC PROCESS,0.00096503,0.16576,0.19013,1,1
3,GO HEART DEVELOPMENT,0.0012071,0.16575,0.24642,1,1
3,GO PROTEIN TARGETING TO LYSOSOME,0.013235,0.16565,0.23802,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00014989,0.16559,0.23735,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.011063,0.16546,0.263,1,1
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00051151,0.16541,0.30605,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00026348,0.16519,0.23025,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.013834,0.16519,0.21946,1,1
3,GO DETECTION OF MECHANICAL STIMULUS,0.020391,0.16519,0.20683,1,1
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00035748,0.16516,0.20654,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.006955,0.16514,0.18263,1,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.013235,0.16506,0.23808,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.010572,0.16494,0.22165,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.052482,0.16487,0.18807,1,1
3,GO NADP METABOLIC PROCESS,0.0080134,0.16483,0.15527,1,1
3,GO ADAPTIVE THERMOGENESIS,0.013235,0.16477,0.18077,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.028348,0.16477,0.16537,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.037377,0.16467,0.17484,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0040644,0.16465,0.22506,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.015776,0.16463,0.29289,1,1
3,GO RESPONSE TO GROWTH FACTOR,0.0042727,0.1646,0.21904,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.037377,0.16458,0.1894,1,1
3,GO L GLUTAMATE IMPORT,0.020391,0.16457,0.20315,1,1
3,GO MAMMARY GLAND DEVELOPMENT,0.0024341,0.16451,0.2518,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00042807,0.16449,0.18293,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.014457,0.16447,0.23997,1,1
3,GO DEPHOSPHORYLATION,5.9985e-05,0.16446,0.25323,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.00012367,0.16445,0.19591,1,1
3,GO RNA SURVEILLANCE,0.0018673,0.16403,0.169,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0063209,0.16385,0.26351,1,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0060238,0.16383,0.23508,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.0016767,0.1638,0.20053,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00057531,0.16345,0.23246,1,1
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00031664,0.16332,0.21331,1,1
3,GO REGULATION OF GTPASE ACTIVITY,0.0047188,0.16321,0.24851,1,1
3,GO CELL AGGREGATION,0.043559,0.16309,0.23755,1,1
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,6.8565e-05,0.16289,0.19784,1,1
3,GO REGULATION OF URINE VOLUME,0.0172,0.16277,0.24237,1,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0027019,0.1626,0.18794,1,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00064645,0.16245,0.29581,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00091199,0.16239,0.22918,1,1
3,GO PROTEIN DEPHOSPHORYLATION,5.9985e-05,0.16226,0.24089,1,1
3,GO CANONICAL WNT SIGNALING PATHWAY,0.0003797,0.16223,0.23317,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.045233,0.16198,0.23326,1,1
3,GO UTP METABOLIC PROCESS,0.034576,0.16185,0.17683,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.0092139,0.16184,0.19434,1,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.010101,0.16175,0.23756,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.00048214,0.16163,0.19458,1,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.052482,0.16144,0.17072,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,0.00020554,0.1614,0.20272,1,1
3,GO NEURON DEATH,0.00081392,0.16091,0.21938,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.012106,0.16061,0.17551,1,1
3,GO RESPONSE TO CAMP,0.034576,0.16056,0.165,1,1
3,GO REGULATION OF HEART MORPHOGENESIS,0.031957,0.16051,0.21781,1,1
3,GO ODONTOGENESIS,0.043559,0.16049,0.18911,1,1
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0023095,0.16046,0.31593,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0076456,0.16039,0.17023,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.0025648,0.16034,0.24298,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.00033648,0.16028,0.24549,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.0015882,0.16024,0.18248,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0027019,0.16001,0.19927,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0060238,0.16001,0.16972,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.00054254,0.15997,0.18618,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0047188,0.15988,0.19001,1,1
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00086166,0.15983,0.21877,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0031545,0.15981,0.24708,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0076456,0.15971,0.24534,1,1
3,GO BASEMENT MEMBRANE ORGANIZATION,0.062884,0.15967,0.26511,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0018673,0.15963,0.18851,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00029789,0.15948,0.22581,1,1
3,GO AMELOGENESIS,0.021265,0.15935,0.225,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0044907,0.15933,0.20537,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00010181,0.15919,0.24669,1,1
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0076456,0.15917,0.19765,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,2.8267e-05,0.15896,0.19326,1,1
3,GO LIPID MODIFICATION,0.00018128,0.15896,0.2553,1,1
3,GO RESPONSE TO DIETARY EXCESS,0.0096484,0.15893,0.2872,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,2.8267e-05,0.15879,0.21845,1,1
3,GO GOLGI VESICLE TRANSPORT,0.00013188,0.15879,0.24898,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.00028019,0.15878,0.25663,1,1
3,GO CARDIAC CHAMBER DEVELOPMENT,0.0080134,0.15847,0.23012,1,1
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.0052065,0.15846,0.18347,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.006955,0.15841,0.1927,1,1
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.013834,0.15829,0.22369,1,1
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00014062,0.15807,0.19984,1,1
3,GO REGULATION OF GROWTH,0.00054254,0.15782,0.22216,1,1
3,GO TUBE DEVELOPMENT,0.058535,0.15772,0.18363,1,1
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.00060992,0.1576,0.16471,1,1
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00035748,0.15759,0.27531,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00068502,0.15746,0.18086,1,1
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.0038653,0.15741,0.22324,1,1
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.00091199,0.15738,0.19536,1,1
3,GO SENSORY PERCEPTION OF PAIN,0.0066311,0.15725,0.19278,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0015882,0.15725,0.17152,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0044907,0.15714,0.27687,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0010798,0.15693,0.23443,1,1
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0049572,0.15683,0.23466,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0083971,0.15671,0.20148,1,1
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,9.5377e-05,0.15662,0.25733,1,1
3,GO REGULATION OF CELLULAR LOCALIZATION,0.00029789,0.15656,0.23741,1,1
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.038848,0.15649,0.18985,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0003797,0.15618,0.26712,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.011574,0.15618,0.20533,1,1
3,GO ANION HOMEOSTASIS,0.0049572,0.15606,0.22218,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.0015041,0.15606,0.20167,1,1
3,GO RESPONSE TO AXON INJURY,0.0023095,0.15593,0.24504,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,0.0029965,0.15587,0.21174,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00081392,0.15572,0.21962,1,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.056456,0.1557,0.25384,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.013834,0.15548,0.24953,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.00072571,0.1553,0.23585,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.00031664,0.15524,0.20467,1,1
3,GO RESPONSE TO STEROID HORMONE,0.0092139,0.15517,0.19737,1,1
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.015776,0.15515,0.1875,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00086166,0.15507,0.16769,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02951,0.15451,0.2046,1,1
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.00051151,0.15451,0.22223,1,1
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.00021879,0.15431,0.23873,1,1
3,GO LIPID LOCALIZATION,0.019548,0.15427,0.1814,1,1
3,GO MUSCLE CELL DEVELOPMENT,0.00045436,0.15406,0.2439,1,1
3,GO RHYTHMIC BEHAVIOR,0.0052065,0.15406,0.20944,1,1
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.013235,0.15396,0.18308,1,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0172,0.1538,0.18208,1,1
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00017019,0.15378,0.23934,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.0023095,0.15364,0.25445,1,1
3,GO CELLULAR RESPONSE TO STARVATION,6.8565e-05,0.15358,0.23399,1,1
3,GO GLYCOSYLATION,0.0015041,0.15353,0.21376,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0023095,0.15335,0.20496,1,1
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.00017019,0.15335,0.23023,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.021265,0.15332,0.19348,1,1
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00015974,0.15326,0.21889,1,1
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.007293,0.15306,0.21663,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.0060238,0.15303,0.16892,1,1
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0014241,0.15291,0.24323,1,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0013481,0.15289,0.21921,1,1
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00023283,0.15288,0.21435,1,1
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0083971,0.15288,0.28762,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00024771,0.1528,0.27539,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0047188,0.15261,0.25341,1,1
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.00010181,0.1519,0.18925,1,1
3,GO GLIAL CELL DIFFERENTIATION,0.007293,0.15167,0.20354,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.00024771,0.15147,0.20149,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.00023283,0.15146,0.20708,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.041938,0.15136,0.1684,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00068502,0.15125,0.19535,1,1
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00020554,0.15111,0.23149,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.033245,0.15099,0.23,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.060677,0.15093,0.20798,1,1
3,GO TISSUE MORPHOGENESIS,0.0054671,0.15086,0.20534,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.056456,0.15079,0.15385,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00081392,0.15069,0.19761,1,1
3,GO MUSCLE HYPERTROPHY,0.008797,0.15044,0.22023,1,1
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.023112,0.15043,0.15829,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0052065,0.15036,0.20207,1,1
3,GO NEGATIVE REGULATION OF GROWTH,0.010572,0.15033,0.18241,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.0052065,0.15029,0.17881,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.0096484,0.1501,0.25547,1,1
3,GO EMBRYONIC EYE MORPHOGENESIS,0.011574,0.15005,0.2521,1,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00012367,0.15001,0.22475,1,1
3,GO ERBB2 SIGNALING PATHWAY,0.010101,0.1499,0.23025,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.0063209,0.14985,0.16074,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.027226,0.14977,0.21469,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0015041,0.14963,0.20372,1,1
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.011574,0.14959,0.20483,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.030713,0.14946,0.17805,1,1
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0060238,0.14935,0.17874,1,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0015882,0.14924,0.21639,1,1
3,GO REGULATION OF FERTILIZATION,0.028348,0.14896,0.1495,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.034576,0.14872,0.15254,1,1
3,GO REGULATION OF HEART GROWTH,0.043559,0.14855,0.15188,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.018736,0.1485,0.1939,1,1
3,GO RESPONSE TO WATER,0.021265,0.1483,0.18065,1,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.050584,0.14822,0.18917,1,1
3,GO MESODERM DEVELOPMENT,0.008797,0.14802,0.18271,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.00048214,0.14798,0.21332,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0031545,0.14781,0.215,1,1
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0003797,0.14776,0.20022,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0047188,0.14748,0.16064,1,1
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.00021879,0.14746,0.21241,1,1
3,GO PROTEIN POLYMERIZATION,0.00031664,0.14744,0.23937,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.038848,0.14723,0.17733,1,1
3,GO SNRNA PROCESSING,0.006955,0.14716,0.13357,1,1
3,GO INTRACELLULAR TRANSPORT,3.7287e-05,0.14699,0.20413,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.028348,0.14692,0.1752,1,1
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.0054671,0.14689,0.20425,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00086166,0.14676,0.21579,1,1
3,GO RECEPTOR INTERNALIZATION,0.006955,0.14667,0.22882,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.052482,0.14667,0.14632,1,1
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0066311,0.14663,0.21283,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0044907,0.14643,0.22045,1,1
3,GO RESPONSE TO INSULIN,0.00026348,0.14627,0.21997,1,1
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0172,0.1457,0.18074,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0028457,0.1457,0.21895,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.012106,0.14556,0.1801,1,1
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.048745,0.14541,0.20135,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.0057394,0.14535,0.19676,1,1
3,GO MUSCLE CELL DIFFERENTIATION,0.0019699,0.1453,0.23077,1,1
3,GO MUSCLE TISSUE DEVELOPMENT,0.0024341,0.14516,0.2213,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.018736,0.14465,0.21742,1,1
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.054439,0.14463,0.16886,1,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.007293,0.14437,0.16454,1,1
3,GO REGULATION OF CELL DIFFERENTIATION,0.0025648,0.14435,0.21155,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0080134,0.14425,0.2514,1,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00068502,0.14406,0.20177,1,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.054439,0.14403,0.19836,1,1
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00015974,0.14399,0.27222,1,1
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.0057394,0.14385,0.16154,1,1
3,GO REGULATION OF GENE SILENCING,0.0023095,0.14385,0.19032,1,1
3,GO REGULATION OF CATABOLIC PROCESS,0.00064645,0.14372,0.19135,1,1
3,GO MIDBRAIN DEVELOPMENT,0.0010209,0.14356,0.19994,1,1
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.006955,0.14305,0.24456,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0013481,0.14291,0.18626,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0092139,0.1429,0.16988,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0027019,0.14255,0.19522,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.060677,0.14247,0.15359,1,1
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.010101,0.14217,0.20127,1,1
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0023095,0.14209,0.19336,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00332,0.14181,0.22714,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00076864,0.14175,0.22325,1,1
3,GO VESICLE CARGO LOADING,0.023112,0.14174,0.21995,1,1
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0019699,0.14143,0.22925,1,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00054254,0.14139,0.21982,1,1
3,GO STEM CELL DIFFERENTIATION,0.011574,0.14126,0.17501,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0042727,0.14124,0.15373,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.040368,0.14107,0.14726,1,1
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.00081392,0.14106,0.22361,1,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.022172,0.14093,0.20142,1,1
3,GO RESPONSE TO HORMONE,0.0063209,0.14083,0.1938,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,0.011574,0.14061,0.19953,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0024341,0.14059,0.19084,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.050584,0.14037,0.1216,1,1
3,GO INCLUSION BODY ASSEMBLY,0.026142,0.14025,0.22173,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.00017019,0.1402,0.17529,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.011574,0.14003,0.19594,1,1
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0044907,0.13992,0.22537,1,1
3,GO REGULATION OF TRANSPORT,0.0013481,0.13974,0.2244,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013235,0.13974,0.24407,1,1
3,GO DIGESTION,0.031957,0.13966,0.15094,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.016475,0.13961,0.2155,1,1
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0060238,0.13947,0.23172,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.015104,0.13943,0.19288,1,1
3,GO RESPONSE TO DRUG,0.012106,0.13921,0.16552,1,1
3,GO REGULATION OF ORGAN GROWTH,0.011574,0.13903,0.18809,1,1
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0021907,0.13891,0.1874,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00332,0.13883,0.1502,1,1
3,GO CARBOHYDRATE TRANSPORT,0.021265,0.13878,0.1749,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0025648,0.1387,0.2679,1,1
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.038848,0.13867,0.20037,1,1
3,GO PROTEIN IMPORT,0.0015882,0.13866,0.17196,1,1
3,GO FIBROBLAST MIGRATION,0.02951,0.13843,0.194,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00072571,0.13836,0.22453,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0044907,0.13821,0.18223,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.026142,0.13812,0.202,1,1
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.010572,0.13811,0.2046,1,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.030713,0.13807,0.20211,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.017954,0.13804,0.18355,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0012758,0.13801,0.14792,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.052482,0.13801,0.18815,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0016767,0.13788,0.21446,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.034576,0.13782,0.25109,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0083971,0.13773,0.14736,1,1
3,GO POSITIVE REGULATION OF HEART RATE,0.062884,0.13772,0.16876,1,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.0014241,0.13771,0.26312,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0057394,0.13767,0.19121,1,1
3,GO TRANSLESION SYNTHESIS,0.020391,0.13746,0.13331,1,1
3,GO FILOPODIUM ASSEMBLY,0.045233,0.13736,0.19398,1,1
3,GO HEART GROWTH,0.011574,0.137,0.19189,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.0080134,0.13691,0.20799,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0049572,0.13688,0.26439,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.022172,0.13643,0.26875,1,1
3,GO ORGANELLE DISASSEMBLY,0.0003797,0.13639,0.22165,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0010209,0.13624,0.20216,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.0092139,0.13621,0.19513,1,1
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0047188,0.136,0.22067,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0024341,0.13599,0.23956,1,1
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0080134,0.13599,0.15662,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.0083971,0.13579,0.17631,1,1
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.00033648,0.13579,0.23125,1,1
3,GO RESPONSE TO METAL ION,0.0092139,0.13562,0.1742,1,1
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.069906,0.13558,0.21861,1,1
3,GO PROTEIN CATABOLIC PROCESS,0.00020554,0.1355,0.19673,1,1
3,GO NEGATIVE REGULATION OF BINDING,0.0024341,0.13517,0.19672,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.015776,0.13507,0.21256,1,1
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0024341,0.13486,0.19667,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0042727,0.13477,0.17191,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00096503,0.13441,0.18437,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.0010209,0.13437,0.2145,1,1
3,GO RESPONSE TO PEPTIDE,0.0042727,0.13435,0.19558,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0021907,0.13434,0.18668,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.056456,0.13413,0.14055,1,1
3,GO REGULATION OF SECRETION,0.0021907,0.13401,0.22059,1,1
3,GO CHEMICAL HOMEOSTASIS,0.016475,0.13389,0.17585,1,1
3,GO REGULATION OF SENSORY PERCEPTION,0.023112,0.13383,0.1974,1,1
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0092139,0.13381,0.21956,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,0.00021879,0.13373,0.20625,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0080134,0.13372,0.21593,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.00020554,0.13358,0.18351,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00051151,0.13351,0.21885,1,1
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.0080134,0.13347,0.19423,1,1
3,GO PEPTIDE SECRETION,0.0066311,0.13345,0.1966,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0172,0.13336,0.1741,1,1
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0013481,0.13334,0.15474,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.026142,0.13326,0.19683,1,1
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.010101,0.13312,0.21226,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00051151,0.13311,0.17701,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0040644,0.13309,0.17476,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.035953,0.13291,0.16443,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0076456,0.13284,0.1465,1,1
3,GO REGULATION OF ATPASE ACTIVITY,0.00048214,0.13278,0.168,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.0015041,0.13269,0.22312,1,1
3,GO QUINONE METABOLIC PROCESS,0.0040644,0.13251,0.18705,1,1
3,GO REGULATION OF BINDING,0.0015882,0.1323,0.19465,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0060238,0.13228,0.17554,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0040644,0.13224,0.23194,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00017019,0.13216,0.24325,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00035748,0.13205,0.21051,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0027019,0.13203,0.1824,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.034576,0.13202,0.18128,1,1
3,GO RECEPTOR METABOLIC PROCESS,0.0080134,0.13188,0.20348,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0031545,0.13181,0.19342,1,1
3,GO PROTEIN TETRAMERIZATION,0.0019699,0.13167,0.18957,1,1
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0096484,0.13161,0.22728,1,1
3,GO REGULATION OF FIBROBLAST MIGRATION,0.023112,0.13133,0.20428,1,1
3,GO LIPID CATABOLIC PROCESS,0.021265,0.13133,0.15894,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.021265,0.13126,0.19531,1,1
3,GO PROTEIN STABILIZATION,0.00015974,0.13073,0.18232,1,1
3,GO REGULATION OF ENDOCYTOSIS,0.020391,0.1306,0.21479,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0044907,0.13054,0.1852,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00014062,0.13045,0.23236,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00060992,0.13013,0.17801,1,1
3,GO VESICLE TARGETING,0.00096503,0.1299,0.2263,1,1
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,4.8997e-05,0.12984,0.19074,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.0020776,0.12975,0.16141,1,1
3,GO INTRACELLULAR PROTEIN TRANSPORT,4.8997e-05,0.12964,0.18216,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00072571,0.12958,0.19548,1,1
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00076864,0.12958,0.18761,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.025096,0.12945,0.19611,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0010209,0.12945,0.18444,1,1
3,GO SARCOMERE ORGANIZATION,0.014457,0.12895,0.169,1,1
3,GO MUSCLE ADAPTATION,0.034576,0.12892,0.18219,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00060992,0.12859,0.20446,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00064645,0.12855,0.17883,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.034576,0.12848,0.20279,1,1
3,GO PROTEIN LOCALIZATION TO MEMBRANE,5.9985e-05,0.12843,0.17839,1,1
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.013235,0.12833,0.21323,1,1
3,GO FAT CELL DIFFERENTIATION,0.028348,0.1283,0.18256,1,1
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0015041,0.12825,0.17578,1,1
3,GO UBIQUINONE METABOLIC PROCESS,0.0018673,0.12821,0.15499,1,1
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.058535,0.12801,0.18617,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.024086,0.12791,0.17665,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.026142,0.12775,0.13661,1,1
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.043559,0.12771,0.11553,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.0080134,0.12763,0.12429,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.0015882,0.12735,0.16583,1,1
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.00010866,0.12723,0.19319,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.00031664,0.12723,0.18271,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.01266,0.12712,0.19039,1,1
3,GO INTERMEMBRANE LIPID TRANSFER,0.013834,0.12694,0.20991,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0028457,0.12675,0.15441,1,1
3,GO AMYLOID BETA FORMATION,0.017954,0.12658,0.20824,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0044907,0.12625,0.18814,1,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.014457,0.12603,0.1926,1,1
3,GO INTRACELLULAR MRNA LOCALIZATION,0.011574,0.12594,0.19487,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.060677,0.12547,0.16539,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.007293,0.12532,0.14926,1,1
3,GO LIPID METABOLIC PROCESS,0.0060238,0.12526,0.17689,1,1
3,GO RESPONSE TO LEPTIN,0.045233,0.12513,0.20906,1,1
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.00029789,0.12506,0.24042,1,1
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.0014241,0.12495,0.1508,1,1
3,GO MEMBRANE ORGANIZATION,0.0012071,0.12486,0.20861,1,1
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0057394,0.12475,0.1843,1,1
3,GO HOMEOSTATIC PROCESS,0.010101,0.12469,0.16795,1,1
3,GO BLASTODERM SEGMENTATION,0.038848,0.12469,0.1884,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00068502,0.12459,0.15951,1,1
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.043559,0.12434,0.14573,1,1
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.043559,0.12426,0.24938,1,1
3,GO MESODERM MORPHOGENESIS,0.034576,0.12423,0.17242,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0060238,0.12409,0.15884,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.048745,0.12405,0.18895,1,1
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.01266,0.12398,0.20589,1,1
3,GO REGULATION OF PROTEIN IMPORT,0.020391,0.12391,0.1608,1,1
3,GO PROGESTERONE METABOLIC PROCESS,0.062884,0.12374,0.23366,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0028457,0.12371,0.21541,1,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.0023095,0.12361,0.20889,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.013235,0.12359,0.22409,1,1
3,GO POSITIVE REGULATION OF BINDING,0.0049572,0.12358,0.16766,1,1
3,GO DETECTION OF STIMULUS,0.0016767,0.12329,0.16777,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00011593,0.12292,0.17131,1,1
3,GO RNA CAPPING,0.0021907,0.12291,0.14122,1,1
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.02951,0.1229,0.13848,1,1
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.00332,0.1229,0.14127,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.026142,0.12278,0.20712,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.020391,0.1227,0.154,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0083971,0.12266,0.20091,1,1
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.007293,0.12242,0.22725,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.0015882,0.1222,0.18153,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.013834,0.12217,0.21295,1,1
3,GO MACROMOLECULE CATABOLIC PROCESS,0.00076864,0.12216,0.15808,1,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0014241,0.12211,0.12772,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015776,0.12198,0.18882,1,1
3,GO SKELETAL SYSTEM DEVELOPMENT,0.019548,0.12173,0.19121,1,1
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.023112,0.12164,0.14757,1,1
3,GO ION HOMEOSTASIS,0.040368,0.12159,0.16058,1,1
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0019699,0.12149,0.20479,1,1
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0052065,0.12141,0.19922,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.016475,0.12136,0.1832,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.006955,0.1213,0.14946,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0042727,0.12119,0.19552,1,1
3,GO THIOESTER METABOLIC PROCESS,0.0021907,0.12086,0.15202,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.013834,0.12083,0.20771,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.02951,0.12081,0.19851,1,1
3,GO SPLEEN DEVELOPMENT,0.0080134,0.12033,0.21923,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.043559,0.12022,0.19232,1,1
3,GO MITOCHONDRIAL FUSION,0.00332,0.12002,0.18442,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0040644,0.11982,0.14611,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.052482,0.1198,0.17547,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.00033648,0.11973,0.13717,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.062884,0.1196,0.1246,1,1
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.031957,0.11904,0.15143,1,1
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.012106,0.11898,0.20672,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.00042807,0.11898,0.20679,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.015104,0.11886,0.17266,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.0020776,0.11884,0.19816,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0049572,0.1188,0.20117,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.017954,0.11871,0.16676,1,1
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014457,0.11848,0.2952,1,1
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.046961,0.11845,0.17797,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034935,0.1184,0.19052,1,1
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.050584,0.11805,0.15898,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,0.0063209,0.11761,0.19153,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.050584,0.1173,0.18561,1,1
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0027019,0.11717,0.17102,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.018736,0.11704,0.16933,1,1
3,GO REGULATION OF ERAD PATHWAY,0.015776,0.11678,0.1614,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.018736,0.11675,0.15547,1,1
3,GO LAMELLIPODIUM ORGANIZATION,0.035953,0.1166,0.18439,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.01266,0.11631,0.19693,1,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.048745,0.11629,0.17545,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.0020776,0.11628,0.16555,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.021265,0.11606,0.22979,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.0031545,0.11553,0.17296,1,1
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.060677,0.11547,0.14541,1,1
3,GO CELLULAR HOMEOSTASIS,0.025096,0.11546,0.15382,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0047188,0.11535,0.20066,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.006955,0.11489,0.18879,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.012106,0.11486,0.17241,1,1
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0052065,0.11483,0.20812,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.017954,0.11477,0.18309,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0016767,0.11473,0.16176,1,1
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,3.9936e-05,0.11462,0.18805,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0076456,0.11445,0.16017,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0029965,0.11429,0.17168,1,1
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.024086,0.11426,0.23287,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.0038653,0.11407,0.18879,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.011574,0.11378,0.17443,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.030713,0.11378,0.20155,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011063,0.11373,0.1609,1,1
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.019548,0.1137,0.12775,1,1
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.012106,0.11348,0.21199,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.062884,0.11337,0.1896,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.030713,0.1133,0.15399,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.034576,0.11315,0.16869,1,1
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.014457,0.11303,0.17633,1,1
3,GO ORGAN GROWTH,0.011574,0.11297,0.20346,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.007293,0.11291,0.1831,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.00021879,0.11283,0.13662,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.020391,0.11267,0.15818,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.045233,0.11258,0.15246,1,1
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0038653,0.11251,0.19642,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0080134,0.11238,0.18998,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.015104,0.11195,0.16892,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.021265,0.11184,0.17866,1,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.025096,0.11178,0.20006,1,1
3,GO STEROID METABOLIC PROCESS,0.012106,0.11101,0.16088,1,1
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0042727,0.111,0.16351,1,1
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.045233,0.11084,0.17454,1,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.016475,0.1105,0.2028,1,1
3,GO PH REDUCTION,0.062884,0.11049,0.13233,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.0057394,0.11044,0.16739,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0031545,0.11034,0.16987,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0172,0.11012,0.18502,1,1
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.027226,0.11005,0.1832,1,1
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.013235,0.11001,0.16091,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.060677,0.10952,0.10557,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.018736,0.10944,0.15295,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.015104,0.10944,0.18992,1,1
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.020391,0.10929,0.15484,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.016475,0.10913,0.14918,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.010572,0.10895,0.1953,1,1
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.00068502,0.1089,0.17743,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.010101,0.10868,0.20624,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.023112,0.10864,0.15425,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.0040644,0.10838,0.14614,1,1
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.020391,0.10816,0.15818,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00086166,0.10799,0.18026,1,1
3,GO COPII COATED VESICLE BUDDING,0.0024341,0.10769,0.21064,1,1
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.046961,0.10751,0.11955,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.025096,0.10732,0.19197,1,1
3,GO ENDOSOME ORGANIZATION,0.0012071,0.10715,0.18174,1,1
3,GO GOLGI VESICLE BUDDING,0.0021907,0.10657,0.21237,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.015104,0.10629,0.29493,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.0042727,0.10623,0.17217,1,1
3,GO PEROXISOME ORGANIZATION,0.0018673,0.10586,0.17071,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.045233,0.10579,0.1669,1,1
3,GO PIGMENT METABOLIC PROCESS,0.0060238,0.10543,0.13618,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.010572,0.10535,0.15279,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00057531,0.10534,0.12638,1,1
3,GO OXIDATION REDUCTION PROCESS,0.0017696,0.10504,0.14654,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.069906,0.10502,0.1601,1,1
3,GO PROTEOLYSIS,0.0172,0.10492,0.16267,1,1
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.011574,0.1049,0.19515,1,1
3,GO ATP METABOLIC PROCESS,0.00068502,0.10483,0.12391,1,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0080134,0.10475,0.14419,1,1
3,GO RESPONSE TO HEAT,0.0066311,0.10474,0.14638,1,1
3,GO CARDIOCYTE DIFFERENTIATION,0.010572,0.1045,0.20857,1,1
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.065157,0.10401,0.18542,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.058535,0.10397,0.13577,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.058535,0.10384,0.12922,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.015776,0.10383,0.14778,1,1
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0027019,0.10379,0.12417,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,0.0042727,0.10373,0.19005,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.025096,0.10325,0.17068,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0034935,0.10324,0.13429,1,1
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0025648,0.10319,0.15964,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.011063,0.103,0.16319,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0023095,0.10279,0.20299,1,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00096503,0.10276,0.15381,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038653,0.10271,0.19769,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.027226,0.10242,0.17017,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.067497,0.10228,0.074527,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.031957,0.10221,0.15502,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.015776,0.10185,0.15808,1,1
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.011063,0.10156,0.17918,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.069906,0.10154,0.087614,1,1
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015776,0.10095,0.1784,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.02951,0.1003,0.16206,1,1
3,GO PROTEIN DESTABILIZATION,0.0047188,0.10016,0.17491,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.013235,0.10007,0.14459,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.0049572,0.099852,0.16156,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION,0.0054671,0.099642,0.15908,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0080134,0.099606,0.20205,1,1
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.056456,0.099418,0.22255,1,1
3,GO MITOCHONDRION ORGANIZATION,0.00026348,0.099157,0.13836,1,1
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.043559,0.098943,0.1579,1,1
3,GO AMINO ACID ACTIVATION,0.038848,0.09838,0.10455,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.043559,0.097356,0.11088,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.024086,0.096583,0.14341,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0038653,0.096411,0.21292,1,1
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.019548,0.096115,0.20631,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0049572,0.095549,0.14858,1,1
3,GO REGENERATION,0.069906,0.095199,0.14755,1,1
3,GO PEROXISOMAL TRANSPORT,0.0027019,0.095132,0.15122,1,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.016475,0.095073,0.16446,1,1
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.013834,0.094603,0.21062,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.043559,0.094585,0.15227,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0013481,0.094578,0.12636,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.018736,0.094469,0.17231,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.011063,0.094445,0.1745,1,1
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0028457,0.093578,0.15934,1,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00076864,0.092994,0.18585,1,1
3,GO SPERM EGG RECOGNITION,0.065157,0.092903,0.091793,1,1
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0054671,0.09186,0.16901,1,1
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.054439,0.091482,0.091917,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0014241,0.091126,0.13059,1,1
3,GO PROTEIN FOLDING,0.00072571,0.090911,0.14447,1,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.019548,0.090764,0.11484,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.020391,0.090707,0.18171,1,1
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.033245,0.089879,0.12142,1,1
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.018736,0.089842,0.12823,1,1
3,GO HORMONE BIOSYNTHETIC PROCESS,0.0034935,0.089721,0.18104,1,1
3,GO MITOCHONDRIAL FISSION,0.0080134,0.08941,0.17718,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0040644,0.086836,0.12886,1,1
3,GO MITOCHONDRION MORPHOGENESIS,0.0063209,0.085508,0.16289,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.040368,0.085123,0.13576,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0047188,0.08456,0.13165,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.017954,0.084342,0.13586,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0057394,0.083954,0.18647,1,1
3,GO AGING,0.034576,0.082502,0.15235,1,1
3,GO CERAMIDE METABOLIC PROCESS,0.01266,0.081594,0.18997,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037377,0.081393,0.13735,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.048745,0.076335,0.12843,1,1
3,GO APOPTOTIC PROCESS,0.058535,0.076048,0.13879,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.018736,0.075168,0.077623,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.050584,0.072972,0.13757,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.035953,0.071534,0.10167,1,1
3,GO TRANSITION METAL ION TRANSPORT,0.043559,0.069825,0.13532,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.013834,0.065857,0.075588,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.028348,0.064478,0.11921,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.043559,0.064184,0.096495,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.0029965,0.063668,0.096571,1,1
3,GO CELLULAR RESPIRATION,0.034576,0.058135,0.061746,1,1
3,GO PROTEIN TARGETING,0.0040644,0.058049,0.075475,1,1
